<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="review-article" dtd-version="1.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Infect. Microbiol.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcimb.2026.1757662</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Modulation of macrophage survival during <italic>Klebsiella pneumoniae</italic> infections</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>N.</surname><given-names>Nithya</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2862405/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Ali</surname><given-names>Anjoom Mohamed</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/3385520/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
</contrib>
<contrib contrib-type="author">
<name><surname>K. P.</surname><given-names>Sruthi</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/3388728/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Mehto</surname><given-names>Subhash</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/3034578/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Antony</surname><given-names>Cecil</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>*</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2862415/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project-administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label><institution>Infection Immunology Lab, National Institute of Technology Calicut, Department of Bioscience and Bioengineering</institution>, <city>Kozhikode</city>,&#xa0;<country country="in">India</country></aff>
<aff id="aff2"><label>2</label><institution>Immuno Biology Lab, Indian Institute of Technology</institution>, <city>Dharwad</city>,&#xa0;<country country="in">India</country></aff>
<author-notes>
<corresp id="c001"><label>*</label>Correspondence: Cecil Antony, <email xlink:href="mailto:cecil@nitc.ac.in">cecil@nitc.ac.in</email></corresp>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-02-25">
<day>25</day>
<month>02</month>
<year>2026</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2026</year>
</pub-date>
<volume>16</volume>
<elocation-id>1757662</elocation-id>
<history>
<date date-type="received">
<day>30</day>
<month>11</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>27</day>
<month>01</month>
<year>2026</year>
</date>
<date date-type="rev-recd">
<day>26</day>
<month>01</month>
<year>2026</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2026 N., Ali, K. P., Mehto and Antony.</copyright-statement>
<copyright-year>2026</copyright-year>
<copyright-holder>N., Ali, K. P., Mehto and Antony</copyright-holder>
<license>
<ali:license_ref start_date="2026-02-25">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p><italic>Klebsiella pneumoniae</italic>, a facultative anaerobe and Gram-negative bacterium, has high clinical significance in public health concerns. <italic>K. pneumoniae</italic> is given its name in recognition of the German-Swiss microbiologist Edwin Klebs. Carl Friedlander first identified <italic>K. pneumoniae</italic> as a bacterium isolated from the lungs of individuals who had died from pneumonia. <italic>K. pneumoniae</italic> is a prominent member of the <italic>Enterobacteriaceae</italic> family, an opportunistic pathogen, and one of the pathogens sweeping the world in the antibiotic resistance pandemic. This organism accounts for approximately one-third of all Gram-negative infections, including pneumonia, urinary tract infections, liver abscesses, and bacteremia. Classically, these infections commonly occur in individuals who are hospitalized or immunocompromised and regularly treated with <italic>&#x3b2;</italic>-lactams along with other antibiotics effective against <italic>Enterobacteriaceae</italic>. Unfortunately, the emergence of multidrug-resistant infections in patients treated at intensive care units (ICUs) has been a serious problem faced by clinicians globally. <italic>K. pneumoniae</italic> has been recently added to the critical list of microorganisms by the World Health Organization (WHO), highlighting the urgent requirement for new therapeutic options to combat this bacterium. Developing new therapeutic interventions requires a comprehensive understanding of host-pathogen interactions and the role of immune cells in clearing the bacteria. To that end, macrophages play a crucial role in safeguarding our body against infectious agents, as well as contributing to processes such as pathogen clearance and tissue homeostasis. Calcium, a secondary messenger, refines the macrophage protective responses and influences cell survival. Many pathogens have evolved tactics to circumvent the innate immune clearance mechanisms exerted by macrophages. Therefore, this review will focus on the modulation of macrophage innate immune responses and survival upon <italic>K. pneumoniae</italic> infection.</p>
</abstract>
<kwd-group>
<kwd>innate immunity</kwd>
<kwd>macrophage</kwd>
<kwd><italic>Klebsiella pneumoniae</italic></kwd>
<kwd>infection</kwd>
<kwd>calcium homeostasis</kwd>
<kwd>survival</kwd>
</kwd-group>
<funding-group>
<funding-statement>The author(s) declared that financial support was received for this work and/or its publication. This research was funded by ICMR grant number OMI/05/2022/ECD and NITC-FRG Phase-II grant number FRG/2022/SoBT_01.</funding-statement>
</funding-group>
<counts>
<fig-count count="8"/>
<table-count count="2"/>
<equation-count count="0"/>
<ref-count count="211"/>
<page-count count="24"/>
<word-count count="13429"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Adaptive &amp; Innate Immunity in Infection</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>Macrophages are a crucial component of the innate immune system, serving as the first line of defense against microbial pathogens and key regulators of immune homeostasis (<xref ref-type="bibr" rid="B35">Chen et&#xa0;al., 2023</xref>). These versatile immune cells exhibit remarkable plasticity and functionality, capable of recognizing, engulfing, and eliminating pathogens while modulating the immune response through the secretion of cytokines and chemokines (<xref ref-type="bibr" rid="B19">Brancewicz et&#xa0;al., 2025</xref>). The survival and functional integrity of macrophages are central to mounting an effective immune response, particularly during bacterial infections. However, the interaction between macrophages and bacterial pathogens is often characterized by a complex interplay of host defense mechanisms and microbial strategies aimed at immune evasion (<xref ref-type="bibr" rid="B139">Pandey et&#xa0;al., 2022</xref>). Among bacterial pathogens, <italic>K. pneumoniae</italic> has emerged as a formidable global health threat due to its multidrug resistance and high virulence. Its association with severe nosocomial as well as community-acquired infections, such as pneumonia, bloodstream infections, and urinary tract infections, confirms its vast incidence (<xref ref-type="bibr" rid="B132">Mohd Asri et&#xa0;al., 2021</xref>).</p>
<p>Despite extensive research into its virulence factors, the mechanisms by which <italic>K. pneumoniae</italic> modulates host immune responses, particularly macrophage survival and function, remain completely grey. Interestingly, the pathogen employs various strategies, including the prevention of phagocytosis, avoidance of autophagic pathways, and modulation of host cell death processes,&#xa0;to evade clearance and to establish infection. Undoubtedly, evasion of macrophage innate immune defense mechanisms not only promotes bacterial survival but also leads to immune dysregulation, resulting in chronic systemic infections. Especially, <italic>K. pneumoniae</italic> has been recognized for evading host immunity, and also displayed increased resistance to multiple antimicrobial drugs, including third-generation antimicrobials (i.e., Tigecycline, colistin, and carbapenem) (<xref ref-type="bibr" rid="B1">Abhinand et&#xa0;al., 2025</xref>). Despite several studies being conducted to understand the biology of <italic>K. pneumoniae</italic> infections worldwide, a significant gap remains. Unfortunately, the interaction of <italic>K. pneumoniae</italic> with the human immune system has not yet been fully understood.</p>
<p>More importantly, calcium signaling, a regulator of cellular homeostasis and immune responses, has garnered increasing attention for its role in regulating macrophage survival and immunity. Calcium plays a pivotal role in processes such as phagocytosis, cytokine production, and the regulation of cell death (<xref ref-type="bibr" rid="B137">Nunes and Demaurex, 2010</xref>). This is an integrative review of the mechanisms, including the most recent discoveries, by which <italic>K. pneumoniae</italic> infections influence macrophage survival, function, and immune regulation.</p>
</sec>
<sec id="s2">
<label>2</label>
<title>Overview of macrophage homeostasis</title>
<p>Macrophages, first described by Metchnikoff during his investigations into primitive organisms devoid of adaptive immunity, are among the oldest cell types in metazoan evolution. Primarily recognized for their phagocytic capabilities, Metchnikoff discovered that macrophages play a crucial role in maintaining homeostasis through tissue resorption and nutrient acquisition, in addition to serving as primary defenders against invading pathogens (<xref ref-type="bibr" rid="B130">Metchnikoff, 1893</xref>). His pioneering research into phagocytosis laid the foundation for our present-day understanding of cellular immunity and the structural basis of host defense (<xref ref-type="bibr" rid="B128">Mechnikov, 1988</xref>). Macrophages found in vertebrate tissues form a network of vast and dynamic organ systems that arise during mid-gestation and continue throughout life (<xref ref-type="bibr" rid="B72">Gordon and Pl&#xfc;ddemann, 2017</xref>). They exhibit structural and functional variation in adult animals by building a complex three-dimensional network in tissues (<xref ref-type="bibr" rid="B196">Wynn et&#xa0;al., 2013</xref>). As immune sentinels, macrophages are the first line of defense against bacteria, conferring protection to the host (<xref ref-type="bibr" rid="B93">Joshi and Saroj, 2023</xref>).</p>
<sec id="s2_1">
<label>2.1</label>
<title>Origins and development of macrophages</title>
<p>Macrophages originate from distinct developmental pathways during embryogenesis and continue to adapt and renew throughout life (<xref ref-type="bibr" rid="B66">Gautier et&#xa0;al., 2012</xref>) as summarized in <xref ref-type="fig" rid="f1"><bold>Figure&#xa0;1</bold></xref>. Macrophage origin, migration, and development have high similarity between humans and mice (<xref ref-type="bibr" rid="B75">Guan et&#xa0;al., 2025</xref>). In early embryonic development, macrophages arise from the yolk sac independently of hematopoietic stem cells (HSCs). These yolk sac-derived macrophages, such as microglia in the brain, establish in tissues and persist throughout adulthood without significant input from circulating monocytes. This discovery has overturned the previous dogma of macrophage ontogeny, revealing that tissue-resident macrophages are not exclusively derived from bone marrow progenitors as previously believed (<xref ref-type="bibr" rid="B134">Mosser et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B68">Ginhoux and Jung, 2014</xref>). A second wave of progenitors is erythro-myeloid precursors (EMPs) originating from the yolk sac. These EMPs subsequently migrate to the developing fetal liver, where they give rise to macrophages that seed tissues such as the liver and spleen (<xref ref-type="bibr" rid="B13">Bian et&#xa0;al., 2020</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Origin and classification of macrophages. Tissue-resident macrophages arise from bone marrow-derived monocytes as well as from the yolk sac and fetal liver. In some instances, tissue-resident macrophages might be replenished by blood monocytes. Different tissue-resident macrophages were known by different names (Langerhans cells, Microglia, Kupffer cells, Osteoclasts, and Alveolar macrophages).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-16-1757662-g001.tif">
<alt-text content-type="machine-generated">Diagram illustrating the origins of tissue-resident macrophages from prenatal sources (yolk sac and fetal liver) and postnatal bone marrow, with arrows leading to differentiated cells in skin, brain, liver, bone, and lungs.</alt-text>
</graphic></fig>
<p>In contrast to yolk sac-derived macrophages (like microglia), which are largely self-renewing, these populations have a greater dependence on circulating monocytes for maintenance (<xref ref-type="bibr" rid="B81">Hirayama et&#xa0;al., 2017</xref>). Postnatally, HSCs in the bone marrow continuously produce monocytes, which can develop into macrophages in response to local signals, especially in high-turnover tissues like the gut or during inflammatory conditions (<xref ref-type="bibr" rid="B72">Gordon and Pl&#xfc;ddemann, 2017</xref>). The tri-lineage origin, comprising the yolk sac, EMPs, and HSCs, demonstrates the complexity of macrophage development and emphasizes their specialized roles in tissue homeostasis. Tissue-resident macrophages maintain their populations primarily through self-renewal under steady-state conditions, whereas monocyte-derived macrophages are recruited and contribute to inflammation or injury (<xref ref-type="bibr" rid="B75">Guan et&#xa0;al., 2025</xref>).</p>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>Functional heterogeneity and plasticity of macrophages</title>
<p>Macrophages exhibit incredible plasticity and functional diversity, enabling them to adapt to the needs of their microenvironments. This plasticity enables them to perform diverse functions, such as pathogen clearance, tissue repair, immune surveillance, and metabolic regulation (<xref ref-type="bibr" rid="B38">Chi et&#xa0;al., 2025</xref>). Macrophages exhibit a range of tissue-specific roles, resulting in a variety of different phenotypes. For instance, the Kupffer cells in the liver regulate lipid metabolism and detoxify harmful substances (<xref ref-type="bibr" rid="B135">Murray and Wynn, 2011</xref>). Similarly, alveolar macrophages in the lungs play an important role in maintaining surfactant homeostasis and providing defense against microbes (<xref ref-type="bibr" rid="B81">Hirayama et&#xa0;al., 2017</xref>). Macrophages in the bone, known as osteoclasts, are responsible for bone matrix resorption, and microglia in the brain are involved in neural development and maintenance. In general, these tissue-specific functions are driven by local cues, such as cytokines, metabolites, and growth factors, which initiate different transcriptional pathways (<xref ref-type="bibr" rid="B72">Gordon and Pl&#xfc;ddemann, 2017</xref>). Macrophages demonstrate remarkable adaptability induced by inflammatory stimuli, which dictates their phenotype. For instance, classically activated macrophages (M1) are characterized by the production of pro-inflammatory cytokines and molecules that help combat invading microbial pathogens. On the contrary, alternatively activated macrophages (M2) produce anti-inflammatory cytokines and growth factors that promote the tissue repair process (<xref ref-type="bibr" rid="B123">Luo et&#xa0;al., 2024</xref>), as shown in <xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2</bold></xref>, which depicts the polarization of macrophages. However, this traditional paradigm oversimplifies the wide and dynamic phenotypic spectrum of macrophage activation states observed <italic>in-vivo</italic>, which are influenced by the specific microenvironment (<xref ref-type="bibr" rid="B134">Mosser et&#xa0;al., 2021</xref>).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>M1 and M2 polarization of macrophages. Pro-inflammatory M1 polarization and anti-inflammatory M2 polarization of macrophages. IFN-&#x3b3;: Interferon gamma, LPS: lipopolysaccharide treatment of Mo macrophages leads to M1 polarization. The induction of interleukin-4 (IL-4) and Interleukin-13 (IL-13) in macrophages leads to M2 polarization. M1 macrophages secrete IL-1beta, Tumor Necrosis Factor (TNF), IL-1beta, IL-6) like pro-inflammatory cytokines. Conversely, M2 macrophages secrete Transforming Growth Factor (TGF), vascular endothelial growth factor (VEGF), and Interleukin-10 (IL-10), which are anti-inflammatory cytokines.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-16-1757662-g002.tif">
<alt-text content-type="machine-generated">Diagram illustrating macrophage polarization, showing M0 macrophages differentiating into M1 or M2 phenotypes. M1 macrophages release pro-inflammatory cytokines and protect against infection, while M2 macrophages promote tissue repair and anti-inflammatory responses.</alt-text>
</graphic></fig>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>Mechanism of tissue homeostasis</title>
<p>Reducing macrophages to their immune functions alone ignores and overshadows their ancillary biological role. Furthermore, macrophages play a major role in host defense, together maintaining tissue integrity and physiological homeostasis (<xref ref-type="bibr" rid="B134">Mosser et&#xa0;al., 2021</xref>). The cellular debris, immune complexes, apoptotic cells, pathogens, and other waste materials are scavenged by macrophages to prevent any disruption in organ function. This proficient phagocytic activity highly facilitates the recycling of cellular components while supporting tissue health (<xref ref-type="bibr" rid="B81">Hirayama et&#xa0;al., 2017</xref>). Macrophages also play a significant role in key metabolic pathways, including the turnover of iron, Ca<sup>2+</sup>, lipids, and amino acids, and bilirubin, upholding the maintenance of homeostatic levels of these molecules (<xref ref-type="bibr" rid="B104">Kosteli et&#xa0;al., 2010</xref>; <xref ref-type="bibr" rid="B15">Biswas and Mantovani, 2012</xref>; <xref ref-type="bibr" rid="B65">Ganz, 2016</xref>; <xref ref-type="bibr" rid="B151">Roodman, 1999</xref>; <xref ref-type="bibr" rid="B163">Suda et&#xa0;al., 1992</xref>). However, the growth factors or signaling molecules secreted by macrophages govern tissue remodeling, wound repair, organogenesis, angiogenesis, and metabolic regulation. Therefore, the multi-angled activities highlight macrophages&#x2019; dual role in host defense and tissue homeostasis (<xref ref-type="bibr" rid="B19">Brancewicz et&#xa0;al., 2025</xref>; <xref ref-type="bibr" rid="B59">Ferrante and Leibovich, 2012</xref>; <xref ref-type="bibr" rid="B75">Guan et&#xa0;al., 2025</xref>).</p>
<p>Exclusively, the Colony-Stimulating Factors (CSFs) play a pivotal role in macrophage homeostasis, balancing survival, proliferation, and differentiation processes. Macrophage CSF1 and its receptor (CSF1R) are essential for the survival and self-renewal of macrophages. More importantly, brain tissue-resident macrophages, i.e., microglia, possess an alternative ligand for CSF1R (i.e., IL-34), which has been reported to be important to the localized maintenance of tissue-resident macrophages (<xref ref-type="bibr" rid="B199">Xiang et&#xa0;al., 2023</xref>). The identity and plasticity of macrophages are additionally confirmed by transcriptional regulators like PU.1, the master transcriptional factor controlling the expression of macrophage-specific genes (<xref ref-type="bibr" rid="B196">Wynn et&#xa0;al., 2013</xref>). However, transcription factors such as MafB and GATA6 are reported to be important for the tissue-specific differentiation of macrophages (<xref ref-type="bibr" rid="B77">Hamada et&#xa0;al., 2020</xref>). Consequently, the transcriptional networks involving these factors allow macrophages to rapidly respond and adapt to physiological changes. In fact, in the brain and liver tissues with minimal macrophage turnover rate, there exists a self-renewal mechanism to replenish the resident macrophage population (<xref ref-type="bibr" rid="B152">R&#xf6;szer, 2018</xref>). Conversely, in the gut tissues with a high macrophage turnover rate, continuous replenishment of macrophages happens from monocyte-derived precursors to restore their numbers (<xref ref-type="bibr" rid="B177">Viola and Boeckxstaens, 2021</xref>). Therefore, this remarkable adaptability of tissue-specific macrophage homeostasis has been lacking in other similar immune cell types.</p>
</sec>
<sec id="s2_4">
<label>2.4</label>
<title>Survival mechanisms</title>
<p>Macrophage survival is closely associated with their ability to detect and respond to environmental signals. Cytokines like IL-10 and Transforming Growth Factor beta (TGF-&#x3b2;) provide anti-apoptotic signals that promote macrophage survival, particularly during tissue repair and the resolution phase of inflammation. Additionally, these cytokines also skew the macrophages toward anti-inflammatory phenotypes, ensuring that they support tissue homeostasis (<xref ref-type="bibr" rid="B202">Yan et&#xa0;al., 2024</xref>). Metabolic reprogramming is important for macrophage survival, where the classically activated (M1) macrophages rely predominantly on glycolysis to maintain their pro-inflammatory nature, while the alternatively activated (M2) macrophages use oxidative phosphorylation and fatty acid oxidation to fulfil their reparative activities. These distinct metabolic changes allow macrophages to meet the energy and biosynthetic needs of their functional roles (<xref ref-type="bibr" rid="B184">Wang et&#xa0;al., 2022</xref>). Efferocytosis, the process by which macrophages phagocytize apoptotic cells, also provides survival signals. By removing cellular debris, macrophages not only prevent tissue damage but also obtain nutrients and growth factors that bolster their homeostatic functions. This process is important for maintaining tissue integrity and alleviating inflammation (<xref ref-type="bibr" rid="B22">Cabrera and Makino, 2022</xref>).</p>
<sec id="s2_4_1">
<label>2.4.1</label>
<title>Regulators of survival and cellular resilience</title>
<p>Macrophage Colony-Stimulating Factor (M-CSF) is required for macrophage survival. It binds to the M-CSF Receptor (CSF1R) and thereby activates downstream signaling pathways, including Phosphoinositide 3-Kinase (PI3K)-AKT and MAPK. These pathways help in cellular proliferation and prevent apoptosis by upregulating survival genes. Similarly, other cytokines such as Tumor Necrosis Factor Alpha (TNF-&#x3b1;) and Interleukin (IL)-6 act in an autocrine or paracrine manner to enhance macrophage survival during immune responses (<xref ref-type="bibr" rid="B78">Han et&#xa0;al., 2022</xref>). At sites of inflammation, cytokine gradients influence the survival and functionality of macrophages. For example, Interferon-&#x3b3; (IFN-&#x3b3;) increases macrophage responsiveness to pathogen-associated molecular patterns (PAMP), whereas IL-10 and IL-4 support the survival of tissue-resident macrophages in homeostatic conditions (<xref ref-type="bibr" rid="B7">Arora et&#xa0;al., 2018</xref>). Macrophage survival is greatly affected by the extracellular matrix (ECM) and the interactions within tissue environments. ECM components, like decorin, provide structural support and deliver biochemical signals that enhance macrophage viability. Notably, decorin binds to macrophage receptors, which helps to block apoptotic processes (<xref ref-type="bibr" rid="B197">Xaus et&#xa0;al., 2001</xref>).</p>
<p>Macrophages also communicate with other immune cells, such as lymphocytes and neutrophils. Consequently, these interactions ensure macrophage persistence in immune niches and their ability to mediate adaptive immune responses (<xref ref-type="bibr" rid="B86">Huang et&#xa0;al., 2025</xref>). Macrophages utilize cell cycle checkpoints to maintain a balance between survival and activation. IFN-&#x3b3;, a cytokine that plays a role in macrophage activation, promotes the expression of cyclin-dependent kinase (CDK) inhibitors such as p21waf1. However, this induction causes halts in cell cycle progression at the G1/S phase, allowing macrophages to focus on their immune activities rather than proliferation. Therefore, the checkpoint strategy not only prepares macrophages for activation but also protects them from apoptosis triggered by inflammatory signals like lipopolysaccharides (LPS) (<xref ref-type="bibr" rid="B197">Xaus et&#xa0;al., 2001</xref>). The NF-&#x3ba;B (Nuclear Factor kappa-light-chain-enhancer of activated B cells) signaling pathway has been an important regulator for macrophage survival. Multiple mechanisms involving inflammation, immunity, and cell survival are controlled by this key transcription factor (<xref ref-type="bibr" rid="B136">Mussbacher et&#xa0;al., 2023</xref>).</p>
<p>In general, NF-&#x3ba;B resides in the cytoplasm as inactive forms by the inhibitory proteins (I&#x3ba;Bs), preventing its translocation to the nucleus. External stimuli like cytokines, microbial products, or stress activate the I&#x3ba;B kinase (IKK) complex, leading to phosphorylation of I&#x3ba;Bs, labelling them for ubiquitination and subsequent proteasomal degradation. Moreover, the translocation of NF-&#x3ba;B, into the nucleus targets transcription of genes, including anti-apoptotic proteins, cytokines etc. Indeed, those environments that promote inflammation, oxidative stress, and apoptosis genes are regulated by NF-&#x3ba;B, supporting macrophage resilience. Unfortunately, any accidental disruption of this pathway might lead to chronic inflammation or immune suppression (<xref ref-type="bibr" rid="B53">Dorrington and Fraser, 2019</xref>). The PI3K-AKT pathway is also an important regulator for macrophage survival, especially during stressed conditions such as infection (<xref ref-type="bibr" rid="B45">De-Leon-Lopez et&#xa0;al., 2023</xref>). When stimulated by growth factors such as cytokines, or PAMPs, PI3K phosphorylates phosphatidylinositol-4,5-bisphosphate (PIP2) resulting in the production of phosphatidylinositol-3,4,5-trisphosphate (PIP3), which acts as a lipid second messenger.</p>
<p>Subsequently, PIP3 then recruits Akt to the plasma membrane, where it will undergo phosphorylation and be activated. Akt, once phosphorylated, can then phosphorylate downstream targets such as Bad and GSK3&#x3b2;, which inhibits apoptosis, promoting anti-apoptotic signaling and increased production of anti-apoptotic proteins like Mcl-1. Especially, multiple mechanisms of macrophages, such as phagocytic function, cytokine release, and survival, are enhanced by the PI3K-AKT pathway, while suppressing the NF-&#x3ba;B activation, emphasizing its role in macrophage viability (<xref ref-type="bibr" rid="B118">Linton et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B182">Wang et&#xa0;al., 1999</xref>). The activation of the PI3K/AKT and NF&#x3ba;B pathways depends on constitutive calcium influx, through a mechanism that involves the calmodulin/calmodulin kinase II (CaM/CaMKII) axis, coupling constitutive calcium influx to the activation of survival signaling (<xref ref-type="bibr" rid="B165">Tano and Vazquez, 2011</xref>). Calcium have role in macrophage cell signaling and biology, which determines the fate of innate immune responses. Therefore, we realized it is important to delineate calcium homeostasis in macrophages, which alters their survival and immune function.</p>
</sec>
</sec>
</sec>
<sec id="s3">
<label>3</label>
<title>Role of calcium in macrophage survival and immune regulation</title>
<p>Calcium (Ca<sup>2+</sup>), a secondary messenger, dictates cell survival and the immune responses against invading pathogens. A fundamental aspect of calcium signaling is that alterations in intracellular calcium concentration [Ca<sup>2+</sup>]<sub>i</sub> elicit specific cellular responses (<xref ref-type="bibr" rid="B12">Berridge et&#xa0;al., 2000</xref>). Calcium entry and exit are governed by transmembrane channels that specifically allow the influx/efflux of Ca<sup>2+</sup> ions based on the cellular demands. In unstimulated cells, the cytosolic calcium concentration [Ca<sup>2+</sup>]<sub>i</sub> is maintained at ~100 nM, commonly referred to as the resting or basal calcium concentration (<xref ref-type="bibr" rid="B16">Bootman and Bultynck, 2020</xref>). Upon stimulation, cytosolic calcium levels rapidly increase from this resting state and subsequently return to baseline following the cessation of stimulation. The magnitude of cytosolic calcium elevation depends on the type, concentration, intensity, and duration of the stimulus, as well as the presence of calcium-buffering proteins (<xref ref-type="bibr" rid="B154">Schwaller, 2010</xref>). To maintain calcium homeostasis, cells rely on tightly regulated mechanisms for calcium transport.</p>
<p>Calcium transport in cells is facilitated by channels that permit the Ca<sup>2+</sup> ion influx, and pumps or exchangers that facilitate Ca<sup>2+</sup> ion efflux. This process involves sodium-calcium exchangers (NCX), intracellular and plasma membrane calcium channels, and several families of pumps, including Plasma Membrane Calcium ATPase (PMCA), Sarco/Endoplasmic Reticulum Calcium ATPase (SERCA), and Secretory Pathway Calcium ATPase (SPCA) (<xref ref-type="bibr" rid="B36">Cheng et&#xa0;al., 2006</xref>). Additional routes of calcium entry comprise TRP channels and ionotropic P2X receptors, which are cation-selective ion channels. Macrophages express channels from multiple TRP (Transient Receptor Potential) subfamilies- TRPC (Canonical), TRPV (Vanilloid), TRPM (Melastatin), TRPML (Mucolipin)- which act as weakly voltage-sensitive, cation-selective channels responding to mechanical, chemical, and thermal stimuli (<xref ref-type="bibr" rid="B48">Desai and Leitinger, 2014</xref>).</p>
<p>The calcium channels regulate the transportation of Ca<sup>2+</sup> ions in response to calcium signaling and cellular demands. Phosphatidylinositol 4,5-bisphosphate (PIP2) and inositol 1,4,5-trisphosphate (IP3) are closely linked molecules that play key roles in calcium signaling inside the cells. PIP2 is hydrolyzed by the enzyme phospholipase C (PLC) into IP3 and diacylglycerol (DAG) upon receptor triggering and activation. Thereafter, IP3 diffuses into the cytoplasm and attaches to its receptor on the endoplasmic reticulum, initiating the release of sequestered Ca<sup>2+</sup> ions into the cytosol (<xref ref-type="bibr" rid="B147">Rasmussen et&#xa0;al., 1990</xref>). The release of ER calcium induces store-operated calcium entry (SOCE) either through calcium release&#x2013;activated calcium (CRAC) channels, mainly composed of STIM1, i.e., ER Ca<sup>2+</sup> ion sensor, and ORAI1 (pore-forming subunit), or via Voltage Gated Calcium Channels (VGCC) or both (<xref ref-type="bibr" rid="B176">Vig and Kinet, 2009</xref>). This is a fundamental and highly conserved mechanism across all cell types, serving as a versatile intracellular messenger that orchestrates diverse physiological processes (<xref ref-type="bibr" rid="B147">Rasmussen et&#xa0;al., 1990</xref>).</p>
<p>Innate immune cells, like macrophages and neutrophils, utilize calcium signals to detect and eliminate pathogens (<xref ref-type="bibr" rid="B30">Chaplin, 2010</xref>). Disruptions in calcium homeostasis have been shown to influence disease progression, immune function, and treatment outcomes (<xref ref-type="bibr" rid="B88">Ingale et&#xa0;al., 2025</xref>). Macrophages, are elements of the innate immune system, depend on calcium signaling to mediate cytokine production, antigen presentation, and pathogen clearance. The pattern and frequency of Ca<sup>2+</sup> ion oscillations can influence downstream transcriptional responses such as NF-&#x3ba;B, NFAT, and MAPK activation (<xref ref-type="bibr" rid="B211">Zhou et&#xa0;al., 2006</xref>). Inhibition of extracellular Ca<sup>2+</sup> ion entry in LPS-stimulated macrophages amplified IL-12 production through the CaMKK&#x3b2;&#x2013;AMPK&#x2013;SIRT1 axis, highlighting the sensitivity of immune responses to calcium dynamics (<xref ref-type="bibr" rid="B120">Liu et&#xa0;al., 2016</xref>). Likewise, calcium a regulator of the cGAS-STING pathway, which detects cytosolic DNA to trigger interferon production, important for innate immunity and autoimmunity. changes in cytosolic calcium influence STING activation and downstream signaling, including NF-&#x3ba;B and IRF3 transcription factors needed for IFN-&#x3b3; and inflammatory cytokine expression (<xref ref-type="bibr" rid="B127">Mathavarajah et&#xa0;al., 2019</xref>). Distinct calcium signatures are associated with macrophage polarization. Influx of extracellular Ca<sup>2+</sup> ions has been shown to be required for macrophage polarization toward the pro-inflammatory M1 phenotype (<xref ref-type="bibr" rid="B193">Wu et&#xa0;al., 2023</xref>). Elevated mitochondrial Ca<sup>2+</sup> ion uptake has been reported to enhance anti-inflammatory M2 polarization and augment phagocytic capacity. Conversely, the suppression of the mitochondrial calcium uniporter (MCU) impairs M2 polarization without affecting the M1 phenotype (<xref ref-type="bibr" rid="B166">Tedesco et&#xa0;al., 2019</xref>).</p>
<sec id="s3_1">
<label>3.1</label>
<title>Regulation of macrophage effector functions by calcium</title>
<p>Calcium signaling has a direct influence on cytokine production in macrophages. The calcium-sensing receptor (CaSR) is widely expressed in tissues such as monocytes and macrophages. IL-1&#x3b2; and IL-6 upregulate the CaSR and also alter systemic calcium concentrations. These cytokines suppress parathyroid hormone secretion and decrease 1,25-dihydroxyvitamin D levels, which contribute to hypocalcemia in critically ill patients, including those with sepsis. The substantial increase in CaSR expression induced by TNF-&#x3b1; may function as a protective response to inflammation. This mechanism has been demonstrated in murine macrophages, where lipopolysaccharide-induced TNF-&#x3b1; release upregulated CaSR and subsequently inhibited TNF-&#x3b1; synthesis. Altogether, these mechanisms demonstrate the bidirectional relationship between inflammatory processes and calcium homeostasis (<xref ref-type="bibr" rid="B79">Hendy and Canaff, 2016</xref>).</p>
<p>Furthermore, antigen binding to immunoreceptors, including the TCR and BCR, the Fc&#x3b3; and Fc&#x3f5; receptors, G protein&#x2013;coupled chemokine receptors, and some innate pattern-recognition receptors such as Dectin-1, results in the depletion of calcium stores that stimulate store-operated calcium entry through CRAC channels (<xref ref-type="bibr" rid="B60">Feske et&#xa0;al., 2015</xref>). In macrophages, studies have demonstrated the involvement of calcium/calmodulin-dependent protein kinase in the pyrimidinoceptor-mediated potentiation of iNOS induction in mouse J774 macrophages (<xref ref-type="bibr" rid="B34">Chen et&#xa0;al., 1998</xref>). Research indicates that the rise in [Ca<sup>2+</sup>]<sub>i</sub> in response to LPS treatment induces ROS generation in murine macrophages (<xref ref-type="bibr" rid="B91">Jin et&#xa0;al., 2006</xref>). [Ca<sup>2+</sup>]<sub>i</sub> governs various functions, including phagocytosis and perhaps phagosome-lysosome fusion.</p>
<p>Phagocytosis, a primary function of macrophages, depends on precise regulation of calcium signaling. Several transcription factors have been identified whose activity is regulated by calcium-activated signaling pathways (<xref ref-type="bibr" rid="B192">West et&#xa0;al., 2001</xref>). A notable example is the adenosine 3&#x2032;,5&#x2032;-monophosphate (cAMP) response element-binding protein (CREB), which plays important roles in cell survival, proliferation, and differentiation. Its significance in immune function is increasingly recognized. CREB plays an important role in macrophage homeostasis by limiting proinflammatory response and inducing antiapoptotic survival signals in macrophages (<xref ref-type="bibr" rid="B190">Wen et&#xa0;al., 2010</xref>). Activation of CREB restricts the intracellular trafficking of <italic>M. tuberculosis</italic> to the phagolysosome by inhibiting MLKL phosphorylation. Therefore, CREB activation constitutes a key mechanism by which <italic>M. tuberculosis</italic> evades the immune response in human macrophages (<xref ref-type="bibr" rid="B111">Leopold Wager et&#xa0;al., 2023</xref>).</p>
<p>The P2X4 receptor (P2X4R), another endolysosomal ATP-gated calcium channel, contributes to macrophage activation and inflammatory responses. P2X4R expression increases during early phagocytosis in alveolar macrophages, suggesting a role in initiating calcium-driven phagocytic signaling. It modulates IL-1&#x3b2; and IL-18 release via inflammasome activation, linking lysosomal Ca<sup>2+</sup> ion fluxes to proinflammatory cytokine production (<xref ref-type="bibr" rid="B3">Alharbi and Parrington, 2021</xref>). While there have been studies on calcium and calcium channels in macrophages, limited research has been done regarding its role with respect to bacterial infection. Both TRPML and P2X4 Ca<sup>2+</sup> ion channels are regulators of calcium signaling in macrophage-mediated immune functions. TRPML1-mediated Ca<sup>2+</sup> release drives phagosome maturation and phagosome-lysosome fusion, processes that engulf and degrade pathogens in macrophages. Knockout of TRPML1 reduces the ability of bone marrow&#x2013;derived macrophages (BMDMs) to phagocytose large particles, highlighting its requirement for efficient phagocytosis. TRPML2-dependent calcium signaling regulates the release of CCL2/MCP1, promoting macrophage recruitment and migration during inflammation. <xref ref-type="fig" rid="f3"><bold>Figure&#xa0;3</bold></xref> gives an overview of calcium homeostasis and reported macrophage effector functions, with persisting gaps in host-pathogen interactions.</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Overview of calcium homeostasis and macrophage effector functions. The figure illustrates the key pathways involved in calcium regulation within macrophages and their impact on effector functions such as phagocytosis, ROS, and pathogen clearance. Intracellular calcium levels are maintained through coordinated activity of plasma membrane channels (e.g., Calcium release-activated calcium channels (CRAC/ORAI1), Transient receptor potential (TRP) channels, Voltage-Gated-Calcium-Channels (VGCCs), endoplasmic reticulum stores (via Inositol triphosphate receptor (IP<sub>3</sub>R), Ryanodine receptor (RyR), and Sarcoplasmic/Endoplasmic Reticulum Calcium ATPase (SERCA), and mitochondrial buffering systems. Multiple mechanisms controlled by calcium homeostasis are still not explored in <italic>K. pneumoniae</italic> infection. Especially, calcium influx/efflux activation and regulation of intracellular calcium levels post-infection. The cross-talk between TLR triggering and calcium-regulated macrophage effector functions is not demonstrated experimentally.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-16-1757662-g003.tif">
<alt-text content-type="machine-generated">Scientific illustration showing intracellular signaling pathways related to calcium (Ca2+) fluxes during Klebsiella pneumoniae infection, including TRP and voltage-gated calcium channel (VGCC) activation or inhibition, TLR, SOCE-ORAI, mitochondrial damage, autophagy, CREB pathway activation, and gene expression. Legend explains symbols for K. pneumoniae, gene expression, phosphorylation, DNA, ryanodine and IP3 receptors, SERCA, cAMP, inhibition, downstream signaling, and gaps in literature.</alt-text>
</graphic></fig>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>Pathogen-mediated disruption of calcium homeostasis</title>
<p>Efficient antigen processing and presentation by macrophages require regulated calcium fluxes. Delvig and Robinson demonstrated that the major histocompatibility complex (MHC) class II-restricted antigen processing in murine macrophages depends on both intracellular [Ca<sup>2+</sup>]<sub>i</sub> and extracellular Ca<sup>2+</sup> ion concentration. Their experiments with bacterial epitopes, such as the M5 protein from <italic>Streptococcus pyogenes</italic>, indicated that the calcium fluxes mediated by thapsigargin-sensitive calcium channels and gadolinium-sensitive pathways are crucial for antigen processing. Disruption of intracellular calcium fluxes impaired this process, thereby underscoring the importance of calcium homeostasis in immune activation (<xref ref-type="bibr" rid="B47">Delvig and Robinson, 1999</xref>).</p>
<p><italic>K. pneumoniae</italic> takes advantage of calcium signaling pathways to evade immune responses. In a murine peritonitis model, peritoneal macrophages from wild-type mice exhibited enhanced SOCE via TRPC1 channels following infection. This influx activates M1-specific pathways, including STAT1 and NF-&#x3ba;B p65 phosphorylation, while boosting expression of inflammatory mediators (e.g., NOS2, TNF-&#x3b1;, IL-6, IL-23, CXCL9/10) and maturation markers (MHC-II, CD80/86). Conversely, TRPC1 deficiency impairs these responses, resulting in elevated bacterial burdens in the peritoneum, liver, and blood (<xref ref-type="bibr" rid="B32">Chauhan et&#xa0;al., 2018</xref>). In another study of <italic>K. pneumoniae</italic> strains HLJ-D2 and HB-AF5 infection in bovine mammary epithelial cells (bMECs), mitochondrial calcium concentration significantly increased at 1, 3, 6, and 12 hours post-infection when compared to controls contributing to mitochondrial damage and pathogenesis of clinical mastitis (<xref ref-type="bibr" rid="B37">Cheng et&#xa0;al., 2021</xref>). However, <italic>K. pneumoniae</italic> facilitates calcium and magnesium homeostasis with DedA family proteins, including YqjA and YghB. These proteins are essential for membrane potential and cation transport, which help in capsule synthesis and resistance to phagocytosis. Therefore, mutant strains that lack these proteins exhibit reduced calcium uptake and increased susceptibility to immune clearance (<xref ref-type="bibr" rid="B167">Tiwari et&#xa0;al., 2024</xref>).</p>
<p>Direct causal links between specific Ca<sup>2+</sup> dynamics and macrophage fate outcomes, such as phagocytosis efficiency, intramacrophage bacterial killing, or apoptosis resistance, are largely absent in <italic>Klebsiella</italic> infection, with existing studies confined to mouse models and lacking human THP-1/PBMC validation, which is needed for clinical translation. Insights into some of these mechanisms can be inferred from studies of other pathogens. For example, <italic>S. aureus</italic> alters calcium fluxes in macrophages, which disrupts cytokine production and inhibits phagosome-lysosome fusion. Inhibiting extracellular calcium influx or intracellular calcium release changes macrophage response, indicating that different calcium sources distinctly regulate immune cell functions (<xref ref-type="bibr" rid="B175">Verma et&#xa0;al., 2020</xref>). Similarly, <italic>M. tuberculosis</italic> increases CACNA1S expression, an L-type voltage-gated calcium channel, to manipulate host calcium signaling. This channel enables calcium influx via the MyD88-independent TLR pathway involving pCREB, STIM1, and STIM2. Subsequently, the upregulation of CACNA1S results in suppression of protective innate immune responses, such as phagolysosome fusion and apoptosis promoting immune evasion (<xref ref-type="bibr" rid="B6">Antony et&#xa0;al., 2015</xref>). However, the disruption of macrophage calcium homeostasis by <italic>K. pneumoniae</italic> has not yet been experimentally well established. Therefore, investigating the calcium regulation in macrophages upon <italic>K. pneumoniae</italic> infection might open new horizons in the near future to combat the pathogen by developing next-generation therapeutics.</p>
</sec>
</sec>
<sec id="s4">
<label>4</label>
<title><italic>K. pneumoniae</italic> pathogenesis and virulence: impact on host immunity</title>
<p><italic>K. pneumoniae</italic> is a clinically significant opportunistic pathogen that causes life-threatening infections like pneumonia, sepsis, and urinary tract infections, particularly in immunocompromised individuals (<xref ref-type="bibr" rid="B29">Chang et&#xa0;al., 2021</xref>). The need to understand its pathogenesis to develop effective treatments is underscored by the rise of multidrug-resistant strains (<xref ref-type="bibr" rid="B105">Ktari et&#xa0;al., 2006</xref>). The emergence of hypervirulent (hvKp) is a large hurdle due to their intrinsic capacity to evade immunity and result in deadly infections in healthy individuals (<xref ref-type="bibr" rid="B44">DeLeo et&#xa0;al., 2023</xref>). At higher concentrations, hvKp strains exhibit increased capsule and siderophore production, which facilitates immune evasion and promotes the development of invasive diseases such as liver abscesses, meningitis, and endophthalmitis. MDR hvKp strains that combine antibiotic resistance with hypervirulence traits have emerged, posing a serious public health problem. These strains are more frequently reported in clinical settings, often associated with community acquired infection that are resistant and difficult to treat (<xref ref-type="bibr" rid="B51">Dong et&#xa0;al., 2022</xref>). <italic>K. pneumoniae</italic> commonly colonizes mucosal surfaces of humans, including the nasopharynx and gastrointestinal tract, with colonization rates varying by site and setting (<xref ref-type="bibr" rid="B126">Martin and Bachman, 2018</xref>). Hospitalized patients frequently have increased rates of gastrointestinal colonization, a reservoir for transmission and subsequent infection (<xref ref-type="bibr" rid="B52">Dorman and Short, 2017</xref>). Genomic studies have also shown that up to 80% of infections occurring in hospitalized patients come from, colonizing strain, which has a higher incidence (<xref ref-type="bibr" rid="B73">Gorrie et&#xa0;al., 2017</xref>). The progression to infection is determined by bacterial density, host risk factors such as immunosuppression, and invasive procedures like endoscopy (<xref ref-type="bibr" rid="B99">Kimmery et&#xa0;al., 1993</xref>).</p>
<sec id="s4_1">
<label>4.1</label>
<title>Key virulence factors</title>
<sec id="s4_1_1">
<label>4.1.1</label>
<title>Capsular polysaccharide: diversifying the pathogen&#x2019;s virulence</title>
<p><italic>K. pneumoniae</italic> establishes infection by defeating host immune defenses and escaping from host tissues through a spectrum of sophisticated virulence factors, such as polysaccharide capsule, lipopolysaccharides, siderophores, and pili (<xref ref-type="bibr" rid="B150">Riwu et&#xa0;al., 2022</xref>). The capsule represents the most extensively studied virulence factor of <italic>K. pneumoniae</italic>. It&#x2019;s a mucoid layer on the bacterial surface, consisting of a repeating glycan polymer that confers protection against host immune responses and facilitates environmental adaptation (<xref ref-type="bibr" rid="B149">Rendueles et&#xa0;al., 2017</xref>). There are 79 capsular polysaccharide (CP) serotypes identified in <italic>K. pneumoniae.</italic> Particularly, the capsule serotypes K1 and K2 are recognized as a major virulence factor in classical <italic>K. pneumoniae</italic> (cKP) infections. Similarly, in hypervirulent <italic>K. pneumoniae</italic> (hvKP) strains, eight capsular serotypes have been reported: K1, K2, K5, K16, K20, K54, K57, and the recently identified KN1 (<xref ref-type="bibr" rid="B158">Shon et&#xa0;al., 2013</xref>; <xref ref-type="bibr" rid="B109">Lee et&#xa0;al., 2016</xref>). <xref ref-type="table" rid="T1"><bold>Table&#xa0;1</bold></xref> summarizes the major hvKP Serotypes and their features (<xref ref-type="table" rid="T1"><bold>Table&#xa0;1</bold></xref>). In addition to aiding colonization and immune evasion, these pathogenic factors also promote severe invasive disease (<xref ref-type="bibr" rid="B28">Catal&#xe1;n-N&#xe1;jera et al., 2017</xref>).</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Major receptors of macrophages and their functions.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Receptor</th>
<th valign="top" align="left">Ligands recognized</th>
<th valign="top" align="left">Function in macrophages</th>
<th valign="top" align="left">Examples of pathogens</th>
<th valign="top" align="left">References</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">TLR2</td>
<td valign="top" align="left">Lipopeptides, peptidoglycan, lipoteichoic acid (LTA), lipoarabinomannan, zymosan, hemagglutinin proteins</td>
<td valign="top" align="left">Recognizes diverse ligands, promotes uptake of bacteria, viruses, parasites</td>
<td valign="top" align="left">Bacteria, viruses, mycobacteria, parasites</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B62">Fu and Harrison, 2021</xref>; <xref ref-type="bibr" rid="B172">Uematsu and Akira, 2007</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">TLR4</td>
<td valign="top" align="left">LPS on Gram-negative bacteria</td>
<td valign="top" align="left">Binds LPS, promotes internalization of Gram-negative bacteria</td>
<td valign="top" align="left">Gram-negative bacteria (e.g., E. coli)</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B174">Uthaisangsook et&#xa0;al., 2002</xref>; <xref ref-type="bibr" rid="B62">Fu and Harrison, 2021</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">TLR5</td>
<td valign="top" align="left">Bacterial flagellin</td>
<td valign="top" align="left">Facilitates the uptake of flagellated bacteria</td>
<td valign="top" align="left"><italic>P. aeruginosa</italic></td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B62">Fu and Harrison, 2021</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">CD14</td>
<td valign="top" align="left">LPS, co-receptor for TLR4</td>
<td valign="top" align="left">Co-receptor aiding uptake and clearance of Gram-negative bacteria</td>
<td valign="top" align="left">NTHi, Acinetobacter baumannii, E. coli</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B100">Knapp et&#xa0;al., 2006</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">NLRs</td>
<td valign="top" align="left">Bacterial peptidoglycan, flagellin, toxins; viral RNA; fungal structures; DAMPs (ATP, uric acid, cholesterol crystals)</td>
<td valign="top" align="left">Cytosolic sensors recognizing PAMPs/DAMPs, activating immune signaling</td>
<td valign="top" align="left">Broad microbial and damage signals</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B4">Almeida-da-Silva et&#xa0;al., 2023</xref>; <xref ref-type="bibr" rid="B133">Moloudizargari et&#xa0;al., 2019</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">RLRs (RIG-I-like receptors)</td>
<td valign="top" align="left">Viral RNA</td>
<td valign="top" align="left">Detect RNA viruses and trigger antiviral responses</td>
<td valign="top" align="left">RNA viruses</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B95">Kawai and Akira, 2009</xref>; <xref ref-type="bibr" rid="B207">Yoneyama and Fujita, 2009</xref>)</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>The polysaccharide capsule protects the bacterium from phagocytosis, serum killing, and enhances its ability to survive and infect the host (<xref ref-type="bibr" rid="B162">Struve and Krogfelt, 2003</xref>). Studies indicate that the capsule plays a significant role in pathogenesis as encapsulated strains are more resistant to host immune clearance. Genes encoding enzymes and regulatory proteins for polysaccharide production, polymerization, and transport regulate the synthesis of the <italic>K. pneumoniae</italic> capsule from the capsular polysaccharide synthesis (<italic>cps</italic>) locus (<xref ref-type="bibr" rid="B138">Opoku-Temeng et&#xa0;al., 2019</xref>). CP inhibits dendritic cell maturation and reduces the dendritic cell-driven production of IL-12, TNF-&#x3b1;, and other cytokines. Consequently, this allows the bacterium to evade host defense and establish infection. CP also suppresses IL-8 expression by interfering with Toll-like receptor (TLR) signaling, especially via the TLR2 and TLR4 pathways (<xref ref-type="bibr" rid="B160">Singh et&#xa0;al., 2025</xref>). <italic>K. pneumoniae&#x2019;</italic>s CP limits the recognition and activation of PRRs by macrophages and neutrophils, leading to innate immune suppression (<xref ref-type="bibr" rid="B117">Lin et&#xa0;al., 2019</xref>). Hypermucoviscosity refers to the highly mucoid and viscous phenotype exhibited by <italic>K. pneumoniae</italic> colonies when cultured on agar plates. Infections caused by carbapenem-resistant hypermucoviscous <italic>K. pneumoniae</italic> are associated with high mortality rates. Therefore, it confirms that hypermucoviscosity also serves as a significant virulence factor in <italic>Klebsiella</italic> (<xref ref-type="bibr" rid="B156">Shankar et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B102">Kochan et&#xa0;al., 2022</xref>).</p>
</sec>
<sec id="s4_1_2">
<label>4.1.2</label>
<title>Lipopolysaccharides: armor against host complement system</title>
<p>Lipopolysaccharides are composed of three distinct components: the lipid-A moiety, a core oligosaccharide, and the O-antigen side chain. The <italic>lpx</italic> gene cluster produces lipid-A, a hydrophobic portion of LPS, which is found in the outer membrane. Lipid-A and the O-antigen are connected via the core oligosaccharide. The O-antigen consists of repeating oligosaccharide units that determine the structural diversity of LPS (<xref ref-type="bibr" rid="B160">Singh et&#xa0;al., 2025</xref>). The length of the O-antigen influences bacterial survival; full-length O-antigens (smooth LPS) are less susceptible to complement-mediated killing than truncated O-antigens (rough LPS) (<xref ref-type="bibr" rid="B142">Pennini et&#xa0;al., 2017</xref>). <italic>K. pneumoniae</italic> employs LPS to evade host complement-mediated clearance by preventing C3b deposition on the bacterial cell wall (<xref ref-type="bibr" rid="B21">Bulati et&#xa0;al., 2021</xref>). Furthermore, the structural modification of the lipid-A component of the pathogen confers resistance to cationic antimicrobial peptides, enhancing the pathogen&#x2019;s immune evasion and virulence. <italic>K. pneumoniae</italic> LPS interacts with Toll-like receptor 4 (TLR4) on host immune cells and activates NF-&#x3ba;B to induce the production of pro-inflammatory cytokines. This mechanism enables the pathogen to exploit the host immune response to damage host tissues while providing an opportunity to the pathogen to survive and spread further (<xref ref-type="bibr" rid="B148">Regueiro et&#xa0;al., 2009</xref>).</p>
</sec>
<sec id="s4_1_3">
<label>4.1.3</label>
<title>Siderophores: the iron importers</title>
<p>Iron levels affect not only siderophore production, but also bacterial growth, capsule formation, lipopolysaccharide production, fimbriae expression, and antibacterial activity (<xref ref-type="bibr" rid="B160">Singh et&#xa0;al., 2025</xref>). <italic>K. pneumoniae</italic> produces siderophores, small high-affinity iron chelating molecules to counteract iron limitation imposed by the host&#x2019;s nutritional immunity (<xref ref-type="bibr" rid="B106">Kumar et&#xa0;al., 2024</xref>). These include siderophores such as Enterobactin, Aerobactin, Salmochelin, and Yersiniabactin (<xref ref-type="bibr" rid="B108">Lawlor, 2007</xref>), which bind to insoluble iron (Fe<sup>3+</sup>) and are subsequently transported into bacterial cells via specialized receptors. This enables the pathogen to secure the nutrient, &#x201c;Fe,&#x201d; for survival and virulence. The roles of Enterobactin, Aerobactin, Salmochelin, and Yersiniabactin in iron transport are illustrated in <xref ref-type="fig" rid="f4"><bold>Figure&#xa0;4</bold></xref>. In addition to iron acquisition, <italic>K. pneumoniae</italic> manipulates host iron metabolism by inducing transferrin receptor 1 (TFR1) via the STAT6-IL-10 axis. This strategy enhances intracellular iron availability, complementing siderophore activity to support bacterial survival within macrophages (<xref ref-type="bibr" rid="B74">Grubwieser et&#xa0;al., 2023</xref>).</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Schematic representation of siderophore-mediated iron acquisition in <italic>Klebsiella pneumoniae</italic>. The bacterial chromosome encodes siderophore biosynthetic gene clusters for Yersiniabactin (Ybt), Aerobactin (Iuc), Salmochelin (Sal) and Enterobactin (Ent). These siderophores are secreted into the extracellular environment where they bind ferric iron (Fe<sup>3+</sup>). The Fe<sup>3+</sup>-siderophore complexes are recognized and transported back into the bacterial cell through specific outer membrane transporters. Once internalized, Fe<sup>3+</sup> is reduced to Fe<sup>2+</sup> and released for cellular metabolic processes. The inset depicts the bacterial surface fimbrial structures, including Type 1 fimbriae and Type 3 fimbriae, which contribute to adhesion and biofilm formation.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-16-1757662-g004.tif">
<alt-text content-type="machine-generated">Illustration of a bacterial cell displaying four types of iron-chelating siderophores&#x2014;enterobactin, yersiniabactin, aerobactin, and salmochelin&#x2014;binding ferric iron (Fe3+) and transporting it across the membrane, with key molecules and genetic loci marked. A magnified membrane inset shows type-3 fimbriae, type-1 fimbriae, and lipopolysaccharide structures.</alt-text>
</graphic></fig>
</sec>
<sec id="s4_1_4">
<label>4.1.4</label>
<title>Fimbriae: bacterial adhesins</title>
<p>Bacterial surfaces have filamentous, non-flagellar extensions called fimbriae. Type-1, Type-3, and Kpc are the three types of fimbriae that have been found in <italic>K. pneumoniae</italic>. Bacterial cell surfaces have thin, stiff, hair-like features called Type-1 fimbriae. The <italic>fim</italic> gene cluster controls how these structures are formed, and intercellular pathways and chaperone proteins manage their assembly. Type-1 fimbriae expression is controlled by the <italic>fimK</italic> gene, and its absence results in a deficiency of type-1 fimbriae (<xref ref-type="bibr" rid="B150">Riwu et&#xa0;al., 2022</xref>). <italic>K. pneumoniae&#x2019;</italic>s type-1 fimbriae help the bacteria adhere to host cells that have mannose receptors. Moreover, the <italic>mrkABCD</italic> gene cluster, which can be chromosomal or plasmid-derived, spirally paraphrases Type-3 fimbria. Attachment to host cells is mediated by the <italic>fimH</italic> and <italic>mrkD</italic> genes, which separately encode type-1 and type-3 fimbriae (<xref ref-type="bibr" rid="B155">Shah et&#xa0;al., 2017</xref>). These fimbrial factors promote colonization, invasion, and pathogenicity, collectively increasing virulence. Chaperone and scaffolding proteins encoded by <italic>mrkB, mrkC</italic>, and <italic>mrkF</italic> genes preserve the stability of fimbrial subunits (<xref ref-type="bibr" rid="B160">Singh et&#xa0;al., 2025</xref>).</p>
</sec>
<sec id="s4_1_5">
<label>4.1.5</label>
<title>Secretory systems of bacteria</title>
<p>The secretory systems of <italic>K. pneumoniae</italic> have also been reported as virulence factors in <italic>K. pneumoniae</italic> infections. Hypervirulent <italic>K. pneumoniae</italic> have been shown to have an elevated presence of the Type I Secretion System (T1SS). The diversity of T1SS in <italic>K. pneumoniae</italic> strains indicates the importance of T1SS in infection dynamics. The Type II Secretion System (T2SS) mediates the release of virulence factors, such as the ADP-ribosylating toxin of <italic>K. pneumoniae</italic>. The Type III Secretion System (T3SS), a widely reported pathogenic factor, was not identified in <italic>K. pneumoniae</italic> and remains insufficiently characterized. The Type IV Secretion System (T4SS), commonly found in multidrug-resistant strains, facilitates gene transfer and contributes to antibiotic resistance and virulence. The function of the Type V Secretion System (T5SS) in <italic>K. pneumoniae</italic> remains poorly understood, and its presence is also still unclear (<xref ref-type="bibr" rid="B205">Yang et&#xa0;al., 2023</xref>).</p>
<p>Type VI Secretion System (T6SS) is a molecular mechanism used by <italic>K. pneumoniae</italic> to acquire a competitive advantage against the gut microbiota. This long-term colonization of the gut microbiota involves targeting the bacterial competitors (<xref ref-type="bibr" rid="B129">Merciecca et&#xa0;al., 2022</xref>). Beyond its role in interbacterial competition and microbiota modulation, T6SS also contributes to immune evasion by delivering effector proteins into host cells, such as the VgrG4 effector, which induces mitochondrial fragmentation and activates immune modulators like NLRX (<xref ref-type="bibr" rid="B119">Liu et&#xa0;al., 2023</xref>). This dual function of T6SS in modulating host and microbial interactions underscores its importance in establishing and maintaining <italic>K. pneumoniae</italic> infections (<xref ref-type="bibr" rid="B82">Hsieh et&#xa0;al., 2019</xref>). <italic>K. pneumoniae</italic> employs distinct strategies to evade the innate immune response (<xref ref-type="bibr" rid="B40">Codo et&#xa0;al., 2018</xref>). <italic>Klebsiella</italic> has become a notorious pathogen that exploits stealth strategies and actively suppresses innate immune defenses to overcome host responses while persisting within tissues (<xref ref-type="bibr" rid="B11">Bengoechea and Sa Pessoa, 2019</xref>).</p>
<p>Additional virulence factors in <italic>K. pneumoniae</italic> include efflux pumps, which are involved in functions such as reducing membrane permeability, preventing drug influx, and actively efflux compounds toxic to the pathogens. The presence of the AcrAB-TolC complex in <italic>K. pneumoniae</italic> helps in exporting antibiotics and host-derived antimicrobials. The EefABC efflux pump in <italic>K. pneumoniae</italic> enhances acid and antibiotic resistance, thereby increasing its competitive potential against the host gut microbiota. The RND-type efflux pump, KexD recognizes multiple substrates and functions with AcrA but not with KexA or KexG. The OqxAB, efflux pumps contribute to MDR phenotype in <italic>K. pneumoniae</italic> and can mobilize via plasmid transposition. Notably, the SMR-type efflux pump KpnEF confers resistance to bile, osmotic stress, and promotes capsule synthesis. Likewise, the MFS-type pump KpnGH confers tolerance to antimicrobials and bile salts, and its deficiency causes reduced <italic>K. pneumoniae</italic> growth in hyperosmotic and microaerobic conditions (<xref ref-type="bibr" rid="B18">Borszekova Pulzova et&#xa0;al., 2016</xref>).</p>
<p>In summary, the pathogen&#x2019;s virulence factors modulate protective immunity by disrupting the innate immunity like complement fixation, phagocytosis, etc. Especially, the virulence factors confer an intracellular survival potential by facilitating <italic>K. pneumoniae</italic> to either prevent or remove excess antimicrobial drugs. They further ensure an uninterrupted supply of the limiting factors, for instance, iron and together provide molecular components for firm adhesion to host cells supporting colonization. It is highlighted that reviewing macrophage-specific molecular mechanisms reported to sense microbial invasion and the downstream signaling will help us better understand the host-<italic>K. pneumoniae</italic> interaction.</p>
</sec>
</sec>
</sec>
<sec id="s5">
<label>5</label>
<title>Pathogens&#x2019; recognition by macrophages</title>
<p>The innate immune system serves as the vanguard of the host defense against microbial pathogens, consisting of physical and anatomical barriers, effector cells, antimicrobial peptides, and other soluble factors (<xref ref-type="bibr" rid="B26">Carroll and Janeway, 1999</xref>). Similarly, the innate immune surveillance mechanism within the host confronting microbial pathogens initiates a series of antimicrobial responses determined by the host-pathogen interaction (<xref ref-type="bibr" rid="B107">Kumar et&#xa0;al., 2011</xref>). As previously noted, macrophages are required for antigen presentation and various immunoregulatory functions in different pathophysiological circumstances (<xref ref-type="bibr" rid="B35">Chen et&#xa0;al., 2023</xref>). In case of bacterial infection, macrophages are vital in the initial immune response by engulfing the bacteria, releasing key cytokines and chemokines that attract neutrophils and other immune cells. On the contrary, the depletion of macrophages enhances the host&#x2019;s vulnerability to infections, underscoring their role in regulating bacterial proliferation (<xref ref-type="bibr" rid="B20">Bruhn et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B146">Qiu et&#xa0;al., 2012</xref>).</p>
<p>The detection of microbial pathogens by macrophages is predominantly facilitated by Pattern Recognition Receptors (PRRs), which could be either innate or germline-encoded, identifying PAMPs and Damage-associated Molecular Patterns (DAMPs). The vertebrate innate immune system classifies PRRs into five principal categories based on their protein domain homology: i) Toll-like receptors (TLRs), ii) NLRs, iii) Retinoic acid-inducible gene-I-like Receptors (RLRs), iv) C-type Lectin Receptors (CLRs), and v) Absent in melanoma-2-Like Receptors (ALRs) (<xref ref-type="bibr" rid="B95">Kawai and Akira, 2009</xref>; <xref ref-type="bibr" rid="B114">Li and Wu, 2021</xref>). The PRRs are composed of ligand recognition domains, intermediate domains, and effector domains, which enable them to bind to microbial markers and recruit adaptor molecules.</p>
<p>One of the major PRRs involved in bacterial infections is the TLRs. Host cells sense various microbial invasions through a diverse set of Toll-like receptors, each tuned to specific pathogen-associated molecules. <italic>K. pneumoniae</italic> activates diverse PRRs in macrophages to modulate immune responses and promote its survival. Among Toll-like receptors, TLR4 recognizes <italic>Klebsiella&#x2019;s</italic> lipid A (LPS), capsular polysaccharides (CPS), murein lipoprotein (LppA), and acylpolygalactosyl (APG), TLR2 detects OmpA. TLR3 senses host-derived dsRNA and TLR9 recognizes unmethylated CpG motifs in bacterial DNA (<xref ref-type="bibr" rid="B113">Li et&#xa0;al., 2025</xref>). Multiple signaling cascades are activated as a result of the above interaction between the specific receptors and their ligands (<xref ref-type="bibr" rid="B131">Mogensen, 2009</xref>). <xref ref-type="table" rid="T2"><bold>Table&#xa0;2</bold></xref> summarizes the major receptors found on macrophages, their ligands, and their functions (<xref ref-type="table" rid="T2"><bold>Table&#xa0;2</bold></xref>).</p>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>Major hvKP Serotypes and their features.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="center">Serotype</th>
<th valign="top" align="center">Clinical association</th>
<th valign="top" align="center">Virulence traits</th>
<th valign="top" align="center">References</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">K1 (KL1)</td>
<td valign="top" align="left">Liver abscess, sepsis</td>
<td valign="top" align="left">Highest virulence, sialic acid mimicry</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B101">Ko, 2017</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">K2 (KL2)</td>
<td valign="top" align="left">Meningitis, lung abscess</td>
<td valign="top" align="left">Strong phagocytosis resistance, high serum survival</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B101">Ko, 2017</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">K5</td>
<td valign="top" align="left">Highly virulent capsular type</td>
<td valign="top" align="left">Intra- and extra-pulmonary infections</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B90">Jiang et&#xa0;al., 2024</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">K20</td>
<td valign="top" align="left">Liver abscess</td>
<td valign="top" align="left">Serum survival</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B116">Lin et&#xa0;al., 2017</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">K54</td>
<td valign="top" align="left">Liver abscess, meningitis</td>
<td valign="top" align="left">Moderate virulence</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B201">Xu et&#xa0;al., 2024</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">K57</td>
<td valign="top" align="left">Pyogenic liver abscesses</td>
<td valign="top" align="left">Adhesion and serum resistance</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B201">Xu et&#xa0;al., 2024</xref>)</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Multiple studies have emphasized the importance of these receptors in the pathogenesis of human diseases. Mutations in human TLR4 have shown a higher incidence of Gram-negative infections in already immunocompromised patients compared to wild type (<xref ref-type="bibr" rid="B2">Agnese et&#xa0;al., 2002</xref>). Similarly, in sepsis patients with a single nucleotide polymorphism in their TLR1 gene display a hypermorphic effect leading to increased susceptibility to organ dysfunction and death in comparison to patients with a normal genotype (<xref ref-type="bibr" rid="B195">Wurfel et&#xa0;al., 2008</xref>). Yet another separate meta-analysis study revealed that TLR2-mutated individuals are at a greater risk of tuberculosis development (<xref ref-type="bibr" rid="B85">Hu et&#xa0;al., 2019</xref>). A significantly higher bacterial burden was observed in <italic>Salmonella</italic> colonization of TLR2/4 double-knockout mice, when compared to the wild-type mice (<xref ref-type="bibr" rid="B189">Weiss et&#xa0;al., 2004</xref>). Yet another study has identified that the 3d mice lacking endosomal TLR signaling due to UNC93B1 mutation, which prevented proper localization of endosomal TLRs, causing high susceptibility to <italic>Klebsiella</italic> even at sublethal doses (<xref ref-type="bibr" rid="B42">De Gaetano et&#xa0;al., 2025</xref>).</p>
<sec id="s5_1">
<label>5.1</label>
<title>Pathogen post-recognition and downstream signaling</title>
<p>Upon engagement of TLRs, either of the two signaling pathways-the MyD88-dependent and TRIF-dependent- associates with a characteristic of TLR2 and TLR4 triggering by microbial pathogens. The TLR2/4 triggering recruits MyD88, and associates with IRAK4/IRAK1 (<xref ref-type="bibr" rid="B43">Deguine and Barton, 2014</xref>; <xref ref-type="bibr" rid="B143">Pereira et&#xa0;al., 2022</xref>), subsequently activating TRAF6 (<xref ref-type="bibr" rid="B143">Pereira et&#xa0;al., 2022</xref>). This initiates downstream activation of TAK1, resulting in phosphorylation of MAPKs and&#xa0;activation of NF-&#x3ba;B (<xref ref-type="bibr" rid="B43">Deguine and Barton, 2014</xref>). Finally, promoting the transcription of proinflammatory cytokines like IL-1, IL-6, and TNF-&#x3b1;. On the contrary, the TRIF-dependent pathway, activated primarily by TLR3 and TLR4, recruits TRIF, which interacts with TRAF3 and ultimately activates IRF3, leading to the production of type I interferons (IFNs) (<xref ref-type="bibr" rid="B84">Hu et&#xa0;al., 2015</xref>). The integration of MyD88 and TRIF pathways, particularly in TLR4 signaling, enables a more comprehensive immune response against diverse pathogens (<xref ref-type="bibr" rid="B143">Pereira et&#xa0;al., 2022</xref>).</p>
<p>The MyD88 pathway usually activates NF-&#x3ba;B instantly but only for a short while, whereas the TRIF pathway activates NF-&#x3ba;B and IRF3 more slowly and for longer, leading to the production of both inflammatory cytokines and Type I IFN (<xref ref-type="bibr" rid="B84">Hu et&#xa0;al., 2015</xref>). Certainly, the activation of two pathways induces the production of inflammatory cytokines and fights against microbial pathogens, as depicted in <xref ref-type="fig" rid="f5"><bold>Figure&#xa0;5</bold></xref>. Likewise, NLRP3 and NLRC3 of the NLR family of receptors influence inflammatory responses of macrophages through the development of the inflammasome. NLRP3 activation leads to the formation of the NLRP3 inflammasome, which has ASC and caspase-1 within it, which in turn activate IL-1&#x3b2; and IL-18 (<xref ref-type="bibr" rid="B49">Ding et&#xa0;al., 2024</xref>; <xref ref-type="bibr" rid="B157">Shao et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B206">Yao et&#xa0;al., 2024</xref>). This pathway triggers pyroptosis, a type of cell death that causes inflammation and helps eliminate pathogens by destroying their niche (<xref ref-type="bibr" rid="B157">Shao et&#xa0;al., 2015</xref>). Conversely, NLRC3 acts as a negative regulator by inhibiting TRAF6-mediated NF-&#x3ba;B activation and inflammasome assembly, thus preserving macrophage homeostasis (<xref ref-type="bibr" rid="B56">Eren et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B157">Shao et&#xa0;al., 2015</xref>).</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Recognition of pathogen-associated ligands by TLRs. TLR4,5,1/2 activates MyD88-dependent pathway. In the MyD88-dependent pathway, TIRAP, an adaptor protein, helps transmit signals from TLR4 to MyD88, which then recruits IRAK4 and TRAF6. TRAF6 activates the TAK1&#x2013;TAB1/2 complex, leading to phosphorylation of the IKK complex as well as MAP kinases. The former results in I&#x3ba;B degradation, allowing NF-&#x3ba;B to translocate into the nucleus, whereas the latter results in the phosphorylation and activation of AP-1. Together, NF-&#x3ba;B and AP-1 induce the production of proinflammatory cytokines. In the TRIF-dependent pathway, TLR4 in the late phase recruits TRAM and TRIF, which interact with TRAF6 and converge on the same downstream MyD88 pathway. Endosomal TLR3 signals solely via TRIF, triggering the TBK1/IKK &#x3f5;&#x2013;IRF3 that drives inflammatory gene expression.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-16-1757662-g005.tif">
<alt-text content-type="machine-generated">Diagram illustrating Toll-like receptor (TLR) signaling pathways with membrane-bound receptors recognizing ligands such as lipopeptides, flagellin, and LPS, leading to cascades involving MYD88, MAPK, NF-&#x3ba;B, AP-1, and IRF3, ultimately resulting in the production of interleukins, pro-inflammatory cytokines, IL-1&#x3b2;, and TNF-&#x3b1;.</alt-text>
</graphic></fig>
<p>The functional responses to the signaling in macrophages are disparate and diverse. The DAMPs and PAMPs, when recognized by the PRRs, lead to the production of antimicrobial peptides (AMPs) like defensins and cathelicidins (<xref ref-type="bibr" rid="B10">Basu et&#xa0;al., 2012</xref>). This disrupts the integrity of microbial membranes, thereby eliminates the pathogens. TLR stimulation induces the generation of Reactive Oxygen Species (ROS) and Reactive Nitrogen Species (RNS) through NADPH oxidase and Inducible nitric oxide synthase (iNOS), which have significant efficacy against numerous bacterial species (<xref ref-type="bibr" rid="B25">Canton et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B181">Wang et&#xa0;al., 2019</xref>). The formation of mitochondrial ROS, enabled by the activation of the TRAF6-ECSIT complex, enhances antimicrobial defenses and functions as a secondary messenger in cytokine signaling (<xref ref-type="bibr" rid="B159">Silwal et&#xa0;al., 2020</xref>). The TLR signaling cascade also promotes the release of chemokines and proinflammatory cytokines like TNF-&#x3b1;, IL-6, and IL-1&#x3b2; to the site of infection for effective pathogen clearance. For instance, upon recognizing mycobacteria, TLRs prompt macrophages to produce IL-12 and TNF-alpha. TNF-alpha production during MTB infection has been primarily due to TLR2-triggering (<xref ref-type="bibr" rid="B173">Underhill et&#xa0;al., 1999</xref>; <xref ref-type="bibr" rid="B61">Flynn and Chan, 2001</xref>).</p>
<p>Furthermore, CXCL1 and CCL2 two important cytokines, attract neutrophils and monocytes to the site of infection for an effective immune response against the invading pathogens (T. <xref ref-type="bibr" rid="B121">Liu et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B17">Boro and Balaji, 2017</xref>). Actively withholding the nutrients is an alternative mechanism employed by macrophages to effectively eliminate the invading pathogens. This process is termed nutrient sequestration, also known as nutritional immunity. Restricting the availability of iron for bacterial growth and virulence, is one such mechanism. Similarly, manganese sequestration has been achieved through the action of natural resistance-associated macrophage protein 1 (NRAMP1), which pumps manganese out of the phagosome (<xref ref-type="bibr" rid="B96">Kehl-Fie and Skaar, 2010</xref>; <xref ref-type="bibr" rid="B191">Wessling-Resnick, 2015</xref>). In conclusion, though macrophages possess multiple mechanisms to eliminate pathogens, many intracellular pathogens have evolved sophisticated immune evasion strategies that inhibit macrophage cell death, thereby sustaining the macrophages as a niche for their survival and replication. Therefore, a complete understanding of macrophage cell death and survival mechanisms upon bacterial infection appears to be more essential.</p>
</sec>
</sec>
<sec id="s6">
<label>6</label>
<title>Orchestration of cell death pathways upon <italic>K. pneumoniae</italic> infection</title>
<p>Programmed cell death is a regulated process mediated by specific molecular machinery for maintaining health, and it also contributes to the pathogenesis of various diseases. A crucial aspect of the immune responses during bacterial infections is the coordinated regulation of host cell death pathways, comprising apoptosis, necroptosis, and pyroptosis (<xref ref-type="bibr" rid="B178">Wanford et&#xa0;al., 2022</xref>). The cell death pathways fall into two main classifications: i) Accidental Cell Death (ACD) and ii) Regulated Cell Death (RCD) (<xref ref-type="bibr" rid="B110">Lee et&#xa0;al., 2023</xref>). ACD happens because of major catastrophic events, while RCD involves programmed cell death (<xref ref-type="bibr" rid="B63">Galluzzi et&#xa0;al., 2015</xref>). RCD types include apoptosis, autophagy, necrosis, lysosome-dependent cell death, and pyroptosis; all of which are sites of morphological and biochemical changes, although some of them may have some similarities in mechanism (<xref ref-type="bibr" rid="B40">Codo et&#xa0;al., 2018</xref>).</p>
<sec id="s6_1">
<label>6.1</label>
<title>Inflammatory cell death</title>
<p>Necrosis, an unregulated form of cell death, occurs due to acute injury. Numerous changes occur during necrosis, such as cellular swelling, membrane rupture, and discharge of intracellular contents, which activate an immune response (<xref ref-type="bibr" rid="B168">Tonnus et&#xa0;al., 2019</xref>). In contrast, necrosis is not caspase-mediated; rather, it is frequently reported in instances involving inflammation beyond the boundaries of the tissue area. <italic>K. pneumoniae</italic> causes necrosis of HepG2 cells through ROS generation, membrane rupture, and secretion of endogenous ligands, i.e., DAMPs, that exacerbate tissue damage. By destabilizing cellular integrity and promoting lysosomal enzyme release, <italic>K. pneumoniae</italic> amplifies inflammation, disrupts hepatocyte function, and facilitates bacterial spread (<xref ref-type="bibr" rid="B203">Yang et&#xa0;al., 2012</xref>).</p>
<p>Pyroptosis is an inflammatory form of RCD that occurs due to infection or cellular stress, which leads to the formation of pores in the plasma membrane by proteins known as gasdermins (<xref ref-type="bibr" rid="B210">Yu et&#xa0;al., 2021</xref>). It is characterized by the production of pro-inflammatory cytokines, such as IL-1&#x3b2; and IL-18, that boost immunity. <italic>K.&#xa0;pneumoniae</italic> activates the NLRP3 and NLRC4 inflammasomes in bone-marrow-derived macrophage cells, leading to caspase-1 activation and IL-1&#x3b2; production. <italic>K. pneumoniae</italic> strains like A28006 induce robust pyroptosis, releasing lactate dehydrogenase (LDH) and pro-inflammatory mediators that promote bacterial clearance. In contrast, the A54970 strain of <italic>K. pneumoniae</italic> suppresses inflammasome activation and pyroptosis by enhancing IL-10 production, which inhibits caspase-1 activity and IL-1&#x3b2; secretion, facilitating bacterial survival and dissemination. Consequently, pyroptosis raises the bacteria&#x2019;s vulnerability to microbicidal agents such as hydrogen peroxide, underscoring its protective role in host defense (<xref ref-type="bibr" rid="B40">Codo et&#xa0;al., 2018</xref>).</p>
</sec>
<sec id="s6_2">
<label>6.2</label>
<title>Non-inflammatory cell death</title>
<p>Apoptosis is a programmed form of cell death for maintaining tissue homeostasis and involves the systematic degradation of cellular components through caspase activation. It is characterized by cell shrinkage, chromatin condensation, and apoptotic body formation, occurring through intrinsic or extrinsic pathways. <italic>Neisseria gonorrhoeae</italic> induces macrophage apoptosis primarily via the mitochondrial pathway, modulating pro-apoptotic and anti-apoptotic factors such as Bax and Bcl-xL (<xref ref-type="bibr" rid="B46">Dell&#x2019;Annunziata et&#xa0;al., 2024</xref>). Additionally, <italic>K. pneumoniae</italic>-derived Outer membrane vesicles (OMVs) strengthen this pro-apoptotic effect by increasing the expression of Bax and Bim, while decreasing Bcl-xL, as well as disrupting the mitochondrial membrane and releasing cytochrome c during infection of HepG2 cells. The entire process involves the activation of Apaf-1, followed by the activation of caspase-9. However, <italic>K. pneumoniae</italic> has the ability to delay apoptosis of immune cells like neutrophils by modulating the Bax/Bcl-2 ratio and increasing Mcl-1 expression, which inhibits caspase-3 activation. Therefore, the pathogen exists inside cells over an extended period of time, avoiding immune defense mechanisms, whereas exacerbation of apoptosis has been reported under certain circumstances, such as with hypervirulent strains. Thus, <italic>K. pneumoniae</italic> inhibits efferocytosis, thereby escalating secondary necrosis, inflammation, and bacterial dissemination (<xref ref-type="bibr" rid="B203">Yang et&#xa0;al., 2012</xref>).</p>
<p>Autophagy is a major cellular pathway that is fundamentally based on the degradation of cytosolic components packed into autophagosomes, which in turn fuse with lysosomes for their degradation. Autophagy activation by the PI3K-AKT-mTOR pathway is enabled by bacterial degradation during <italic>K. pneumoniae</italic> infection of <italic>Caenorhabditis elegans</italic> (<xref ref-type="bibr" rid="B94">Kamaladevi and Balamurugan, 2017</xref>). Although the pathogen subverts this process by recruiting Rab14 to block phagosome maturation and Atg7 to prevent inflammation. These strategies are well documented, but the molecular details of how <italic>K. pneumoniae</italic> exploits host autophagy machinery remain incomplete. However, not much is known about how specific virulence factors and host receptors regulate autophagy modulation during infection. Furthermore, there is an important need to connect autophagy with other immune responses, such as cytokine production and cell death. These gaps confirm the need for further detailed investigation studies to unravel the manipulation of&#xa0;autophagy by <italic>K. pneumoniae</italic> (<xref ref-type="bibr" rid="B188">Wei et&#xa0;al., 2023</xref>). Autophagy is a&#xa0;mechanism used by macrophage for resistance against <italic>K.&#xa0;pneumoniae</italic> infection. Research shows that <italic>K. pneumoniae</italic> can activate ATG7, which is in turn involved in autophagosomal membrane elongation, triggering autophagy. The <italic>atg7</italic> KO mice are more susceptible to <italic>K. pneumoniae</italic> infection, have reduced bacterial clearance, enhanced lung injury, and decreased survival rates. The mechanism involves ATG7 competitively inhibiting the interaction between p-I&#x3ba;B&#x3b1; and ubiquitin, reducing p-I&#x3ba;B&#x3b1; ubiquitination, which promotes NF-&#x3ba;B translocation to the nucleus, and increasing inflammatory damage (<xref ref-type="bibr" rid="B113">Li et&#xa0;al., 2025</xref>).</p>
<p>Ferroptosis is a distinct form of iron-dependent regulated cell death driven by the accumulation of lipid peroxides to lethal levels within the cells (<xref ref-type="bibr" rid="B50">Dixon et&#xa0;al., 2012</xref>). This phenomenon has been associated with disrupted iron homeostasis, oxidative stress due to increased ROS, and suppression of antioxidant status, especially through glutathione peroxidase 4 (GPX4) (<xref ref-type="bibr" rid="B200">Xie et&#xa0;al., 2016</xref>). As an emerging area of study, ferroptosis has been investigated for its role in various diseases, offering potential therapeutic avenues. In bacterial and viral infections, ferroptosis displays diverse interactions. For example, an opportunistic pathogen, <italic>Pseudomonas aeruginosa</italic> causes ferroptosis in bronchial epithelial cells through the production of 15-hydroperoxy-AA-PE via its lipoxygenase enzyme, pLoxA (<xref ref-type="bibr" rid="B153">Sadikot et&#xa0;al., 2005</xref>). The RNS produced by host macrophages can, in turn, neutralize this process and inhibit phospholipid peroxidation.</p>
<p><italic>M. tuberculosis</italic> infection induces ferroptosis in host macrophages by decreasing GPX4 levels and increasing lipid peroxidation, ROS, and free iron concentrations. Although iron chelation and ferroptosis inhibitors such as ferrostatin-1 can mitigate these effects, <italic>Mycobacterium</italic> employs secreted proteins to neutralize ROS, thereby complicating its interaction with ferroptosis pathways (<xref ref-type="bibr" rid="B5">Amaral et&#xa0;al., 2019</xref>). In viral infections, particularly those caused by SARS-CoV-2, ferroptosis is an important factor in disease progression (<xref ref-type="bibr" rid="B198">Xia et&#xa0;al., 2021</xref>). SARS-CoV-2 disrupts iron metabolism, resulting in iron overload and excessive ROS production, while also suppressing GPX4 expression. These alterations accelerate lipid peroxidation and cell death. Therapeutic strategies, including selenium supplementation and iron chelation, have demonstrated potential to reduce the damage associated with SARS-CoV-2-induced ferroptosis (<xref ref-type="bibr" rid="B183">Wang et&#xa0;al., 2021</xref>).</p>
<p>The involvement of ferroptosis in <italic>K. pneumoniae</italic> infections appears to vary by cell type. In bovine mammary epithelial cells, infection with <italic>K. pneumoniae</italic> triggers classical ferroptosis, characterized by iron accumulation, increased lipid peroxidation, enhanced ROS levels, and a suppression of the Nrf2/xCT/GPX4 antioxidant pathway, ultimately resulting in epithelial injury and&#xa0;inflammatory responses. The use of ferrostatin-1 to inhibit ferroptosis restores antioxidant signaling and reduces inflammation, emphasizing ferroptosis as a major contributor to tissue damage during mastitis (<xref ref-type="bibr" rid="B124">Mao et&#xa0;al., 2025</xref>). Conversely, in a mouse model of pulmonary infection, carbapenem-resistant hypervirulent <italic>K. pneumoniae</italic> inhibits ferroptosis-related pathways in macrophages by upregulating SLC7A11 and glutathione, which restricts iron-dependent oxidative stress and promotes the survival of bacteria within cells. Interestingly, reactivation of lipid peroxidation related to ferroptosis in macrophages improves bacterial clearance without causing significant macrophage death (<xref ref-type="bibr" rid="B209">Yu et&#xa0;al., 2025</xref>). Recent macrophage infection models further support this distinction by demonstrating modulation of iron-dependent oxidative stress pathways. These include alterations in glutathione metabolism, lipid peroxidation, and ferroptosis-associated regulators such as SLC7A11. Such findings suggest the presence of ferroptosis-associated redox signaling rather than the execution of classical ferroptotic cell death. Collectively, these results underscore a context-dependent role for ferroptosis in <italic>K. pneumoniae</italic> pathogenesis. Epithelial ferroptosis appears to contribute to tissue injury, whereas suppression of ferroptosis-associated oxidative mechanisms in macrophages promotes immune evasion and intracellular persistence. <xref ref-type="fig" rid="f6"><bold>Figure&#xa0;6</bold></xref> summarizes the inflammatory and non-inflammatory forms of cell death. Although apoptosis, autophagy, necrosis, and pyroptosis are well-established contributors to macrophage responses during <italic>K. pneumoniae</italic> infection, the precise contribution of ferroptosis in immune cells remains incompletely understood and requires further investigation.</p>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>Induction of inflammatory and non-inflammatory cell death. <bold>(A)</bold> Necrosis, an unregulated form of cell death. Excessive generation of ROS levels promotes oxidative membrane damage and loss of cellular integrity, leading to necrosis. <bold>(B)</bold> Pyroptosis is an inflammatory form of RCD characterized by the production of pro-inflammatory cytokines, such as IL-1&#x3b2; and IL-18, and occurs due to infection or cellular stress, which results in the formation of a pore in the plasma membrane by gasdermin. <italic>K</italic>. <italic>pneumoniae</italic> activates the NLRP3 and NLRC4 inflammasomes in Bone-marrow-derived macrophage cells, leading to caspase-1 activation and IL-1&#x3b2; production. <bold>(C)</bold> Induction of macrophage apoptosis by modulating pro-apoptotic and anti-apoptotic factors such as BAX and Bcl-xL via mitochondrial disruption, leading to the release of cytochrome c. <bold>(D)</bold> Ferroptosis is a distinct form of iron-dependent regulated cell death driven by the accumulated ROS, leading to the oxidation of polyunsaturated fatty acids in the plasma membrane.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-16-1757662-g006.tif">
<alt-text content-type="machine-generated">Four labeled scientific cell illustrations show different cell death mechanisms. Panel A depicts a cell with three red reactive oxygen species (ROS) bursts. Panel B shows a cell with activated NLRP3/NLRC4, caspase-1, gasdermin pores, and IL-1&#x3b2; release. Panel C highlights mitochondrial damage, increased Bax/Bim, decreased BCL-XL, and a mitochondrion. Panel D illustrates mitochondrial damage, iron (Fe), ROS, reactive nitrogen species (RNS), oxygen (O2), and lipid peroxidation.</alt-text>
</graphic></fig>
</sec>
</sec>
<sec id="s7">
<label>7</label>
<title>Autophagy as a survival strategy in infected macrophages</title>
<p>Autophagy is a highly conserved process through which eukaryotic cells sequester their own cytoplasmic contents into a phagophore and later recycle them via lysosomes for the metabolic processes of the cell (<xref ref-type="bibr" rid="B71">Gomes and Dikic, 2014</xref>). Autophagy is classified into three types, namely Macroautophagy, microautophagy, and chaperone-mediated autophagy (CMP) (<xref ref-type="bibr" rid="B140">Parzych and Klionsky, 2014</xref>). Macroautophagy makes use of autophagosomes to traffic the extracellular components into the cell, which subsequently fuses with lysosomes for degradation. The cytosolic components are directly taken up by the lysosomes via membrane invagination in microautophagy, whereas chaperons transport the targeted proteins across the lysosomal membrane for their degradation in CMP (<xref ref-type="bibr" rid="B69">Glick et&#xa0;al., 2010</xref>).</p>
<sec id="s7_1">
<label>7.1</label>
<title>Autophagic mechanisms in pathogen elimination</title>
<p>The host cells utilize the mechanism of autophagy for their survival upon infection and manage pathogen elimination, regulate inflammation, and maintain cellular homeostasis (<xref ref-type="bibr" rid="B9">Bah and Vergne, 2017</xref>). This mechanism allows macrophages to eliminate intracellular pathogens by a process called xenophagy (<xref ref-type="bibr" rid="B71">Gomes and Dikic, 2014</xref>), or discard damaged organelles via mitophagy (<xref ref-type="bibr" rid="B208">Youle et&#xa0;al., 2014</xref>), and further modulate immune signaling pathways. Autophagy has been triggered by multiple events that stimulate innate immune signaling to fulfill dual protective functions: eliminating inflammatory causes and curtailing excessive immune activation. The above interaction facilitates efficient pathogen elimination while reducing uncontrolled inflammation (<xref ref-type="bibr" rid="B33">Chauhan et&#xa0;al., 2022</xref>). Thus, the interplay between autophagy and inflammation is crucial for maintaining cellular homeostasis during infection and innate immune activation.</p>
<sec id="s7_1_1">
<label>7.1.1</label>
<title>Xenophagy: discriminatory elimination of intracellular pathogens</title>
<p>Xenophagy is a form of selective autophagy that targets invading microbes for lysosomal degradation. The pathogens that enter host cells initially reside in a pathogen-containing vacuole (<xref ref-type="bibr" rid="B31">Chaudhary and Miller, 2019</xref>). When these vacuoles rupture, bacterial components are exposed in the cytoplasm, which are then tagged with ubiquitin molecules. Consequently, the tagged molecules are recognized by autophagy receptors, which then fuse with lysosomes, degrading the bacterial components (<xref ref-type="bibr" rid="B112">Levine, 2005</xref>). In <italic>Salmonella typhimurium</italic>, galectins identify compromised phagosomal membranes and activate ubiquitin ligases, thereby initiating xenophagy in endothelial cells (<xref ref-type="bibr" rid="B14">Birmingham et&#xa0;al., 2006</xref>). In macrophages, during wild-type <italic>M. tuberculosis</italic> infection, the bacterial ESX-1 system tags bacterial components through ubiquitination and subsequently delivers them to autophagosomes (<xref ref-type="bibr" rid="B187">Watson et&#xa0;al., 2012</xref>). In addition to conventional autophagy, macrophages utilize LC3-associated phagocytosis (LAP), a non-canonical mechanism that directly conjugates LC3 to single membrane phagosome-forming structures called LAPosomes, which then mature into phagolysosomes. LAP relies on Rubicon, Beclin-1, and ROS generated from NADPH oxidase 2 (NOX2) for its initiation (<xref ref-type="bibr" rid="B70">Gluschko et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B80">Herb et&#xa0;al., 2020</xref>). The intracellular pathogen <italic>Listeria monocytogenes</italic> has been reported to be killed by LAP in macrophages rather than the canonical autophagy pathway (<xref ref-type="bibr" rid="B70">Gluschko et&#xa0;al., 2018</xref>).</p>
</sec>
</sec>
<sec id="s7_2">
<label>7.2</label>
<title>Autophagy in the regulation of inflammation</title>
<p>Autophagy alleviates inflammasomal activation by eliminating damaged mitochondria through mitophagy (<xref ref-type="bibr" rid="B185">Wang S. et&#xa0;al., 2023</xref>). Dysfunctional mitochondria emit ROS and disperse their mitochondrial DNA (mtDNA), which are powerful activators of the NLRP3 inflammasome. NLRP3 inflammasome has been reported for its host defense against multiple bacterial invasions (<xref ref-type="bibr" rid="B97">Kelley et&#xa0;al., 2019</xref>). In <italic>P. aeruginosa</italic> infections, the deficiency of Atg7 in macrophages leads to the buildup of mtDNA and increased release of IL-1&#x3b2;, inducing pyroptosis (<xref ref-type="bibr" rid="B144">Pu et&#xa0;al., 2017</xref>). Furthermore, autophagy directly degrades inflammasome components through proteins like TRIM20 and Immunity-Related GTPase family M (IRGM). These proteins interact with inflammasome subunits, such as NLRP3 and AIM2, inducing autophagic destruction (<xref ref-type="bibr" rid="B170">Traver et&#xa0;al., 2011</xref>). Additionally, autophagy governs immune responses by influencing cytokine production and macrophage polarization (<xref ref-type="bibr" rid="B194">Wu and Lu, 2019</xref>). M2 macrophages lacking Atg5 exhibit a proinflammatory transformation to M1-like phenotype characterized by elevated production of TNF-&#x3b1; and IL-6. These findings highlight autophagy as a pivotal regulator in modulating pro- and anti-inflammatory macrophage states.</p>
</sec>
<sec id="s7_3">
<label>7.3</label>
<title>Pathogen tactics to undermine autophagy</title>
<p>It is imperative that pathogens develop novel strategies that sabotage host surveillance and elimination mechanisms. The&#xa0;intracellular defense mechanisms, like production of ROS, RNS, phagosome-lysosome fusion and degradation pathways, must be evaded successfully for intracellular survival (<xref ref-type="bibr" rid="B41">Colombo, 2005</xref>). To circumvent xenophagy, pathogens have developed strategies to avoid their detection. For example, <italic>L. monocytogenes</italic> synthesizes ActA and InlK proteins that attract host actin and major vault protein and thus camouflages under the host proteins and thereby inhibits detection by autophagy receptors (<xref ref-type="bibr" rid="B54">Dortet et&#xa0;al., 2012</xref>). <italic>Francisella tularensis</italic> synthesizes O-antigen polysaccharides that protect the bacterium from cytosolic sensors, thus evading autophagic targeting (<xref ref-type="bibr" rid="B89">Jessop et&#xa0;al., 2025</xref>). Pathogens can suppress autophagy induction as seen in <italic>S. typhimurium</italic> infection. The bacteria stimulate the mTOR pathway through FAK/AKT signaling and degrade AMPK, hence inhibiting autophagy (<xref ref-type="bibr" rid="B64">Ganesan et&#xa0;al., 2017</xref>). Likewise, <italic>M. tuberculosis</italic> employs host miRNA miR-30c-1-3p to suppress the production of ATG4B and ATG9B, thereby obstructing autophagosome biogenesis (<xref ref-type="bibr" rid="B141">Peng et&#xa0;al., 2025</xref>). Some pathogens utilize the autophagic route as a site for replication. <italic>Brucella melitensis</italic> stimulates the production of autophagosomes to create Brucella-Containing Vacuoles (BCVs), facilitating bacterial multiplication (<xref ref-type="bibr" rid="B145">Qin et&#xa0;al., 2024</xref>). Similarly, <italic>Coxiella burnetii</italic> utilizes the effector protein Cig2 to facilitate the fusion of autophagosomes with its vacuole, thereby enlarging the replicative compartment and enhancing bacterial viability (<xref ref-type="bibr" rid="B103">Kohler et&#xa0;al., 2016</xref>).</p>
<p>Macrophages employ diverse cell death pathways during <italic>K. pneumoniae</italic> infection, forming a unified model where autophagy serves as the primary defense mechanism, while <italic>K. pneumoniae</italic> strategically shifts the balance toward inflammatory lysis (pyroptosis/necroptosis) and away from immunologically silent apoptosis to evade clearance, thereby amplifying pathogenesis. Autophagy, driven by ATG7 activation, promotes KP degradation via autophagolysosome formation, but <italic>K. pneumoniae</italic> evades this by PI3K&#x2013;AKT&#x2013;mTOR/Rab14-mediated xenophagy, allowing intracellular replication. <italic>K. pneumoniae</italic> preferentially induces pyroptosis (NLRP3/NLRC4/caspase-1/11&#x2013;GSDMD) and necroptosis, which release IL-1&#x3b2;/IL-18 and DAMPs to recruit neutrophils while compromising membrane integrity for bacterial escape; deficiencies in these pathways (NLRP3, caspase-11, NLRC4, IL-1R1) increase mortality by impairing early phagocytic killing, highlighting their net protective role despite pathology. Conversely, <italic>K. pneumoniae</italic> suppresses apoptosis via CPS-mediated Bax/Bcl-2 modulation and Mcl-1 upregulation (primarily in neutrophils, with macrophage implications), preventing PS exposure and efferocytosis to favor dissemination (<xref ref-type="bibr" rid="B113">Li et&#xa0;al., 2025</xref>).</p>
</sec>
<sec id="s7_4">
<label>7.4</label>
<title>Implications of autophagy dysregulation</title>
<p>Genetic and functional defects in autophagy compromise the macrophages&#x2019; capacity to eliminate intracellular infections. Studies have shown that conditional knockout of Atg5 in myeloid cell lineages resulted in increased <italic>M. tuberculosis</italic> burden. Similarly, the deficiency of Atg7 in alveolar macrophages worsens <italic>P. aeruginosa</italic> sepsis due to impaired mitophagy (<xref ref-type="bibr" rid="B186">Wang et&#xa0;al., 2025</xref>; <xref ref-type="bibr" rid="B144">Pu et&#xa0;al., 2017</xref>). The absence of autophagy leads to unregulated inflammasome activation and increased inflammatory damage. Ultimately, a defect in autophagy leads to increased metabolic depletion of macrophages. Notably, the accumulation of impaired mitochondria and misfolded protein aggregates depletes energy reserves, which further impair phagocytic function and reduce cellular viability upon infection or food deprivation (<xref ref-type="bibr" rid="B164">Tabibzadeh, 2023</xref>). Autophagy in macrophages functions at the intersection of antimicrobial defense, inflammatory management, and cellular homeostasis and is involved in eradicating intracellular infections. However, it is often exploited and undermined by many pathogens (<xref ref-type="bibr" rid="B41">Colombo, 2005</xref>; <xref ref-type="bibr" rid="B141">Peng et&#xa0;al., 2025</xref>; <xref ref-type="bibr" rid="B145">Qin et&#xa0;al., 2024</xref>; <xref ref-type="bibr" rid="B103">Kohler et&#xa0;al., 2016</xref>).</p>
<p>Intracellular pathogens prevent macrophage death to promote their replication. For example, the obligate intracellular pathogen <italic>C. burnetii</italic> releases effectors that prevent mitochondria-dependent apoptosis and also inhibit pyroptosis through IcaA-mediated suppression of caspase-11. It is also reported that NLRP3/caspase-1activation is observed due to cytosolic LPS exposure. On the contrary, Legionella pneumophila utilizes its T4SS for prolonged activation of NF-&#x3ba;B signaling to increase pro-survival factors such as BCL-2 and SidF. Likewise, <italic>Leishmania</italic> subverts macrophage apoptosis by activating the host PI3K/AKT pathways, which leads to the phosphorylation of BAD, further promoting cell survival (<xref ref-type="bibr" rid="B39">Chow et&#xa0;al., 2016</xref>). However, pathogens have developed intricate strategies to counteract autophagy, leading to a dynamic interaction that influences infection outcomes. Unraveling how pathogens exploit macrophage survival to ensure their own persistence promises novel avenues.</p>
</sec>
</sec>
<sec id="s8">
<label>8</label>
<title>Impact of <italic>K. pneumoniae</italic> infection on macrophage defense mechanisms</title>
<p>Besides having a primary role in identification and eliminating pathogens, macrophages have also served as a bridge between innate and adaptive immunity. Therefore, it&#x2019;s no surprise that human pathogens like K. pneumoniae have evolved sophisticated strategies that manipulate macrophage defense mechanisms in their favor, enabling survival and replication within the host. In particular, macrophages infected with <italic>K. pneumoniae</italic> exhibit increased glycolysis and activation of the IRG1&#x2013;itaconate anti-inflammatory pathway, a hallmark of rearrangement of the TCA cycle (<xref ref-type="bibr" rid="B113">Li et&#xa0;al., 2025</xref>). <italic>K. pneumoniae</italic> can adapt and exploit the microenvironment of the host. This adaptability is the reason behind its pathogenic success. The bacterium alters macrophage responses by inducing an IFN-mediated signaling cascade that promotes an anti-inflammatory macrophage phenotype. This phenotype is defined by increased production of IL-10, which suppresses AIM2 inflammasome activation and reduces secretion of IL-1&#x3b2;, thereby facilitating bacterial persistence.</p>
<p>Furthermore, <italic>K. pneumoniae</italic> manipulates the Toll/interleukin-1 receptor domain-containing adaptor molecule 1 (TICAM-1) to suppress MyD88- and TRIF-mediated inflammatory pathways. This downregulates the activation of key mitogen-activated protein (MAP) kinases, including extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK), which impairs robust immune responses (<xref ref-type="bibr" rid="B58">Feriotti et&#xa0;al., 2022</xref>; <xref ref-type="bibr" rid="B98">Kim et&#xa0;al., 2021</xref>). The STAT6-IL-10 axis is also important in the aspect of immune modulation by <italic>K. pneumoniae</italic>. Transferrin receptor 1 (TFR1) expression in macrophages is induced by the activation of this pathway, which in turn increases iron uptake and promotes intracellular survival of bacteria. Inhibition of IL-10 or STAT6 markedly reduces TFR1 expression, limiting iron availability and decreasing its survival (<xref ref-type="bibr" rid="B74">Grubwieser et&#xa0;al., 2023</xref>). A novel macrophage polarization state, termed &#x201c;M(Kp),&#x201d; has been identified by recent studies during infection with <italic>K. pneumoniae</italic>. This anti-inflammatory M2-like polarization state differs from any of the known M2 subtypes and is driven explicitly by activation of the TLR2/4-type I IFN&#x2013;IL-10&#x2013;STAT6 signaling axis (<xref ref-type="bibr" rid="B55">Dumigan et&#xa0;al., 2022</xref>). The key markers in M(Kp) polarization include Fizz1, Arg1, iNOS, CD163, CD206, and type I IFN and IL-10 signaling-regulated genes, along with a reduction of MHC-II and iNOS expression (<xref ref-type="bibr" rid="B113">Li et&#xa0;al., 2025</xref>) as depicted in <xref ref-type="fig" rid="f7"><bold>Figure&#xa0;7</bold></xref>.</p>
<fig id="f7" position="float">
<label>Figure&#xa0;7</label>
<caption>
<p>Macrophage polarization upon <italic>K. pneumoniae</italic> infection. <italic>K. pneumoniae</italic> induces a polarization state, M(Kp), resembling M2 macrophages. This state is mediated by STAT6 signaling and characterized by upregulation of Arg1, Fizz1, iNOS, CD163, and CD206.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-16-1757662-g007.tif">
<alt-text content-type="machine-generated">Illustration shows the process of macrophage polarization during Klebsiella pneumoniae (Kpn) infection, with a macrophage containing Kpn bacteria, activation of STAT6, and a note listing key markers: Arg1, Fizz1, iNOS, CD163, CD206.</alt-text>
</graphic></fig>
<p>Disruption of anatomical barriers is a cornerstone of the <italic>Klebsiella</italic> pathogenesis. Chronic obstructive pulmonary disease (COPD), smoking, and mechanical ventilation weaken the epithelial integrity of the respiratory tract. This facilitates bacterial adherence and invasion (<xref ref-type="bibr" rid="B76">Hakansson et&#xa0;al., 2018</xref>). CP and fimbriae help in adherence to epithelial cells and resistance to immune clearance (<xref ref-type="bibr" rid="B8">Asokan et&#xa0;al., 2025</xref>). In the gastrointestinal tract, <italic>K. pneumoniae</italic> is normally a commensal organism. However, under conditions such as antibiotic-induced dysbiosis, it can transition to a pathogenic state (<xref ref-type="bibr" rid="B92">Joseph et&#xa0;al., 2021</xref>). Dysbiosis allows <italic>K. pneumoniae</italic> to dominate the gut microbiome, adhere to the intestinal lining, and translocate to sterile sites, resulting in systemic infections. Hypervirulent strains intensify this process via enhanced adhesive and immune-evasive properties (<xref ref-type="bibr" rid="B83">Hsu et&#xa0;al., 2015</xref>). Antibiotic pre-treatment can trigger dissemination of <italic>K. pneumoniae</italic> from the gut to other tissues, including the liver and spleen, with both capsular polysaccharides and the T6SS playing an important role in successful colonization (<xref ref-type="bibr" rid="B23">Calderon-Gonzalez et&#xa0;al., 2023</xref>).</p>
<p><italic>K. pneumoniae</italic> demonstrates notable phenotypic plasticity, allowing it to survive in various host environments. For example, Selective pressures, such as immune responses or nutrient limitations during urinary tract infections, can switch hyper-mucoviscous (hvKP) strains to hypo-mucoviscous forms. This will increase the bacterial adhesion to epithelial cells and support biofilm formation, facilitating chronic colonization while decreasing systemic virulence (<xref ref-type="bibr" rid="B161">Song et&#xa0;al., 2024</xref>). OMVs constitute another adaptive strategy utilized by <italic>K. pneumoniae</italic> (<xref ref-type="bibr" rid="B115">Liang et&#xa0;al., 2022</xref>). OMVs transport bioactive molecules, like toxins, LPS, and nucleic acids, that modulate host immune responses, promote antibiotic resistance, and facilitate immune evasion. Additionally, OMVs are involved in promoting the dissemination of resistance and virulence factors, as well as horizontal gene transfer within bacterial populations (<xref ref-type="bibr" rid="B122">Lu et&#xa0;al., 2025</xref>). <italic>K. pneumoniae</italic>&#x2019;s genomic plasticity and its accessory genome help in its adaptability and rapid acquisition of mobile genetic elements encoding resistance mechanisms and virulence factors. This genetic variability enhances the pathogens&#x2019; ability to evade immune defense and adapt to environmental conditions (<xref ref-type="bibr" rid="B57">Faruk et&#xa0;al., 2024</xref>).</p>
<p>Phagocytosis is an important determinant of macrophage-mediated clearance of <italic>K. pneumoniae</italic>. Clinical isolates show differences in susceptibility to macrophage phagocytosis, with hypermucoviscous strains being particularly resistant (van der <xref ref-type="bibr" rid="B67">Geest et&#xa0;al., 2023</xref>). Capsule confers resistance to the bacterium by inhibiting recognition by macrophage receptors and preventing opsonization. But the capsule-mutants are readily phagocytosed and are less virulent, highlighting the capsule&#x2019;s role in immune evasion (<xref ref-type="bibr" rid="B188">Wei et&#xa0;al., 2023</xref>). Once internalized, <italic>K. pneumoniae</italic> manipulates phagosome maturation to promote its survival. It inhibits phagosome-lysosome fusion, promoting their replication in vacuolar compartments known as the <italic>Klebsiella</italic>-containing vacuole. This adaptation enables intracellular persistence and protects against lysosomal degradation (<xref ref-type="bibr" rid="B24">Cano et&#xa0;al., 2015</xref>).</p>
<p>Macrophages produce ROS as antimicrobial agents (<xref ref-type="bibr" rid="B169">Tran and Mills, 2024</xref>). <italic>K. pneumoniae</italic> resists ROS-mediated killing via antioxidant mechanisms, like its polysaccharide capsule and LPS (<xref ref-type="bibr" rid="B11">Bengoechea and Sa Pessoa, 2019</xref>). For example, infections caused by carbapenamase producing <italic>K. pneumoniae</italic> (KPC)-ST258, which are a major cause of healthcare-associated infections worldwide and the polysaccharide part of LPS is responsible for the inhibition of fMLP-induced ROS. <italic>K. pneumoniae</italic> KPC ST258 is a poor inducer of the main bactericidal responses of PMN, ROS generation, and NETs formation compared to another opportunistic Gram-negative bacillus, like <italic>E. coli</italic> (<xref ref-type="bibr" rid="B27">Castillo et&#xa0;al., 2019</xref>). These structures neutralize oxidative stress and facilitate bacterial survival within the hostile intracellular environment of macrophages. <xref ref-type="fig" rid="f8"><bold>Figure&#xa0;8</bold></xref>, depicts the major immune evasion mechanisms by <italic>K. pneumoniae.</italic> The pathogen modifies macrophages&#x2019; cytokine production to facilitate its survival. The CP induces macrophages to produce the pro-inflammatory cytokines, TNF-&#x3b1; and IL-6 (<xref ref-type="bibr" rid="B204">Yang et&#xa0;al., 2011</xref>).</p>
<fig id="f8" position="float">
<label>Figure&#xa0;8</label>
<caption>
<p><italic>K. pneumoniae</italic> subverting host innate immune defense. <italic>K. pneumoniae</italic> evades host defenses through multiple strategies, including inhibition of phagosome lysosome fusion, inhibition of phagocytosis, blocks C3b deposition to evade CR1-mediated macrophage recognition and blocking ROS-mediated killing.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-16-1757662-g008.tif">
<alt-text content-type="machine-generated">Diagram illustrating how Kpn bacteria evade macrophage killing by reducing phagocytosis, inhibiting phagosome-lysosome fusion, blocking ROS-mediated killing, and preventing C3b deposition for CR1 recognition.</alt-text>
</graphic></fig>
<p>The OmpA protein family, a surface-exposed porin, represents a crucial outer membrane protein (OMP) in <italic>K. pneumoniae</italic>. Experimental evidence indicates that deletion of OmpA in <italic>K. pneumoniae</italic> results in increased IL-8 production in bronchial epithelial cells, along with elevated TNF-&#x3b1; and IL-6 levels in mouse lungs. These findings suggest that OmpA may play a significant role in suppressing cytokine secretion by macrophages (<xref ref-type="bibr" rid="B125">March et&#xa0;al., 2011</xref>). Additionally, macrophages that are deficient in Regnase-1, a protein that regulates IL-17 and type I interferon responses, exhibit increased resistance to <italic>K. pneumoniae</italic> infection. These macrophages exhibited enhanced type I interferon signaling that promoted better bacterial clearance (<xref ref-type="bibr" rid="B171">Trevejo-Nu&#xf1;ez et&#xa0;al., 2021</xref>). Collectively, these demonstrate the potential to modulate cytokine pathways to improve infection outcomes. <italic>K. pneumoniae</italic> alters macrophage cell death pathways, like apoptosis, pyroptosis, to avoid detection by the immune system. By promoting anti-apoptotic signaling via extracellular signal-regulated kinase (ERK) 1/2, K. pneumoniae inhibits macrophage apoptosis, allowing the pathogen to use these cells as a site for replication and dissemination. On the other hand, hypervirulent strains can trigger excessive inflammation that leads to necroptosis, which plays a role in causing tissue damage and disrupting immune function (<xref ref-type="bibr" rid="B188">Wei et&#xa0;al., 2023</xref>; <xref ref-type="bibr" rid="B87">Huang et&#xa0;al., 2013</xref>).</p>
<p>Classically, microbial pathogens are phagocytosed by macrophages, followed by phagosome&#x2013;lysosome fusion, bacterial killing, and resolution of infection. This intracellular processing is often accompanied by ROS generation, host cell death, ultimately limiting bacterial survival. However, accumulating evidence indicates that hypervirulent strains of <italic>K. pneumoniae</italic> have been reported to subvert host innate defenses, such as evading phagolysosome maturation and promoting intracellular persistence. Therefore, the discussed evasion strategies enable bacterial survival within host cells and contribute to enhanced pathogenicity and disease severity (<xref ref-type="bibr" rid="B113">Li et&#xa0;al., 2025</xref>). Serotype K1/K2 of <italic>K. pneumoniae</italic> strains have been previously reported to be considerably more resistant to phagocytosis than non-K1/K2 strains. Studies have shown that engulfment of the hvKp by macrophages has been significantly lower than the classical <italic>K. pneumoniae</italic> (cKp) (<xref ref-type="bibr" rid="B180">Wang X. et&#xa0;al., 2023</xref>). Enhanced autophagy and intact phagosome&#x2013;lysosome fusion in alveolar macrophages promote intracellular killing; whereas blocking autophagy reduces clearance of <italic>K. pneumoniae</italic> from alveolar macrophages, indicating its survival in the host. Several studies now show that <italic>K. pneumoniae</italic> can turn macrophages into intracellular niches that support replication and dissemination. Most importantly, hypervirulent strains can survive and even replicate within macrophage vacuoles by inhibiting phagosome maturation and preventing fusion with lysosomes, as demonstrated in both <italic>in vitro</italic> macrophage models and <italic>in vivo</italic> tissue macrophages. <italic>K. pneumoniae</italic> interferes with macrophage death pathways, inhibiting apoptosis and modulating autophagy so that infected macrophages remain viable long enough to serve as reservoirs. Capsule polysaccharide and other virulence factors drive anti-inflammatory signaling, generating macrophages that survive, produce regulatory mediators, and thereby create a permissive niche for chronic persistence and abscess formation rather than rapid clearance (<xref ref-type="bibr" rid="B113">Li et&#xa0;al., 2025</xref>).</p>
<p><italic>K. pneumoniae</italic>, mainly hvKp strains, exhibit a remarkable capacity to persist and replicate within macrophages, a process that underpins their ability to form hepatic abscesses. Wanford and colleagues in their study demonstrated that intracellular replication within macrophages is a key mechanism facilitating abscess formation upon hvKp infection (<xref ref-type="bibr" rid="B179">Wanford et&#xa0;al., 2021</xref>). Using complementary mouse and pig infection models, along with <italic>in vitro</italic> macrophage and neutrophil assays, they revealed how hvKp subverts innate immune defenses in the liver and resists Kupffer cell-mediated clearance, explaining the strong hepatic tropism of hypervirulent K1 and K2 strains. The authors provided evidence that these hvKp strains could survive and multiply within hepatic as well as in splenic macrophages, forming large intracellular clusters visualized by microscopy. Gentamicin protection assays confirmed their viable intracellular state, and intracellular CFU counts increased over time for hvKp but not for non-hypervirulent isolates, highlighting a specific capacity for resistance to tissue macrophage clearance. However, the molecular mechanisms by which <italic>K. pneumoniae</italic> overcomes macrophage defenses are not fully elucidated. Building on this gap, another group uncovered the mechanisms through which <italic>K. pneumoniae</italic> hijacks host immune signaling. It has been shown that the pathogen exploits type I interferon (IFN) and IL-10 pathways in a TLR4-dependent manner. This promotes STAT6 phosphorylation and leads to the emergence of a distinct macrophage polarization state termed M(Kp). Interestingly, the STAT6-dependent macrophage reprogramming by the pathogen promotes bacterial persistence within macrophages across species, as confirmed in murine, human, and porcine cells. Mechanistic analyses further established that STAT6 activation is essential for <italic>K. pneumoniae</italic> intracellular survival, whereas STAT6 loss <italic>in vivo</italic> facilitates bacterial clearance. Thus, <italic>K. pneumoniae</italic> has evolved to manipulate an evolutionarily conserved innate immune axis, TLR4&#x2013;type I IFN&#x2013;IL10&#x2013;STAT6, to reprogram macrophages in its favor (<xref ref-type="bibr" rid="B55">Dumigan et&#xa0;al., 2022</xref>). This anti-immune strategy, driven by the bacterial capsule, differs fundamentally from those used by pathogens such as <italic>Listeria</italic>, <italic>Salmonella</italic>, <italic>Shigella</italic>, or <italic>Mycobacterium</italic>, which rely on direct effector protein delivery to modulate host functions. Moreover, IL-10 production, a hallmark of M(Kp) polarization, has been reported to be governed by the TLR4&#x2013;MyD88&#x2013;CREB signaling pathway and is indispensable for intracellular bacterial survival (<xref ref-type="bibr" rid="B113">Li et&#xa0;al., 2025</xref>). Together, these studies reveal that <italic>K. pneumoniae</italic> exploits conserved immune signaling pathways to rewire macrophage function, providing a mechanistic basis for its ability to resist clearance and drive abscess formation.</p>
</sec>
<sec id="s9" sec-type="conclusions">
<label>9</label>
<title>Conclusion</title>
<p>The Gram-negative opportunistic pathogen <italic>K. pneumoniae</italic> has attracted increasing attention due to the emergence of hypervirulent and antibiotic-resistant strains over the recent decades. The rising prevalence of these isolates has severely restricted, and in some cases eliminated, therapeutic options available for <italic>Klebsiella</italic> infections. This pathogen highlights the disparity between unmet clinical needs and the present research efforts. Indeed, the innate immune cells that defend the host against invading bacteria through myriad defense mechanisms; regrettably, the majority of them are modulated by the pathogens to create a safe niche for their intracellular survival. Recent studies indicate that <italic>Klebsiella</italic> has evolved mechanisms to actively suppress innate immune responses, underscoring the diversity. <italic>K. pneumoniae</italic>&#x2019;s capacity for both extracellular and intracellular existence, forming the M(Kp), an anti-inflammatory phenotype of macrophages, which exemplifies its sophisticated immune suppression strategies. The intracellular persistence is also promoted by the accumulation of anti-inflammatory metabolites, such as itaconate and IL-10, which inhibit effective bacterial clearance. Investigations into calcium regulation upon <italic>K. pneumoniae</italic> infection might open new insights into host-pathogen interaction and host innate immune suppression mechanisms exploited by the pathogen for intracellular survival. Especially, calcium signaling and homeostasis upon <italic>K. pneumoniae</italic> infection of host cells remain untouched when compared to other human bacterial pathogens.</p>
<p>Moreover, <italic>K. pneumoniae</italic> survives within macrophages by deviating from the canonical endocytic pathway and residing in a distinct intracellular compartment that does not fuse with lysosomes. <italic>K. pneumoniae</italic> manipulates the PI3K&#x2013;AKT&#x2013;Rab14 axis to regulate phagosome maturation, indicating its ability to evade and escape from phagocytes. Understanding these mechanisms by which <italic>K. pneumoniae</italic> interacts with immune defenses and modulates metabolic pathways has importance in developing effective treatments. Autophagy and apoptosis generally facilitate bacterial clearance. Surprisingly, <italic>K. pneumoniae</italic> infection induces autophagy and is dependent on the PI3K-AKT-mTOR pathway, and inhibition of this pathway increases the susceptibility of the host to <italic>K. pneumoniae</italic> infection. Autophagy promotion by <italic>K. pneumoniae</italic> can occur through surface recognition or cytoplasmic sensing, although the specific signaling molecules and receptors involved are not fully understood. However, the underlying mechanisms have not been systematically investigated, and numerous knowledge gaps need to be filled in. Identifying the virulence factors involved in host&#x2013;pathogen interactions, particularly those required for <italic>K. pneumoniae</italic>-induced autophagy, cell death, and cytokine production, is essential. Further studies focusing on the infection biology of <italic>Klebsiella</italic> will enable more precise identification of vulnerable aspects of the immune system and reveal new strategies employed by this pathogen to counteract immune responses.</p>
</sec>
</body>
<back>
<sec id="s10" sec-type="author-contributions">
<title>Author contributions</title>
<p>NN: Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. AA: Writing &#x2013; review &amp; editing, Writing &#x2013; original draft. SK: Writing &#x2013; review &amp; editing, Writing &#x2013; original draft. SM: Writing &#x2013; review &amp; editing, Writing &#x2013; original draft. CA: Investigation, Supervision, Conceptualization, Methodology, Writing &#x2013; review &amp; editing, Visualization, Resources, Project administration, Writing &#x2013; original draft, Funding acquisition.</p></sec>
<ack>
<title>Acknowledgments</title>
<p>We thank Biorendor for providing drawing support. All images created with <ext-link ext-link-type="uri" xlink:href="http://www.Biorendor.com">Biorendor.com</ext-link>, with permission. We used Grammarly to assist with language editing of this manuscript.</p>
</ack>
<sec id="s12" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec>
<sec id="s13" sec-type="ai-statement">
<title>Generative AI statement</title>
<p>The author(s) declared that generative AI was not used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p></sec>
<sec id="s14" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Abhinand</surname> <given-names>K.</given-names></name>
<name><surname>Menon</surname> <given-names>A. M.</given-names></name>
<name><surname>Thomas</surname> <given-names>S. S.</given-names></name>
<name><surname>Anil</surname> <given-names>A. B.</given-names></name>
<name><surname>Mohanan</surname> <given-names>P.C.P.</given-names></name>
<name><surname>Arun</surname> <given-names>K. B.</given-names></name>
<etal/>
</person-group>. (<year>2025</year>). 
<article-title>Klebsiella pneumoniae: host interactions, virulence mechanisms, and novel therapeutic strategies</article-title>. <source>Microbial Pathogenesis</source> <volume>207</volume>, <elocation-id>107856</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.micpath.2025.107856</pub-id>, PMID: <pub-id pub-id-type="pmid">40602443</pub-id>
</mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Agnese</surname> <given-names>D. M.</given-names></name>
<name><surname>Calvano</surname> <given-names>J. E.</given-names></name>
<name><surname>Hahm</surname> <given-names>S. J.</given-names></name>
<name><surname>Coyle</surname> <given-names>S. M.</given-names></name>
<name><surname>Corbett</surname> <given-names>S. A.</given-names></name>
<name><surname>Calvano</surname> <given-names>S. E.</given-names></name>
<etal/>
</person-group>. (<year>2002</year>). 
<article-title>Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections</article-title>. <source>J. Infect. Dis.</source> <volume>186</volume>, <fpage>1522</fpage>&#x2013;<lpage>1255</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1086/344893</pub-id>, PMID: <pub-id pub-id-type="pmid">12404174</pub-id>
</mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Alharbi</surname> <given-names>A. F.</given-names></name>
<name><surname>Parrington</surname> <given-names>J.</given-names></name>
</person-group> (<year>2021</year>). 
<article-title>Deciphering the role of endolysosomal Ca2+ Channels in immunity</article-title>. <source>Front. Immunol.</source> <volume>12</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2021.656965</pub-id>, PMID: <pub-id pub-id-type="pmid">33986747</pub-id>
</mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Almeida-da-Silva</surname> <given-names>C&#xe1;ssioL. C.</given-names></name>
<name><surname>Savio</surname> <given-names>L. E. B.</given-names></name>
<name><surname>Coutinho-Silva</surname> <given-names>R.</given-names></name>
<name><surname>Ojcius</surname> <given-names>D. M.</given-names></name>
</person-group> (<year>2023</year>). 
<article-title>The role of NOD-like receptors in innate immunity</article-title>. <source>Front. Immunol.</source> <volume>14</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2023.1122586</pub-id>, PMID: <pub-id pub-id-type="pmid">37006312</pub-id>
</mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Amaral</surname> <given-names>E. P.</given-names></name>
<name><surname>Costa</surname> <given-names>D. L.</given-names></name>
<name><surname>Namasivayam</surname> <given-names>S.</given-names></name>
<name><surname>Riteau</surname> <given-names>N.</given-names></name>
<name><surname>Kamenyeva</surname> <given-names>O.</given-names></name>
<name><surname>Mittereder</surname> <given-names>L.</given-names></name>
<etal/>
</person-group>. (<year>2019</year>). 
<article-title>A major role for ferroptosis in mycobacterium tuberculosis&#x2013;induced cell death and tissue necrosis</article-title>. <source>J. Exp. Med.</source> <volume>216</volume>, <fpage>556</fpage>&#x2013;<lpage>705</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1084/jem.20181776</pub-id>, PMID: <pub-id pub-id-type="pmid">30787033</pub-id>
</mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Antony</surname> <given-names>C.</given-names></name>
<name><surname>Mehto</surname> <given-names>S.</given-names></name>
<name><surname>Tiwari</surname> <given-names>B. K.</given-names></name>
<name><surname>Singh</surname> <given-names>Y.</given-names></name>
<name><surname>Natarajan</surname> <given-names>K.</given-names></name>
</person-group> (<year>2015</year>). 
<article-title>Regulation of L-type voltage gated calcium channel CACNA1S in macrophages upon mycobacterium tuberculosis infection</article-title>. <source>PLoS One</source> <volume>10</volume>, <fpage>1</fpage>&#x2013;<lpage>185</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0124263</pub-id>, PMID: <pub-id pub-id-type="pmid">25915405</pub-id>
</mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Arora</surname> <given-names>S.</given-names></name>
<name><surname>Dev</surname> <given-names>K.</given-names></name>
<name><surname>Agarwal</surname> <given-names>B.</given-names></name>
<name><surname>Das</surname> <given-names>P.</given-names></name>
<name><surname>Syed</surname> <given-names>M. A.</given-names></name>
</person-group> (<year>2018</year>). 
<article-title>Macrophages: their role, activation and polarization in pulmonary diseases</article-title>. <source>Immunobiology</source> <volume>223</volume>, <fpage>383</fpage>&#x2013;<lpage>396</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.imbio.2017.11.001</pub-id>, PMID: <pub-id pub-id-type="pmid">29146235</pub-id>
</mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Asokan</surname> <given-names>S.</given-names></name>
<name><surname>Jacob</surname> <given-names>T.</given-names></name>
<name><surname>Jacob</surname> <given-names>J.</given-names></name>
<name><surname>AlSosowaa</surname> <given-names>A. A.</given-names></name>
<name><surname>Cherian</surname> <given-names>T.</given-names></name>
<name><surname>Peijnenburg</surname> <given-names>W. J.G.M.</given-names></name>
<etal/>
</person-group>. (<year>2025</year>). 
<article-title>Klebsiella pneumoniae: A growing threat in the era of antimicrobial resistance</article-title>. <source>Microbe</source> <volume>7</volume>, <elocation-id>100333</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.microb.2025.100333</pub-id>
</mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Bah</surname> <given-names>A.</given-names></name>
<name><surname>Vergne</surname> <given-names>I.</given-names></name>
</person-group> (<year>2017</year>). 
<article-title>Macrophage autophagy and bacterial infections</article-title>. <source>Front. Immunol.</source> <volume>8</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2017.01483</pub-id>, PMID: <pub-id pub-id-type="pmid">29163544</pub-id>
</mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Basu</surname> <given-names>J.</given-names></name>
<name><surname>Shin</surname> <given-names>D. M.</given-names></name>
<name><surname>Jo</surname> <given-names>E. K.</given-names></name>
</person-group> (<year>2012</year>). 
<article-title>Mycobacterial signaling through toll-like receptors</article-title>. <source>Front. Cell. Infection Microbiol.</source> <volume>2</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2012.00145</pub-id>, PMID: <pub-id pub-id-type="pmid">23189273</pub-id>
</mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Bengoechea</surname> <given-names>Jos&#xe9;A.</given-names></name>
<name><surname>Sa Pessoa</surname> <given-names>J.</given-names></name>
</person-group> (<year>2019</year>). 
<article-title>Klebsiella pneumoniae infection biology: living to counteract host defences</article-title>. <source>FEMS Microbiol. Rev.</source> <volume>43</volume>, <fpage>123</fpage>&#x2013;<lpage>445</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/femsre/fuy043</pub-id>, PMID: <pub-id pub-id-type="pmid">30452654</pub-id>
</mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Berridge</surname> <given-names>M. J.</given-names></name>
<name><surname>Lipp</surname> <given-names>P.</given-names></name>
<name><surname>Bootman</surname> <given-names>M. D.</given-names></name>
</person-group> (<year>2000</year>). 
<article-title>The versatility and universality of calcium signalling</article-title>. <source>Nat. Rev. Mol. Cell Biol.</source> <volume>1</volume>, <fpage>11</fpage>&#x2013;<lpage>215</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/35036035</pub-id>, PMID: <pub-id pub-id-type="pmid">11413485</pub-id>
</mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Bian</surname> <given-names>Z.</given-names></name>
<name><surname>Gong</surname> <given-names>Y.</given-names></name>
<name><surname>Huang</surname> <given-names>T.</given-names></name>
<name><surname>Lee</surname> <given-names>C. Z.W.</given-names></name>
<name><surname>Bian</surname> <given-names>L.</given-names></name>
<name><surname>Bai</surname> <given-names>Z.</given-names></name>
<etal/>
</person-group>. (<year>2020</year>). 
<article-title>Deciphering human macrophage development at single-cell resolution</article-title>. <source>Nature</source> <volume>582</volume>, <fpage>571</fpage>&#x2013;<lpage>576</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41586-020-2316-7</pub-id>, PMID: <pub-id pub-id-type="pmid">32499656</pub-id>
</mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Birmingham</surname> <given-names>C. L.</given-names></name>
<name><surname>Smith</surname> <given-names>A. C.</given-names></name>
<name><surname>Bakowski</surname> <given-names>M. A.</given-names></name>
<name><surname>Yoshimori</surname> <given-names>T.</given-names></name>
<name><surname>Brumell</surname> <given-names>J. H.</given-names></name>
</person-group> (<year>2006</year>). 
<article-title>Autophagy controls salmonella infection in response to damage to the salmonella-containing vacuole</article-title>. <source>J. Biol. Chem.</source> <volume>281</volume>, <fpage>11374</fpage>&#x2013;<lpage>11835</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M509157200</pub-id>, PMID: <pub-id pub-id-type="pmid">16495224</pub-id>
</mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Biswas</surname> <given-names>S. K.</given-names></name>
<name><surname>Mantovani</surname> <given-names>A.</given-names></name>
</person-group> (<year>2012</year>). 
<article-title>Orchestration of metabolism by macrophages</article-title>. <source>Cell Metab.</source> <volume>15</volume>, <fpage>432</fpage>&#x2013;<lpage>375</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cmet.2011.11.013</pub-id>, PMID: <pub-id pub-id-type="pmid">22482726</pub-id>
</mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Bootman</surname> <given-names>M. D.</given-names></name>
<name><surname>Bultynck</surname> <given-names>G.</given-names></name>
</person-group> (<year>2020</year>). 
<article-title>Fundamentals of cellular calcium signaling: A primer</article-title>. <source>Cold Spring Harbor Perspect. Biol.</source> <volume>12</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1101/cshperspect.a038802</pub-id>, PMID: <pub-id pub-id-type="pmid">31427372</pub-id>
</mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Boro</surname> <given-names>M.</given-names></name>
<name><surname>Balaji</surname> <given-names>K. N.</given-names></name>
</person-group> (<year>2017</year>). 
<article-title>CXCL1 and CXCL2 regulate NLRP3 inflammasome activation via G-protein&#x2013;coupled receptor CXCR2</article-title>. <source>J. Immunol.</source> <volume>199</volume>, <fpage>1660</fpage>&#x2013;<lpage>1715</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.1700129</pub-id>, PMID: <pub-id pub-id-type="pmid">28739876</pub-id>
</mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Borszekova Pulzova</surname> <given-names>L.</given-names></name>
<name><surname>Navr&#xe1;tilov&#xe1;</surname> <given-names>L.</given-names></name>
<name><surname>Comor</surname> <given-names>L.</given-names></name>
</person-group> (<year>2016</year>). 
<article-title>Alterations in outer membrane permeability favor drug-resistant phenotype of Klebsiella pneumoniae</article-title>. <source>Microbial Drug Resistance</source> <volume>23</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1089/mdr.2016.0017</pub-id>, PMID: <pub-id pub-id-type="pmid">27526080</pub-id>
</mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Brancewicz</surname> <given-names>J.</given-names></name>
<name><surname>W&#xf3;jcik</surname> <given-names>N.</given-names></name>
<name><surname>Sarnowska</surname> <given-names>Z.</given-names></name>
<name><surname>Robak</surname> <given-names>J.</given-names></name>
<name><surname>Kr&#xf3;l</surname> <given-names>M.</given-names></name>
</person-group> (<year>2025</year>). 
<article-title>The multifaceted role of macrophages in biology and diseases</article-title>. <source>Int. J. Mol. Sci.</source> <volume>26</volume>, <fpage>2107</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms26052107</pub-id>, PMID: <pub-id pub-id-type="pmid">40076729</pub-id>
</mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Bruhn</surname> <given-names>K. W.</given-names></name>
<name><surname>Pantapalangkoor</surname> <given-names>P.</given-names></name>
<name><surname>Nielsen</surname> <given-names>T.</given-names></name>
<name><surname>Tan</surname> <given-names>B.</given-names></name>
<name><surname>Junus</surname> <given-names>J.</given-names></name>
<name><surname>Hujer</surname> <given-names>K. M.</given-names></name>
<etal/>
</person-group>. (<year>2015</year>). 
<article-title>Host fate is rapidly determined by innate effector-microbial interactions during acinetobacter baumannii bacteremia</article-title>. <source>J. Infect. Dis.</source> <volume>211</volume>, <fpage>1296</fpage>&#x2013;<lpage>13055</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/INFDIS/JIU593</pub-id>, PMID: <pub-id pub-id-type="pmid">25378635</pub-id>
</mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Bulati</surname> <given-names>M.</given-names></name>
<name><surname>Bus&#xe0;</surname> <given-names>R.</given-names></name>
<name><surname>Carcione</surname> <given-names>C.</given-names></name>
<name><surname>Iannolo</surname> <given-names>G.</given-names></name>
<name><surname>Di Mento</surname> <given-names>G.</given-names></name>
<name><surname>Cuscino</surname> <given-names>N.</given-names></name>
<etal/>
</person-group>. (<year>2021</year>). 
<article-title>Klebsiella pneumoniae lipopolysaccharides serotype O2afg induce poor inflammatory immune responses <italic>ex vivo</italic></article-title>. <source>Microorganisms</source> <volume>9</volume>, <fpage>1</fpage>&#x2013;<lpage>15</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/microorganisms9061317</pub-id>, PMID: <pub-id pub-id-type="pmid">34204279</pub-id>
</mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Cabrera</surname> <given-names>J. T. O.</given-names></name>
<name><surname>Makino</surname> <given-names>A.</given-names></name>
</person-group> (<year>2022</year>). 
<article-title>Efferocytosis of vascular cells in cardiovascular disease</article-title>. <source>Pharmacol. Ther.</source> <volume>229</volume>, <elocation-id>107919</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.pharmthera.2021.107919</pub-id>, PMID: <pub-id pub-id-type="pmid">34171333</pub-id>
</mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Calderon-Gonzalez</surname> <given-names>R.</given-names></name>
<name><surname>Lee</surname> <given-names>A.</given-names></name>
<name><surname>Lopez-Campos</surname> <given-names>G.</given-names></name>
<name><surname>Hancock</surname> <given-names>S. J.</given-names></name>
<name><surname>Sa-Pessoa</surname> <given-names>J.</given-names></name>
<name><surname>Dumigan</surname> <given-names>A.</given-names></name>
<etal/>
</person-group>. (<year>2023</year>). 
<article-title>Modelling the gastrointestinal carriage of Klebsiella pneumoniae infections</article-title>. <source>MBio</source> <volume>14</volume>, <elocation-id>e03121225</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/mbio.03121-22</pub-id>, PMID: <pub-id pub-id-type="pmid">36598189</pub-id>
</mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Cano</surname> <given-names>V.</given-names></name>
<name><surname>March</surname> <given-names>C.</given-names></name>
<name><surname>Insua</surname> <given-names>J. L.</given-names></name>
<name><surname>Aguil&#xf3;</surname> <given-names>N.</given-names></name>
<name><surname>Llobet</surname> <given-names>E.</given-names></name>
<name><surname>Moranta</surname> <given-names>D.</given-names></name>
<etal/>
</person-group>. (<year>2015</year>). 
<article-title>Klebsiella pneumoniae survives within macrophages by avoiding delivery to lysosomes</article-title>. <source>Cell. Microbiol.</source> <volume>17</volume>, <fpage>1537</fpage>&#x2013;<lpage>1560</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/cmi.12466</pub-id>, PMID: <pub-id pub-id-type="pmid">26045209</pub-id>
</mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Canton</surname> <given-names>M.</given-names></name>
<name><surname>S&#xe1;nchez-Rodr&#xed;guez</surname> <given-names>R.</given-names></name>
<name><surname>Spera</surname> <given-names>I.</given-names></name>
<name><surname>Venegas</surname> <given-names>F. C.</given-names></name>
<name><surname>Favia</surname> <given-names>M.</given-names></name>
<name><surname>Viola</surname> <given-names>A.</given-names></name>
<etal/>
</person-group>. (<year>2021</year>). 
<article-title>Reactive oxygen species in macrophages: sources and targets</article-title>. <source>Front. Immunol.</source> <volume>12</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2021.734229</pub-id>, PMID: <pub-id pub-id-type="pmid">34659222</pub-id>
</mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Carroll</surname> <given-names>M. C.</given-names></name>
<name><surname>Janeway</surname> <given-names>Jr.</given-names></name>
</person-group> (<year>1999</year>). 
<article-title>Innate immunity: editorial overview</article-title>. <source>Curr. Opin. Immunol.</source> <volume>11</volume>, <fpage>11</fpage>&#x2013;<lpage>12</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0952-7915(99)80002-8</pub-id>, PMID: <pub-id pub-id-type="pmid">10047548</pub-id>
</mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Castillo</surname> <given-names>L. A.</given-names></name>
<name><surname>Birnberg-Weiss</surname> <given-names>F.</given-names></name>
<name><surname>Rodriguez-Rodrigues</surname> <given-names>N.</given-names></name>
<name><surname>Martire-Greco</surname> <given-names>D.</given-names></name>
<name><surname>Bigi</surname> <given-names>F.</given-names></name>
<name><surname>Landoni</surname> <given-names>V. I.</given-names></name>
<etal/>
</person-group>. (<year>2019</year>). 
<article-title>Klebsiella pneumoniae ST258 negatively regulates the oxidative burst in human neutrophils</article-title>. <source>Front. Immunol.</source> <volume>10</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2019.00929</pub-id>, PMID: <pub-id pub-id-type="pmid">31105712</pub-id>
</mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Catal&#xe1;n-N&#xe1;jera</surname> <given-names>J. C.</given-names></name>
<name><surname>Garza-Ramos</surname> <given-names>U.</given-names></name>
<name><surname>Barrios-Camacho</surname> <given-names>H.</given-names></name>
</person-group> (<year>2017</year>). 
<article-title>Hypervirulence and hypermucoviscosity: Two different but complementary Klebsiella spp. phenotypes</article-title>? <source>Virulence</source> <volume>8</volume>, <fpage>1111</fpage>&#x2013;<lpage>23</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/21505594.2017.1317412</pub-id>, PMID: <pub-id pub-id-type="pmid">28402698</pub-id>
</mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Chang</surname> <given-names>D.</given-names></name>
<name><surname>Sharma</surname> <given-names>L.</given-names></name>
<name><surname>Dela Cruz</surname> <given-names>C. S.</given-names></name>
<name><surname>Zhang</surname> <given-names>D.</given-names></name>
</person-group> (<year>2021</year>). 
<article-title>Clinical epidemiology, risk factors, and control strategies of Klebsiella pneumoniae infection</article-title>. <source>Front. Microbiol.</source> <volume>12</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2021.750662</pub-id>, PMID: <pub-id pub-id-type="pmid">34992583</pub-id>
</mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Chaplin</surname> <given-names>D. D.</given-names></name>
</person-group> (<year>2010</year>). 
<article-title>Overview of the immune response</article-title>. <source>J. Allergy Clin. Immunol.</source> <volume>125</volume>, <fpage>S3</fpage>&#x2013;<lpage>23</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jaci.2009.12.980</pub-id>, PMID: <pub-id pub-id-type="pmid">20176265</pub-id>
</mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Chaudhary</surname> <given-names>A.</given-names></name>
<name><surname>Miller</surname> <given-names>S. I.</given-names></name>
</person-group> (<year>2019</year>). 
<article-title>Xenophagy: pathogen-containing vacuoles are hard to digest</article-title>. <source>Curr. Biol.</source> <volume>29</volume>, <fpage>R1086</fpage>&#x2013;<lpage>R1088</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cub.2019.08.069</pub-id>, PMID: <pub-id pub-id-type="pmid">31639355</pub-id>
</mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Chauhan</surname> <given-names>A.</given-names></name>
<name><surname>Sun</surname> <given-names>Y.</given-names></name>
<name><surname>Sukumaran</surname> <given-names>P.</given-names></name>
<name><surname>Quenum Zangbede</surname> <given-names>F. O.</given-names></name>
<name><surname>Jondle</surname> <given-names>C. N.</given-names></name>
<name><surname>Sharma</surname> <given-names>A.</given-names></name>
<etal/>
</person-group>. (<year>2018</year>). 
<article-title>M1 macrophage polarization is dependent on TRPC1-mediated calcium entry</article-title>. <source>IScience</source> <volume>8</volume>, <fpage>85</fpage>&#x2013;<lpage>102</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.isci.2018.09.014</pub-id>, PMID: <pub-id pub-id-type="pmid">30293012</pub-id>
</mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Chauhan</surname> <given-names>S.</given-names></name>
<name><surname>Jena</surname> <given-names>K. K.</given-names></name>
<name><surname>Mehto</surname> <given-names>S.</given-names></name>
<name><surname>Chauhan</surname> <given-names>N. R.</given-names></name>
<name><surname>Sahu</surname> <given-names>R.</given-names></name>
<name><surname>Dhar</surname> <given-names>K.</given-names></name>
<etal/>
</person-group>. (<year>2022</year>). 
<article-title>Innate immunity and inflammophagy: balancing the defence and immune homeostasis</article-title>. <source>FEBS J.</source> <volume>289</volume>, <fpage>4112</fpage>&#x2013;<lpage>4315</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/febs.16298</pub-id>, PMID: <pub-id pub-id-type="pmid">34826185</pub-id>
</mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Chen</surname> <given-names>B.-C.</given-names></name>
<name><surname>Chou</surname> <given-names>C.-F.</given-names></name>
<name><surname>Lin</surname> <given-names>W.-W.</given-names></name>
</person-group> (<year>1998</year>). 
<article-title>Pyrimidinoceptor-mediated potentiation of inducible nitric-oxide synthase induction in J774 macrophages: ROLE OF INTRACELLULAR CALCIUM*</article-title>. <source>J. Biol. Chem.</source> <volume>273</volume>, <fpage>29754</fpage>&#x2013;<lpage>29635</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.273.45.29754</pub-id>, PMID: <pub-id pub-id-type="pmid">9792689</pub-id>
</mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Chen</surname> <given-names>S.</given-names></name>
<name><surname>Saeed</surname> <given-names>A. F.U.H.</given-names></name>
<name><surname>Liu</surname> <given-names>Q.</given-names></name>
<name><surname>Jiang</surname> <given-names>Q.</given-names></name>
<name><surname>Xu</surname> <given-names>H.</given-names></name>
<name><surname>Xiao</surname> <given-names>G. G.</given-names></name>
<etal/>
</person-group>. (<year>2023</year>). 
<article-title>Macrophages in immunoregulation and therapeutics</article-title>. <source>Signal Transduction Targeted Ther.</source> <volume>8</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41392-023-01452-1</pub-id>, PMID: <pub-id pub-id-type="pmid">37211559</pub-id>
</mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Cheng</surname> <given-names>H.-p.</given-names></name>
<name><surname>Wei</surname> <given-names>S.</given-names></name>
<name><surname>Wei</surname> <given-names>L.-p.</given-names></name>
<name><surname>Verkhratsky</surname> <given-names>A.</given-names></name>
</person-group> (<year>2006</year>). 
<article-title>Calcium signaling in physiology and pathophysiology</article-title>. <source>Acta Pharmacologica Sin</source><page-range>767&#x2013;772</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1745-7254.2006.00399.x</pub-id>, PMID: <pub-id pub-id-type="pmid">16787558</pub-id>
</mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Cheng</surname> <given-names>J.</given-names></name>
<name><surname>Zhang</surname> <given-names>J.</given-names></name>
<name><surname>Yang</surname> <given-names>J.</given-names></name>
<name><surname>Yi</surname> <given-names>B.</given-names></name>
<name><surname>Liu</surname> <given-names>G.</given-names></name>
<name><surname>Zhou</surname> <given-names>M.</given-names></name>
<etal/>
</person-group>. (<year>2021</year>). 
<article-title>Klebsiella pneumoniae infection causes mitochondrial damage and dysfunction in bovine mammary epithelial cells</article-title>. <source>Veterinary Res.</source> <volume>52</volume>, <fpage>175</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13567-021-00898-x</pub-id>, PMID: <pub-id pub-id-type="pmid">33568211</pub-id>
</mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Chi</surname> <given-names>Y.</given-names></name>
<name><surname>Jiang</surname> <given-names>H.</given-names></name>
<name><surname>Yin</surname> <given-names>Y.</given-names></name>
<name><surname>Zhou</surname> <given-names>X.</given-names></name>
<name><surname>Shao</surname> <given-names>Y.</given-names></name>
<name><surname>Li</surname> <given-names>Y.</given-names></name>
<etal/>
</person-group>. (<year>2025</year>). 
<article-title>Macrophage signaling pathways in health and disease: from bench to bedside applications</article-title>. <source>MedComm</source> <volume>6</volume>, <elocation-id>e702565</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/mco2.70256</pub-id>, PMID: <pub-id pub-id-type="pmid">40529613</pub-id>
</mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Chow</surname> <given-names>S. H.</given-names></name>
<name><surname>Deo</surname> <given-names>P.</given-names></name>
<name><surname>Naderer</surname> <given-names>T.</given-names></name>
</person-group> (<year>2016</year>). 
<article-title>Macrophage cell death in microbial infections</article-title>. <source>Cell. Microbiol.</source> <volume>18</volume>, <fpage>466</fpage>&#x2013;<lpage>745</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/cmi.12573</pub-id>, PMID: <pub-id pub-id-type="pmid">26833712</pub-id>
</mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Codo</surname> <given-names>A. C.</given-names></name>
<name><surname>Saraiva</surname> <given-names>A. C.</given-names></name>
<name><surname>dos Santos</surname> <given-names>L. L.</given-names></name>
<name><surname>Visconde</surname> <given-names>M. F.</given-names></name>
<name><surname>Gales</surname> <given-names>A. C.</given-names></name>
<name><surname>Zamboni</surname> <given-names>D. S.</given-names></name>
<etal/>
</person-group>. (<year>2018</year>). 
<article-title>Inhibition of inflammasome activation by a clinical strain of Klebsiella pneumoniae impairs efferocytosis and leads to bacterial dissemination</article-title>. <source>Cell Death Dis.</source> <volume>9</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41419-018-1214-5</pub-id>, PMID: <pub-id pub-id-type="pmid">30518854</pub-id>
</mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Colombo</surname> <given-names>M. I.</given-names></name>
</person-group> (<year>2005</year>). 
<article-title>Pathogens and autophagy: subverting to survive</article-title>. <source>Cell Death Differentiation</source> <volume>12 Suppl 2</volume>, <fpage>1481</fpage>&#x2013;<lpage>1483</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/sj.cdd.4401767</pub-id>, PMID: <pub-id pub-id-type="pmid">16247495</pub-id>
</mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>De Gaetano</surname> <given-names>G. V.</given-names></name>
<name><surname>Fam&#xe0;</surname> <given-names>A.</given-names></name>
<name><surname>Lentini</surname> <given-names>G.</given-names></name>
<name><surname>Coppolino</surname> <given-names>F.</given-names></name>
<name><surname>Venza</surname> <given-names>M.</given-names></name>
<name><surname>Venza</surname> <given-names>I.</given-names></name>
<etal/>
</person-group>. (<year>2025</year>). 
<article-title>Role of endosomal toll-like receptors in immune sensing of Klebsiella pneumoniae</article-title>. <source>Front. Immunol.</source> <volume>16</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2025.1538425</pub-id>, PMID: <pub-id pub-id-type="pmid">40248691</pub-id>
</mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Deguine</surname> <given-names>J.</given-names></name>
<name><surname>Barton</surname> <given-names>G. M.</given-names></name>
</person-group> (<year>2014</year>). 
<article-title>MyD88: A central player in innate immune signaling</article-title>. <source>F1000Prime Rep.</source> <volume>6</volume>, <fpage>1</fpage>&#x2013;<lpage>7</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.12703/P6-97</pub-id>, PMID: <pub-id pub-id-type="pmid">25580251</pub-id>
</mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>DeLeo</surname> <given-names>F. R.</given-names></name>
<name><surname>Porter</surname> <given-names>A. R.</given-names></name>
<name><surname>Kobayashi</surname> <given-names>S. D.</given-names></name>
<name><surname>Freedman</surname> <given-names>B.</given-names></name>
<name><surname>Hao</surname> <given-names>M.</given-names></name>
<name><surname>Jiang</surname> <given-names>J.</given-names></name>
<etal/>
</person-group>. (<year>2023</year>). 
<article-title>Interaction of multidrug-resistant hypervirulent Klebsiella pneumoniae with components of human innate host defense</article-title>. <source>MBio</source> <volume>14</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/MBIO.01949-23</pub-id>, PMID: <pub-id pub-id-type="pmid">37671860</pub-id>
</mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>De-Leon-Lopez</surname> <given-names>Y. S.</given-names></name>
<name><surname>Thompson</surname> <given-names>M. E.</given-names></name>
<name><surname>Kean</surname> <given-names>J. J.</given-names></name>
<name><surname>Flaherty</surname> <given-names>R. A.</given-names></name>
</person-group> (<year>2023</year>). 
<article-title>The PI3K-Akt pathway is a multifaceted regulator of the macrophage response to diverse group B streptococcus isolates</article-title>. <source>Front. Cell. Infection Microbiol.</source> <volume>13</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2023.1258275</pub-id>, PMID: <pub-id pub-id-type="pmid">37928185</pub-id>
</mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Dell&#x2019;Annunziata</surname> <given-names>F.</given-names></name>
<name><surname>Ciaglia</surname> <given-names>E.</given-names></name>
<name><surname>Folliero</surname> <given-names>V.</given-names></name>
<name><surname>Lopardo</surname> <given-names>V.</given-names></name>
<name><surname>Maciag</surname> <given-names>A.</given-names></name>
<name><surname>Galdiero</surname> <given-names>M.</given-names></name>
<etal/>
</person-group>. (<year>2024</year>). 
<article-title>Klebsiella pneumoniae-OMVs activate death-signaling pathways in human bronchial epithelial host cells (BEAS-2B)</article-title>. <source>Heliyon</source> <volume>10</volume>, <elocation-id>e290175</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.heliyon.2024.e29017</pub-id>, PMID: <pub-id pub-id-type="pmid">38644830</pub-id>
</mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Delvig</surname> <given-names>A. A.</given-names></name>
<name><surname>Robinson</surname> <given-names>J. H.</given-names></name>
</person-group> (<year>1999</year>). 
<article-title>The role of calcium homeostasis and flux during bacterial antigen processing in murine macrophages</article-title>. <source>Eur. J. Immunol.</source> <volume>29</volume>, <fpage>2414</fpage>&#x2013;<lpage>2195</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/(SICI)1521-4141(199908)29:08&lt;2414::AID-IMMU2414&gt;3.0.CO;2-P</pub-id>, PMID: <pub-id pub-id-type="pmid">10458754</pub-id>
</mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Desai</surname> <given-names>B. N.</given-names></name>
<name><surname>Leitinger</surname> <given-names>N.</given-names></name>
</person-group> (<year>2014</year>). 
<article-title>Purinergic and calcium signaling in macrophage function and plasticity</article-title>. <source>Front. Immunol.</source> <volume>5</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2014.00580</pub-id>, PMID: <pub-id pub-id-type="pmid">25505897</pub-id>
</mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ding</surname> <given-names>P.</given-names></name>
<name><surname>Song</surname> <given-names>Y.</given-names></name>
<name><surname>Yang</surname> <given-names>Y.</given-names></name>
<name><surname>Zeng</surname> <given-names>C.</given-names></name>
</person-group> (<year>2024</year>). 
<article-title>NLRP3 inflammasome and pyroptosis in cardiovascular diseases and exercise intervention</article-title>. <source>Front. Pharmacol.</source> <volume>15</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fphar.2024.1368835</pub-id>, PMID: <pub-id pub-id-type="pmid">38681198</pub-id>
</mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Dixon</surname> <given-names>S. J.</given-names></name>
<name><surname>Lemberg</surname> <given-names>K. M.</given-names></name>
<name><surname>Lamprecht</surname> <given-names>M. R.</given-names></name>
<name><surname>Skouta</surname> <given-names>R.</given-names></name>
<name><surname>Zaitsev</surname> <given-names>E. M.</given-names></name>
<name><surname>Gleason</surname> <given-names>C. E.</given-names></name>
<etal/>
</person-group>. (<year>2012</year>). 
<article-title>Ferroptosis: an iron-dependent form of nonapoptotic cell death</article-title>. <source>Cell</source> <volume>149</volume>, <fpage>1060</fpage>&#x2013;<lpage>1072</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cell.2012.03.042</pub-id>, PMID: <pub-id pub-id-type="pmid">22632970</pub-id>
</mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Dong</surname> <given-names>N.</given-names></name>
<name><surname>Yang</surname> <given-names>X.</given-names></name>
<name><surname>Chan</surname> <given-names>E. W. C.</given-names></name>
<name><surname>Zhang</surname> <given-names>R.</given-names></name>
<name><surname>Chen</surname> <given-names>S.</given-names></name>
</person-group> (<year>2022</year>). 
<article-title>Klebsiella species: taxonomy, hypervirulence and multidrug resistance</article-title>. <source>EBioMedicine</source> <volume>79</volume>, <elocation-id>103998</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ebiom.2022.103998</pub-id>, PMID: <pub-id pub-id-type="pmid">35405387</pub-id>
</mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Dorman</surname> <given-names>M. J.</given-names></name>
<name><surname>Short</surname> <given-names>F. L.</given-names></name>
</person-group> (<year>2017</year>). 
<article-title>Genome watch: Klebsiella pneumoniae: when a colonizer turns bad</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>15</volume>, <fpage>15</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrmicro.2017.64</pub-id>, PMID: <pub-id pub-id-type="pmid">28579608</pub-id>
</mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Dorrington</surname> <given-names>M. G.</given-names></name>
<name><surname>Fraser</surname> <given-names>I. D.C.</given-names></name>
</person-group> (<year>2019</year>). 
<article-title>NF-KB signaling in macrophages: dynamics, crosstalk, and signal integration</article-title>. <source>Front. Immunol.</source> <volume>10</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2019.00705</pub-id>, PMID: <pub-id pub-id-type="pmid">31024544</pub-id>
</mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Dortet</surname> <given-names>L.</given-names></name>
<name><surname>Mostowy</surname> <given-names>S.</given-names></name>
<name><surname>Cossart</surname> <given-names>P.</given-names></name>
</person-group> (<year>2012</year>). 
<article-title>Listeria and autophagy escape: involvement of inlK, an internalin-like protein</article-title>. <source>Autophagy</source> <volume>8</volume>, <fpage>132</fpage>&#x2013;<lpage>345</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4161/auto.8.1.18218</pub-id>, PMID: <pub-id pub-id-type="pmid">22082958</pub-id>
</mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Dumigan</surname> <given-names>A.</given-names></name>
<name><surname>Cappa</surname> <given-names>O.</given-names></name>
<name><surname>Morris</surname> <given-names>B.</given-names></name>
<name><surname>S&#xe1; Pessoa</surname> <given-names>J.</given-names></name>
<name><surname>Calderon-Gonzalez</surname> <given-names>R.</given-names></name>
<name><surname>Mills</surname> <given-names>G.</given-names></name>
<etal/>
</person-group>. (<year>2022</year>). 
<article-title><italic>In vivo</italic> single-cell transcriptomics reveal klebsiella pneumoniae skews lung macrophages to promote infection</article-title>. <source>EMBO Mol. Med.</source> <volume>14</volume>, <elocation-id>e168885</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.15252/emmm.202216888</pub-id>, PMID: <pub-id pub-id-type="pmid">36337046</pub-id>
</mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Eren</surname> <given-names>E.</given-names></name>
<name><surname>Berber</surname> <given-names>M.</given-names></name>
<name><surname>&#xd6;z&#xf6;ren</surname> <given-names>N.</given-names></name>
</person-group> (<year>2017</year>). 
<article-title>NLRC3 protein inhibits inflammation by disrupting NALP3 inflammasome assembly via competition with the adaptor protein ASC for pro-caspase-1 binding</article-title>. <source>J. Biol. Chem.</source> <volume>292</volume>, <fpage>12691</fpage>&#x2013;<lpage>17015</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M116.769695</pub-id>, PMID: <pub-id pub-id-type="pmid">28584053</pub-id>
</mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Faruk</surname> <given-names>M. O.</given-names></name>
<name><surname>Sarkar</surname> <given-names>Md. M. H.</given-names></name>
<name><surname>Ismail Hossain</surname> <given-names>M. D.</given-names></name>
<name><surname>Shabuj</surname> <given-names>A. A.-M.</given-names></name>
<name><surname>Bhim</surname> <given-names>M.</given-names></name>
<name><surname>Mehzabin</surname> <given-names>K.</given-names></name>
<etal/>
</person-group>. (<year>2024</year>). 
<article-title>Genomic characterization and functional insights of multidrug-resistant Klebsiella pneumoniae strain BCSIR-JUMIID</article-title>. <source>BioRxiv</source>. doi:&#xa0;<pub-id pub-id-type="doi">10.1101/2024.11.27.625610</pub-id>
</mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Feriotti</surname> <given-names>C.</given-names></name>
<name><surname>S&#xe1;-Pessoa</surname> <given-names>J.</given-names></name>
<name><surname>Calder&#xf3;n-Gonz&#xe1;lez</surname> <given-names>R.</given-names></name>
<name><surname>Gu</surname> <given-names>L.</given-names></name>
<name><surname>Morris</surname> <given-names>B.</given-names></name>
<name><surname>Sugisawa</surname> <given-names>R.</given-names></name>
<etal/>
</person-group>. (<year>2022</year>). 
<article-title>Klebsiella pneumoniae hijacks the toll-IL-1R protein SARM1 in a type I IFN-dependent manner to antagonize host immunity</article-title>. <source>Cell Rep.</source> <volume>40</volume>, <elocation-id>111167</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.celrep.2022.111167</pub-id>, PMID: <pub-id pub-id-type="pmid">35947948</pub-id>
</mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ferrante</surname> <given-names>C. J.</given-names></name>
<name><surname>Leibovich</surname> <given-names>S. J.</given-names></name>
</person-group> (<year>2012</year>). 
<article-title>Regulation of macrophage polarization and wound healing</article-title>. <source>Adv. Wound Care</source> <volume>1</volume>, <fpage>10</fpage>&#x2013;<lpage>165</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1089/wound.2011.0307</pub-id>, PMID: <pub-id pub-id-type="pmid">24527272</pub-id>
</mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Feske</surname> <given-names>S.</given-names></name>
<name><surname>Wulff</surname> <given-names>H.</given-names></name>
<name><surname>Skolnik</surname> <given-names>E. Y.</given-names></name>
</person-group> (<year>2015</year>). 
<article-title>Ion channels in innate and adaptive immunity</article-title>. <source>Annu. Rev. Immunol.</source> <volume>33</volume>, <fpage>291</fpage>&#x2013;<lpage>353</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev-immunol-032414-112212</pub-id>, PMID: <pub-id pub-id-type="pmid">25861976</pub-id>
</mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Flynn</surname> <given-names>J. L.</given-names></name>
<name><surname>Chan</surname> <given-names>J.</given-names></name>
</person-group> (<year>2001</year>). 
<article-title>Immunology of tuberculosis</article-title>. <source>Annu. Rev. Immunol.</source> <volume>19</volume>, <fpage>93</fpage>&#x2013;<lpage>129</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev.immunol.19.1.93</pub-id>, PMID: <pub-id pub-id-type="pmid">11244032</pub-id>
</mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Fu</surname> <given-names>Y. L.</given-names></name>
<name><surname>Harrison</surname> <given-names>R. E.</given-names></name>
</person-group> (<year>2021</year>). 
<article-title>Microbial phagocytic receptors and their potential involvement in cytokine induction in macrophages</article-title>. <source>Front. Immunol.</source> <volume>12</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2021.662063</pub-id>, PMID: <pub-id pub-id-type="pmid">33995386</pub-id>
</mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Galluzzi</surname> <given-names>L.</given-names></name>
<name><surname>Bravo-San Pedro</surname> <given-names>J. M.</given-names></name>
<name><surname>Vitale</surname> <given-names>I.</given-names></name>
<name><surname>Aaronson</surname> <given-names>S. A.</given-names></name>
<name><surname>Abrams</surname> <given-names>J. M.</given-names></name>
<name><surname>Adam</surname> <given-names>D.</given-names></name>
<etal/>
</person-group>. (<year>2015</year>). 
<article-title>Essential versus accessory aspects of cell death: recommendations of the NCCD 2015</article-title>. <source>Cell Death Differentiation</source> <volume>22</volume>, <fpage>58</fpage>&#x2013;<lpage>73</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/cdd.2014.137</pub-id>, PMID: <pub-id pub-id-type="pmid">25236395</pub-id>
</mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ganesan</surname> <given-names>R.</given-names></name>
<name><surname>Hos</surname> <given-names>N. J.</given-names></name>
<name><surname>Gutierrez</surname> <given-names>S.</given-names></name>
<name><surname>Fischer</surname> <given-names>J.</given-names></name>
<name><surname>Robinson</surname> <given-names>N.</given-names></name>
<name><surname>Stepek</surname> <given-names>M.</given-names></name>
<etal/>
</person-group>. (<year>2017</year>). 
<article-title>Salmonella typhimurium disrupts sirt1/AMPK checkpoint control of MTOR to impair autophagy</article-title>. <source>Preprint</source><fpage>1</fpage>&#x2013;<lpage>22</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.ppat.1006227</pub-id>, PMID: <pub-id pub-id-type="pmid">28192515</pub-id>
</mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ganz</surname> <given-names>T.</given-names></name>
</person-group> (<year>2016</year>). 
<article-title>Macrophages and iron metabolism</article-title>. <source>Microbiol. Spectr.</source> <volume>4</volume>, <page-range>803&#x2013;812</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/microbiolspec.MCHD-0037-2016</pub-id>, PMID: <pub-id pub-id-type="pmid">27763254</pub-id>
</mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Gautier</surname> <given-names>E. L.</given-names></name>
<name><surname>Shay</surname> <given-names>T.</given-names></name>
<name><surname>Miller</surname> <given-names>J.</given-names></name>
<name><surname>Greter</surname> <given-names>M.</given-names></name>
<name><surname>Jakubzick</surname> <given-names>C.</given-names></name>
<name><surname>Ivanov</surname> <given-names>S.</given-names></name>
<etal/>
</person-group>. (<year>2012</year>). 
<article-title>Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages</article-title>. <source>Nat. Immunol.</source> <volume>13</volume>, <fpage>1118</fpage>&#x2013;<lpage>1128</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ni.2419</pub-id>, PMID: <pub-id pub-id-type="pmid">23023392</pub-id>
</mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Geest</surname> <given-names>R. v. d.</given-names></name>
<name><surname>Fan</surname> <given-names>H.</given-names></name>
<name><surname>Pe&#xf1;aloza</surname> <given-names>Hern&#xe1;nF.</given-names></name>
<name><surname>Bain</surname> <given-names>W. G.</given-names></name>
<name><surname>Xiong</surname> <given-names>Z.</given-names></name>
<name><surname>Kohli</surname> <given-names>N.</given-names></name>
<etal/>
</person-group>. (<year>2023</year>). 
<article-title>Phagocytosis is a primary determinant of pulmonary clearance of clinical Klebsiella pneumoniae isolates</article-title>. <source>Front. Cell. Infection Microbiol.</source> <volume>13</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2023.1150658</pub-id>, PMID: <pub-id pub-id-type="pmid">37056705</pub-id>
</mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ginhoux</surname> <given-names>F.</given-names></name>
<name><surname>Jung</surname> <given-names>S.</given-names></name>
</person-group> (<year>2014</year>). 
<article-title>Monocytes and macrophages: developmental pathways and tissue homeostasis</article-title>. <source>Nat. Rev. Immunol.</source> <volume>14</volume>, <fpage>392</fpage>&#x2013;<lpage>4045</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nri3671</pub-id>, PMID: <pub-id pub-id-type="pmid">24854589</pub-id>
</mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Glick</surname> <given-names>D.</given-names></name>
<name><surname>Barth</surname> <given-names>S.</given-names></name>
<name><surname>Macleod</surname> <given-names>K. F.</given-names></name>
</person-group> (<year>2010</year>). 
<article-title>Autophagy: cellular and molecular mechanisms</article-title>. <source>J. Pathol.</source> <volume>221</volume>, <fpage>3</fpage>&#x2013;<lpage>125</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/path.2697</pub-id>, PMID: <pub-id pub-id-type="pmid">20225336</pub-id>
</mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Gluschko</surname> <given-names>A.</given-names></name>
<name><surname>Herb</surname> <given-names>M.</given-names></name>
<name><surname>Wiegmann</surname> <given-names>K.</given-names></name>
<name><surname>Krut</surname> <given-names>O.</given-names></name>
<name><surname>Neiss</surname> <given-names>W. F.</given-names></name>
<name><surname>Uterm&#xf6;hlen</surname> <given-names>O.</given-names></name>
<etal/>
</person-group>. (<year>2018</year>). 
<article-title>The B2 integrin Mac-1 induces protective LC3-associated phagocytosis of listeria monocytogenes</article-title>. <source>Cell Host Microbe</source> <volume>23</volume>, <fpage>324</fpage>&#x2013;<lpage>3375.e5</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.chom.2018.01.018</pub-id>, PMID: <pub-id pub-id-type="pmid">29544096</pub-id>
</mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Gomes</surname> <given-names>L. C.</given-names></name>
<name><surname>Dikic</surname> <given-names>I.</given-names></name>
</person-group> (<year>2014</year>). 
<article-title>Autophagy in antimicrobial immunity</article-title>. <source>Mol. Cell</source> <volume>54</volume>, <fpage>224</fpage>&#x2013;<lpage>335</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.molcel.2014.03.009</pub-id>, PMID: <pub-id pub-id-type="pmid">24766886</pub-id>
</mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Gordon</surname> <given-names>S.</given-names></name>
<name><surname>Pl&#xfc;ddemann</surname> <given-names>A.</given-names></name>
</person-group> (<year>2017</year>). 
<article-title>Tissue macrophages: heterogeneity and functions</article-title>. <source>BMC Biol.</source> <volume>15</volume>, <fpage>535</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12915-017-0392-4</pub-id>, PMID: <pub-id pub-id-type="pmid">28662662</pub-id>
</mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Gorrie</surname> <given-names>C. L.</given-names></name>
<name><surname>Eta</surname> <given-names>M. M.</given-names></name>
<name><surname>Wick</surname> <given-names>R. R.</given-names></name>
<name><surname>Edwards</surname> <given-names>D. J.</given-names></name>
<name><surname>Thomson</surname> <given-names>N. R.</given-names></name>
<name><surname>Strugnell</surname> <given-names>R. A.</given-names></name>
<etal/>
</person-group>. (<year>2017</year>). 
<article-title>Gastrointestinal carriage is a major reservoir of Klebsiella pneumoniae infection in intensive care patients</article-title>. <source>Clin. Infect. Dis.</source> <volume>65</volume>, <fpage>208</fpage>&#x2013;<lpage>215</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/cid/cix270</pub-id>, PMID: <pub-id pub-id-type="pmid">28369261</pub-id>
</mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Grubwieser</surname> <given-names>P.</given-names></name>
<name><surname>Hilbe</surname> <given-names>R.</given-names></name>
<name><surname>Gehrer</surname> <given-names>C. M.</given-names></name>
<name><surname>Grander</surname> <given-names>M.</given-names></name>
<name><surname>Brigo</surname> <given-names>N.</given-names></name>
<name><surname>Hoffmann</surname> <given-names>A.</given-names></name>
<etal/>
</person-group>. (<year>2023</year>). 
<article-title>Klebsiella pneumoniae manipulates human macrophages to acquire iron</article-title>. <source>Front. Microbiol.</source> <volume>14</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2023.1223113</pub-id>, PMID: <pub-id pub-id-type="pmid">37637102</pub-id>
</mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Guan</surname> <given-names>F.</given-names></name>
<name><surname>Wang</surname> <given-names>R.</given-names></name>
<name><surname>Yi</surname> <given-names>Z.</given-names></name>
<name><surname>Luo</surname> <given-names>P.</given-names></name>
<name><surname>Liu</surname> <given-names>W.</given-names></name>
<name><surname>Xie</surname> <given-names>Y.</given-names></name>
<etal/>
</person-group>. (<year>2025</year>). 
<article-title>Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets</article-title>. <source>Signal Transduction Targeted Ther.</source> <volume>10</volume>, <fpage>935</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41392-025-02124-y</pub-id>, PMID: <pub-id pub-id-type="pmid">40055311</pub-id>
</mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Hakansson</surname> <given-names>A. P.</given-names></name>
<name><surname>Orihuela</surname> <given-names>C. J.</given-names></name>
<name><surname>Bogaert</surname> <given-names>D.</given-names></name>
</person-group> (<year>2018</year>). 
<article-title>Bacterial-host interactions: physiology and pathophysiology of respiratory infection</article-title>. <source>Physiol. Rev.</source> <volume>98</volume>, <fpage>781</fpage>&#x2013;<lpage>811</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1152/physrev.00040.2016</pub-id>, PMID: <pub-id pub-id-type="pmid">29488821</pub-id>
</mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Hamada</surname> <given-names>M.</given-names></name>
<name><surname>Tsunakawa</surname> <given-names>Y.</given-names></name>
<name><surname>Jeon</surname> <given-names>H.</given-names></name>
<name><surname>Yadav</surname> <given-names>M. K.</given-names></name>
<name><surname>Takahashi</surname> <given-names>S.</given-names></name>
</person-group> (<year>2020</year>). 
<article-title>Role of mafB in macrophages</article-title>. <source>Exp. Anim.</source> <volume>69</volume>, <fpage>1</fpage>&#x2013;<lpage>105</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1538/expanim.19-0076</pub-id>, PMID: <pub-id pub-id-type="pmid">31582643</pub-id>
</mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Han</surname> <given-names>J.</given-names></name>
<name><surname>Chitu</surname> <given-names>V.</given-names></name>
<name><surname>Richard Stanley</surname> <given-names>E.</given-names></name>
<name><surname>Wszolek</surname> <given-names>Z. K.</given-names></name>
<name><surname>Karrenbauer</surname> <given-names>V. D.</given-names></name>
<name><surname>Harris</surname> <given-names>R. A.</given-names></name>
</person-group> (<year>2022</year>). 
<article-title>Inhibition of colony stimulating factor-1 receptor (CSF-1R) as a potential therapeutic strategy for neurodegenerative diseases: opportunities and challenges</article-title>. <source>Cell. Mol. Life Sciences : CMLS</source> <volume>79</volume>, <fpage>2195</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00018-022-04225-1</pub-id>, PMID: <pub-id pub-id-type="pmid">35366105</pub-id>
</mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Hendy</surname> <given-names>G. N.</given-names></name>
<name><surname>Canaff</surname> <given-names>L.</given-names></name>
</person-group> (<year>2016</year>). 
<article-title>Calcium-sensing receptor, proinflammatory cytokines and calcium homeostasis</article-title>. <source>Semin. Cell Dev. Biol.</source> <volume>49</volume>, <fpage>37</fpage>&#x2013;<lpage>43</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.semcdb.2015.11.006</pub-id>, PMID: <pub-id pub-id-type="pmid">26612442</pub-id>
</mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Herb</surname> <given-names>M.</given-names></name>
<name><surname>Gluschko</surname> <given-names>A.</given-names></name>
<name><surname>Schramm</surname> <given-names>M.</given-names></name>
</person-group> (<year>2020</year>). 
<article-title>LC3-associated phagocytosis - the highway to hell for phagocytosed microbes</article-title>. <source>Semin. Cell Dev. Biol.</source> <volume>101</volume>, <fpage>68</fpage>&#x2013;<lpage>76</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.semcdb.2019.04.016</pub-id>, PMID: <pub-id pub-id-type="pmid">31029766</pub-id>
</mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Hirayama</surname> <given-names>D.</given-names></name>
<name><surname>Iida</surname> <given-names>T.</given-names></name>
<name><surname>Nakase</surname> <given-names>H.</given-names></name>
</person-group> (<year>2017</year>). 
<article-title>The phagocytic function of macrophage-enforcing innate immunity and tissue homeostasis</article-title>. <source>Int. J. Mol. Sci.</source> <volume>19</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms19010092</pub-id>, PMID: <pub-id pub-id-type="pmid">29286292</pub-id>
</mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Hsieh</surname> <given-names>P. F.</given-names></name>
<name><surname>Lu</surname> <given-names>Yi R.</given-names></name>
<name><surname>Lin</surname> <given-names>T. L.</given-names></name>
<name><surname>Lai</surname> <given-names>Li Y.</given-names></name>
<name><surname>Wang</surname> <given-names>J. T.</given-names></name>
</person-group> (<year>2019</year>). 
<article-title>Klebsiella pneumoniae type VI secretion system contributes to bacterial competition, cell invasion, type-1 fimbriae expression, and <italic>in vivo</italic> colonization</article-title>. <source>J. Infect. Dis.</source> <volume>219</volume>, <fpage>637</fpage>&#x2013;<lpage>475</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/infdis/jiy534</pub-id>, PMID: <pub-id pub-id-type="pmid">30202982</pub-id>
</mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Hsu</surname> <given-names>C.-R.</given-names></name>
<name><surname>Pan</surname> <given-names>Y.-J.</given-names></name>
<name><surname>Liu</surname> <given-names>J.-Y.</given-names></name>
<name><surname>Chen</surname> <given-names>C.-T.</given-names></name>
<name><surname>Lin</surname> <given-names>T.-L.</given-names></name>
<name><surname>Wang</surname> <given-names>J.-T.</given-names></name>
</person-group> (<year>2015</year>). 
<article-title>Klebsiella Pneumoniae Translocates across the Intestinal Epithelium via Rho GTPase- and Phosphatidylinositol 3-Kinase/Akt-Dependent Cell Invasion</article-title>. <source>Infection Immun.</source> <volume>83</volume>, <fpage>769</fpage>&#x2013;<lpage>795</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.02345-14</pub-id>, PMID: <pub-id pub-id-type="pmid">25452552</pub-id>
</mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Hu</surname> <given-names>W.</given-names></name>
<name><surname>Jain</surname> <given-names>A.</given-names></name>
<name><surname>Gao</surname> <given-names>Y.</given-names></name>
<name><surname>Dozmorov</surname> <given-names>I. M.</given-names></name>
<name><surname>Mandraju</surname> <given-names>R.</given-names></name>
<name><surname>Wakeland</surname> <given-names>E. K.</given-names></name>
<etal/>
</person-group>. (<year>2015</year>). 
<article-title>Differential outcome of TRIF-mediated signaling in TLR4 and TLR3 induced DC maturation</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A</source> <volume>112</volume>, <fpage>13994</fpage>&#x2013;<lpage>13995</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.1510760112</pub-id>, PMID: <pub-id pub-id-type="pmid">26508631</pub-id>
</mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Hu</surname> <given-names>L.</given-names></name>
<name><surname>Tao</surname> <given-names>H.</given-names></name>
<name><surname>Tao</surname> <given-names>X.</given-names></name>
<name><surname>Tang</surname> <given-names>X.</given-names></name>
<name><surname>Xu</surname> <given-names>C.</given-names></name>
</person-group> (<year>2019</year>). 
<article-title>TLR2 Arg753Gln gene polymorphism associated with tuberculosis susceptibility: an updated meta-analysis</article-title>. <source>BioMed. Res. Int.</source> <volume>2019</volume>, <elocation-id>2628101</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2019/2628101</pub-id>, PMID: <pub-id pub-id-type="pmid">30733958</pub-id>
</mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Huang</surname> <given-names>H.-K.</given-names></name>
<name><surname>Liu</surname> <given-names>S.-P.</given-names></name>
<name><surname>Deng</surname> <given-names>X.</given-names></name>
<name><surname>Zhao</surname> <given-names>R.-L.</given-names></name>
<name><surname>Feng</surname> <given-names>Y.</given-names></name>
<name><surname>Wu</surname> <given-names>J.-S.</given-names></name>
</person-group> (<year>2025</year>). 
<article-title>Crosstalk between macrophages and diverse immune cells accelerates the development of acute lung injury</article-title>. <source>Life Sci.</source> <volume>380</volume>, <elocation-id>123925</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.lfs.2025.123925</pub-id>, PMID: <pub-id pub-id-type="pmid">40876736</pub-id>
</mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Huang</surname> <given-names>H.</given-names></name>
<name><surname>Weaver</surname> <given-names>A.</given-names></name>
<name><surname>Wu</surname> <given-names>E.</given-names></name>
<name><surname>Li</surname> <given-names>Y.</given-names></name>
<name><surname>Gao</surname> <given-names>H.</given-names></name>
<name><surname>Fan</surname> <given-names>W.</given-names></name>
<etal/>
</person-group>. (<year>2013</year>). 
<article-title>Lipid-based signaling modulates DNA repair response and survival against Klebsiella pneumoniae infection in host cells and in mice</article-title>. <source>Am. J. Respir. Cell Mol. Biol.</source> <volume>49</volume>, <fpage>798</fpage>&#x2013;<lpage>8075</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1165/rcmb.2013-0069OC</pub-id>, PMID: <pub-id pub-id-type="pmid">23742126</pub-id>
</mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ingale</surname> <given-names>S.</given-names></name>
<name><surname>Rathored</surname> <given-names>J.</given-names></name>
<name><surname>Shende</surname> <given-names>S.</given-names></name>
<name><surname>Wankhade</surname> <given-names>S.</given-names></name>
</person-group> (<year>2025</year>). 
<article-title>The role of calcium homeostasis in modulating the immune response in cancer and infectious diseases</article-title>. <source>Multidiscip. Rev.</source> <volume>8</volume>, <fpage>1</fpage>&#x2013;<lpage>105</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.31893/MULTIREV.2025034</pub-id>
</mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Jessop</surname> <given-names>F.</given-names></name>
<name><surname>Borhnsen</surname> <given-names>E.</given-names></name>
<name><surname>Schwarz</surname> <given-names>B.</given-names></name>
<name><surname>Stromberg</surname> <given-names>K. A.</given-names></name>
<name><surname>Miltko</surname> <given-names>M.</given-names></name>
<name><surname>Jones</surname> <given-names>T.</given-names></name>
<etal/>
</person-group>. (<year>2025</year>). 
<article-title>Lactate metabolism is exploited by Francisella tularensis via its O-antigen capsule to limit macrophage-mediated activation and cell death</article-title>. <source>MBio</source> <volume>16</volume>, <elocation-id>e0068125</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/mbio.00681-25</pub-id>, PMID: <pub-id pub-id-type="pmid">40981418</pub-id>
</mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Jiang</surname> <given-names>M.</given-names></name>
<name><surname>Zhang</surname> <given-names>H.</given-names></name>
<name><surname>Lu</surname> <given-names>W.</given-names></name>
<name><surname>Qiu</surname> <given-names>X.</given-names></name>
<name><surname>Lin</surname> <given-names>C.</given-names></name>
<name><surname>Zhao</surname> <given-names>R.</given-names></name>
<etal/>
</person-group>. (<year>2024</year>). 
<article-title>Molecular characteristics of virulence genes in carbapenem-resistant and carbapenem-sensitive Klebsiella pneumoniae in relation to different capsule serotypes in Ningbo, China</article-title>. <source>Infection Drug Resistance</source> <volume>17</volume>, <fpage>2109</fpage>&#x2013;<lpage>2120</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.2147/IDR.S461666</pub-id>, PMID: <pub-id pub-id-type="pmid">38828374</pub-id>
</mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Jin</surname> <given-names>S.-W.</given-names></name>
<name><surname>Zhang</surname> <given-names>L.</given-names></name>
<name><surname>Lian</surname> <given-names>Q.-Q.</given-names></name>
<name><surname>Yao</surname> <given-names>S.-L.</given-names></name>
<name><surname>Wu</surname> <given-names>P.</given-names></name>
<name><surname>Zhou</surname> <given-names>X.-Y.</given-names></name>
<etal/>
</person-group>. (<year>2006</year>). 
<article-title>Close functional coupling between Ca2+ Release-activated Ca2+ Channels and reactive oxygen species production in murine macrophages</article-title>. <source>Mediators Inflammation</source> <volume>2006</volume>, <elocation-id>36192</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/MI/2006/36192</pub-id>, PMID: <pub-id pub-id-type="pmid">17392583</pub-id>
</mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Joseph</surname> <given-names>L.</given-names></name>
<name><surname>Merciecca</surname> <given-names>T.</given-names></name>
<name><surname>Forestier</surname> <given-names>C.</given-names></name>
<name><surname>Balestrino</surname> <given-names>D.</given-names></name>
<name><surname>Miquel</surname> <given-names>S.</given-names></name>
</person-group> (<year>2021</year>). 
<article-title>From Klebsiella pneumoniae colonization to dissemination: an overview of studies implementing murine models</article-title>. <source>Microorganisms</source> <volume>9</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/microorganisms9061282</pub-id>, PMID: <pub-id pub-id-type="pmid">34204632</pub-id>
</mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Joshi</surname> <given-names>R.</given-names></name>
<name><surname>Saroj</surname> <given-names>S. D.</given-names></name>
</person-group> (<year>2023</year>). 
<article-title>Survival and evasion of neisseria meningitidis from macrophages</article-title>. <source>Med. Microecology</source> <volume>17</volume>, <elocation-id>100087</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.medmic.2023.100087</pub-id>
</mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kamaladevi</surname> <given-names>A.</given-names></name>
<name><surname>Balamurugan</surname> <given-names>K.</given-names></name>
</person-group> (<year>2017</year>). 
<article-title>Global proteomics revealed Klebsiella pneumoniae induced autophagy and oxidative stress in caenorhabditis elegans by inhibiting PI3K/AKT/MTOR pathway during infection</article-title>. <source>Front. Cell. Infection Microbiol.</source> <volume>7</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2017.00393</pub-id>, PMID: <pub-id pub-id-type="pmid">28932706</pub-id>
</mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kawai</surname> <given-names>T.</given-names></name>
<name><surname>Akira</surname> <given-names>S.</given-names></name>
</person-group> (<year>2009</year>). 
<article-title>The roles of TLRs, RLRs and NLRs in pathogen recognition</article-title>. <source>Int. Immunol.</source> <volume>21</volume>, <fpage>317</fpage>&#x2013;<lpage>375</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/intimm/dxp017</pub-id>, PMID: <pub-id pub-id-type="pmid">19246554</pub-id>
</mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kehl-Fie</surname> <given-names>T. E.</given-names></name>
<name><surname>Skaar</surname> <given-names>E. P.</given-names></name>
</person-group> (<year>2010</year>). 
<article-title>Nutritional immunity beyond iron: A role for manganese and zinc</article-title>. <source>Curr. Opin. Chem. Biol.</source> <volume>14</volume>, <page-range>218&#x2013;224</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cbpa.2009.11.008</pub-id>, PMID: <pub-id pub-id-type="pmid">20015678</pub-id>
</mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kelley</surname> <given-names>N.</given-names></name>
<name><surname>Jeltema</surname> <given-names>D.</given-names></name>
<name><surname>Duan</surname> <given-names>Y.</given-names></name>
<name><surname>He</surname> <given-names>Y.</given-names></name>
</person-group> (<year>2019</year>). 
<article-title>The NLRP3 inflammasome: an overview of mechanisms of activation and regulation</article-title>. <source>Int. J. Mol. Sci.</source> <volume>20</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms20133328</pub-id>, PMID: <pub-id pub-id-type="pmid">31284572</pub-id>
</mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kim</surname> <given-names>T.-H.</given-names></name>
<name><surname>Yang</surname> <given-names>K.</given-names></name>
<name><surname>Kim</surname> <given-names>M.</given-names></name>
<name><surname>Kim</surname> <given-names>H.-S.</given-names></name>
<name><surname>Kang</surname> <given-names>J. L.</given-names></name>
</person-group> (<year>2021</year>). 
<article-title>Apoptosis inhibitor of macrophage (AIM) contributes to IL-10-induced anti-inflammatory response through inhibition of inflammasome activation</article-title>. <source>Cell Death Dis.</source> <volume>12</volume>, <fpage>195</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41419-020-03332-w</pub-id>, PMID: <pub-id pub-id-type="pmid">33414479</pub-id>
</mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kimmery</surname> <given-names>M. B.</given-names></name>
<name><surname>Burnett</surname> <given-names>D. A.</given-names></name>
<name><surname>Carr-Locke</surname> <given-names>D. L.</given-names></name>
<name><surname>DiMarino</surname> <given-names>A. J.</given-names></name>
<name><surname>Jensen</surname> <given-names>D. M.</given-names></name>
<name><surname>Katon</surname> <given-names>R.</given-names></name>
<etal/>
</person-group>. (<year>1993</year>). 
<article-title>Transmission of infection by gastrointestinal endoscopy</article-title>. <source>Gastrointestinal Endoscopy</source> <volume>39</volume>, <fpage>885</fpage>&#x2013;<lpage>885</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0016-5107(93)70316-8</pub-id>
</mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Knapp</surname> <given-names>S.</given-names></name>
<name><surname>Wieland</surname> <given-names>C. W.</given-names></name>
<name><surname>Florquin</surname> <given-names>S.</given-names></name>
<name><surname>Pantophlet</surname> <given-names>R.</given-names></name>
<name><surname>Dijkshoorn</surname> <given-names>L.</given-names></name>
<name><surname>Tshimbalanga</surname> <given-names>N.</given-names></name>
<etal/>
</person-group>. (<year>2006</year>). 
<article-title>Differential roles of CD14 and toll-like receptors 4 and 2 in murine acinetobacter pneumonia</article-title>. <source>Am. J. Respir. Crit. Care Med.</source> <volume>173</volume>, <fpage>122</fpage>&#x2013;<lpage>295</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1164/rccm.200505-730oc</pub-id>, PMID: <pub-id pub-id-type="pmid">16210672</pub-id>
</mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ko</surname> <given-names>K. S.</given-names></name>
</person-group> (<year>2017</year>). 
<article-title>The contribution of capsule polysaccharide genes to virulence of Klebsiella pneumoniae</article-title>. <source>Virulence</source> <volume>8</volume>, <fpage>485</fpage>&#x2013;<lpage>486</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/21505594.2016.1240862</pub-id>, PMID: <pub-id pub-id-type="pmid">27715471</pub-id>
</mixed-citation>
</ref>
<ref id="B102">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kochan</surname> <given-names>T. J.</given-names></name>
<name><surname>Nozick</surname> <given-names>S. H.</given-names></name>
<name><surname>Medernach</surname> <given-names>R. L.</given-names></name>
<name><surname>Cheung</surname> <given-names>B. H.</given-names></name>
<name><surname>Gatesy</surname> <given-names>S. W.M.</given-names></name>
<name><surname>Lebrun-Corbin</surname> <given-names>M.</given-names></name>
<etal/>
</person-group>. (<year>2022</year>). 
<article-title>Genomic surveillance for multidrug-resistant or hypervirulent Klebsiella pneumoniae among United States bloodstream isolates</article-title>. <source>BMC Infect. Dis.</source> <volume>22</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12879-022-07558-1</pub-id>, PMID: <pub-id pub-id-type="pmid">35799130</pub-id>
</mixed-citation>
</ref>
<ref id="B103">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kohler</surname> <given-names>L. J.</given-names></name>
<name><surname>Reed</surname> <given-names>S. C.O.</given-names></name>
<name><surname>Sarraf</surname> <given-names>S. A.</given-names></name>
<name><surname>Arteaga</surname> <given-names>D. D.</given-names></name>
<name><surname>Newton</surname> <given-names>H. J.</given-names></name>
<name><surname>Roy</surname> <given-names>C. R.</given-names></name>
</person-group> (<year>2016</year>). 
<article-title>Effector protein cig2 decreases host tolerance of infection by directing constitutive fusion of autophagosomes with the coxiella-containing vacuole</article-title>. <source>MBio</source> <volume>7</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/mBio.01127-16</pub-id>, PMID: <pub-id pub-id-type="pmid">27435465</pub-id>
</mixed-citation>
</ref>
<ref id="B104">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kosteli</surname> <given-names>A.</given-names></name>
<name><surname>Sugaru</surname> <given-names>E.</given-names></name>
<name><surname>Haemmerle</surname> <given-names>G.</given-names></name>
<name><surname>Martin</surname> <given-names>J. F.</given-names></name>
<name><surname>Lei</surname> <given-names>J.</given-names></name>
<name><surname>Zechner</surname> <given-names>R.</given-names></name>
<etal/>
</person-group>. (<year>2010</year>). 
<article-title>Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue</article-title>. <source>J. Clin. Invest.</source> <volume>120</volume>, <fpage>3466</fpage>&#x2013;<lpage>3795</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1172/JCI42845</pub-id>, PMID: <pub-id pub-id-type="pmid">20877011</pub-id>
</mixed-citation>
</ref>
<ref id="B105">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ktari</surname> <given-names>S.</given-names></name>
<name><surname>Arlet</surname> <given-names>G.</given-names></name>
<name><surname>Mnif</surname> <given-names>B.</given-names></name>
<name><surname>Gautier</surname> <given-names>V.</given-names></name>
<name><surname>Mahjoubi</surname> <given-names>F.</given-names></name>
<name><surname>Jmeaa</surname> <given-names>M. B.</given-names></name>
<etal/>
</person-group>. (<year>2006</year>). 
<article-title>Emergence of multidrug-resistant Klebsiella pneumoniae isolates producing VIM-4 metallo-&#x3b2;-lactamase, CTX-M-15 extended-spectrum &#x3b2;-lactamase, and CMY-4 ampC &#x3b2;-lactamase in a Tunisian university hospital</article-title>. <source>Antimicrobial Agents Chemotherapy</source> <volume>50</volume>, <fpage>4198</fpage>&#x2013;<lpage>42015</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/AAC.00663-06</pub-id>, PMID: <pub-id pub-id-type="pmid">17015633</pub-id>
</mixed-citation>
</ref>
<ref id="B106">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kumar</surname> <given-names>A.</given-names></name>
<name><surname>Chakravorty</surname> <given-names>S.</given-names></name>
<name><surname>Yang</surname> <given-names>T.</given-names></name>
<name><surname>Russo</surname> <given-names>T. A.</given-names></name>
<name><surname>Newton</surname> <given-names>S. M.</given-names></name>
<name><surname>Klebba</surname> <given-names>P. E.</given-names></name>
</person-group> (<year>2024</year>). 
<article-title>Siderophore-mediated iron acquisition by Klebsiella pneumoniae</article-title>. <source>J. Bacteriology</source> <volume>206</volume>, <fpage>e0002424</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/jb.00024-24</pub-id>, PMID: <pub-id pub-id-type="pmid">38591913</pub-id>
</mixed-citation>
</ref>
<ref id="B107">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kumar</surname> <given-names>H.</given-names></name>
<name><surname>Kawai</surname> <given-names>T.</given-names></name>
<name><surname>Akira</surname> <given-names>S.</given-names></name>
</person-group> (<year>2011</year>). 
<article-title>Pathogen recognition by the innate immune system</article-title>. <source>Int. Rev. Immunol.</source> <volume>30</volume>, <fpage>16</fpage>&#x2013;<lpage>345</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3109/08830185.2010.529976</pub-id>, PMID: <pub-id pub-id-type="pmid">21235323</pub-id>
</mixed-citation>
</ref>
<ref id="B108">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Lawlor</surname> <given-names>M. S.</given-names></name>
</person-group> (<year>2007</year>). 
<article-title>Digital Commons @ Becker Yersiniabactin Is a Virulence Factor for Klebsiella Pneumoniae during Pulmonary Infection Please Let Us Know How This Document Benefits You. Yersiniabactin Is a Virulence Factor for Klebsiella Pneumoniae during Pulmonary Infectio</article-title>. <source>Infect. Immun.</source> <volume>75</volume>, <page-range>1463&#x2013;1472</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.00372-06.Published</pub-id>
</mixed-citation>
</ref>
<ref id="B109">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Lee</surname> <given-names>I.</given-names></name>
<name><surname>Molton</surname> <given-names>J.</given-names></name>
<name><surname>Wyres</surname> <given-names>K.</given-names></name>
<name><surname>Gorrie</surname> <given-names>C.</given-names></name>
<name><surname>Wong</surname> <given-names>J.</given-names></name>
<name><surname>Hoh</surname> <given-names>C.</given-names></name>
<etal/>
</person-group>. (<year>2016</year>). 
<article-title>Differential host susceptibility and bacterial virulence factors driving Klebsiella liver abscess in an ethnically diverse population</article-title>. <source>Sci. Rep.</source> <volume>6</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/srep29316</pub-id>, PMID: <pub-id pub-id-type="pmid">27406977</pub-id>
</mixed-citation>
</ref>
<ref id="B110">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Lee</surname> <given-names>E.</given-names></name>
<name><surname>Song</surname> <given-names>C. H.</given-names></name>
<name><surname>Bae</surname> <given-names>S. J.</given-names></name>
<name><surname>Ha</surname> <given-names>Ki T.</given-names></name>
<name><surname>Karki</surname> <given-names>R.</given-names></name>
</person-group> (<year>2023</year>). 
<article-title>Regulated cell death pathways and their roles in homeostasis, infection, inflammation, and tumorigenesis</article-title>. <source>Exp. Mol. Med.</source> <volume>55</volume>, <fpage>1632</fpage>&#x2013;<lpage>1435</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s12276-023-01069-y</pub-id>, PMID: <pub-id pub-id-type="pmid">37612410</pub-id>
</mixed-citation>
</ref>
<ref id="B111">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Leopold Wager</surname> <given-names>C. M.</given-names></name>
<name><surname>Bonifacio</surname> <given-names>J. R.</given-names></name>
<name><surname>Simper</surname> <given-names>J.</given-names></name>
<name><surname>Naoun</surname> <given-names>A. A.</given-names></name>
<name><surname>Arnett</surname> <given-names>E.</given-names></name>
<name><surname>Schlesinger</surname> <given-names>L. S.</given-names></name>
</person-group> (<year>2023</year>). 
<article-title>Activation of transcription factor CREB in human macrophages by mycobacterium tuberculosis promotes bacterial survival, reduces NF-KB nuclear transit and limits phagolysosome fusion by reduced necroptotic signaling</article-title>. <source>PloS Pathog.</source> <volume>19</volume>, <elocation-id>e10112975</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.ppat.1011297</pub-id>, PMID: <pub-id pub-id-type="pmid">37000865</pub-id>
</mixed-citation>
</ref>
<ref id="B112">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Levine</surname> <given-names>B.</given-names></name>
</person-group> (<year>2005</year>). 
<article-title>Eating oneself and uninvited guests: autophagy-related pathways in cellular defense</article-title>. <source>Cell</source> <volume>120</volume>, <fpage>159</fpage>&#x2013;<lpage>162</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cell.2005.01.005</pub-id>, PMID: <pub-id pub-id-type="pmid">15680321</pub-id>
</mixed-citation>
</ref>
<ref id="B113">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Li</surname> <given-names>Y.</given-names></name>
<name><surname>Li</surname> <given-names>X.</given-names></name>
<name><surname>Wu</surname> <given-names>W.</given-names></name>
<name><surname>Liu</surname> <given-names>P.</given-names></name>
<name><surname>Liu</surname> <given-names>J.</given-names></name>
<name><surname>Jiang</surname> <given-names>H.</given-names></name>
<etal/>
</person-group>. (<year>2025</year>). 
<article-title>Insights into the roles of macrophages in Klebsiella pneumoniae infections: A comprehensive review</article-title>. <source>Cell. Mol. Biol. Lett.</source> <volume>30</volume>, <fpage>34</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s11658-025-00717-7</pub-id>, PMID: <pub-id pub-id-type="pmid">40140770</pub-id>
</mixed-citation>
</ref>
<ref id="B114">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Li</surname> <given-names>D.</given-names></name>
<name><surname>Wu</surname> <given-names>M.</given-names></name>
</person-group> (<year>2021</year>). 
<article-title>Pattern recognition receptors in health and diseases</article-title>. <source>Signal Transduction Targeted Ther.</source> <volume>6</volume>, <fpage>1</fpage>&#x2013;<lpage>245</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41392-021-00687-0</pub-id>, PMID: <pub-id pub-id-type="pmid">34344870</pub-id>
</mixed-citation>
</ref>
<ref id="B115">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Liang</surname> <given-names>Z.</given-names></name>
<name><surname>Wang</surname> <given-names>Y.</given-names></name>
<name><surname>Lai</surname> <given-names>Y.</given-names></name>
<name><surname>Zhang</surname> <given-names>J.</given-names></name>
<name><surname>Yin</surname> <given-names>L.</given-names></name>
<name><surname>Yu</surname> <given-names>X.</given-names></name>
<etal/>
</person-group>. (<year>2022</year>). 
<article-title>Host defense against the infection of Klebsiella pneumoniae: new strategy to kill the bacterium in the era of antibiotics</article-title>? <source>Front. Cell. Infection Microbiol.</source> <volume>12</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2022.1050396</pub-id>, PMID: <pub-id pub-id-type="pmid">36506034</pub-id>
</mixed-citation>
</ref>
<ref id="B116">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Lin</surname> <given-names>C.-L.</given-names></name>
<name><surname>Chen</surname> <given-names>F.-H.</given-names></name>
<name><surname>Huang</surname> <given-names>L.-Y.</given-names></name>
<name><surname>Chang</surname> <given-names>J.-C.</given-names></name>
<name><surname>Chen</surname> <given-names>J.-H.</given-names></name>
<name><surname>Tsai</surname> <given-names>Y.-K.</given-names></name>
<etal/>
</person-group>. (<year>2017</year>). 
<article-title>Effect in virulence of switching conserved homologous capsular polysaccharide genes from Klebsiella pneumoniae serotype K1 into K20</article-title>. <source>Virulence</source> <volume>8</volume>, <fpage>487</fpage>&#x2013;<lpage>935</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/21505594.2016.1228508</pub-id>, PMID: <pub-id pub-id-type="pmid">27565716</pub-id>
</mixed-citation>
</ref>
<ref id="B117">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Lin</surname> <given-names>T. H.</given-names></name>
<name><surname>Wu</surname> <given-names>C. C.</given-names></name>
<name><surname>Kuo</surname> <given-names>J. T.</given-names></name>
<name><surname>Chu</surname> <given-names>H. F.</given-names></name>
<name><surname>Lee</surname> <given-names>D. Y.</given-names></name>
<name><surname>Lin</surname> <given-names>C. T.</given-names></name>
</person-group> (<year>2019</year>). 
<article-title>Fnr-dependent rmpa and Rmpa2 regulation of capsule polysaccharide biosynthesis in Klebsiella pneumoniae</article-title>. <source>Front. Microbiol.</source> <volume>10</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2019.02436</pub-id>, PMID: <pub-id pub-id-type="pmid">31736888</pub-id>
</mixed-citation>
</ref>
<ref id="B118">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Linton</surname> <given-names>M. F.</given-names></name>
<name><surname>Moslehi</surname> <given-names>J. J.</given-names></name>
<name><surname>Babaev</surname> <given-names>V. R.</given-names></name>
</person-group> (<year>2019</year>). 
<article-title>Akt signaling in macrophage polarization, survival, and atherosclerosis</article-title>. <source>Int. J. Mol. Sci.</source> <volume>20</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms20112703</pub-id>, PMID: <pub-id pub-id-type="pmid">31159424</pub-id>
</mixed-citation>
</ref>
<ref id="B119">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Liu</surname> <given-names>W.</given-names></name>
<name><surname>Li</surname> <given-names>M.</given-names></name>
<name><surname>Cao</surname> <given-names>S.</given-names></name>
<name><surname>Ishaq</surname> <given-names>H. M.</given-names></name>
<name><surname>Zhao</surname> <given-names>H.</given-names></name>
<name><surname>Yang</surname> <given-names>F.</given-names></name>
<etal/>
</person-group>. (<year>2023</year>). 
<article-title>The biological and regulatory role of type VI secretion system of Klebsiella pneumoniae</article-title>. <source>Infection Drug Resistance</source> <volume>16</volume>, <fpage>6911</fpage>&#x2013;<lpage>6922</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.2147/IDR.S426657</pub-id>, PMID: <pub-id pub-id-type="pmid">37928603</pub-id>
</mixed-citation>
</ref>
<ref id="B120">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Liu</surname> <given-names>X.</given-names></name>
<name><surname>Wang</surname> <given-names>N.</given-names></name>
<name><surname>Zhu</surname> <given-names>Y.</given-names></name>
<name><surname>Yang</surname> <given-names>Y.</given-names></name>
<name><surname>Chen</surname> <given-names>X.</given-names></name>
<name><surname>Fan</surname> <given-names>S.</given-names></name>
<etal/>
</person-group>. (<year>2016</year>). 
<article-title>Inhibition of extracellular calcium influx results in enhanced IL-12 production in LPS-treated murine macrophages by downregulation of the caMKK&#x3b2;-AMPK-SIRT1 signaling pathway</article-title>. <source>Mediators Inflammation</source> <volume>2016</volume>, <elocation-id>6152713</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2016/6152713</pub-id>, PMID: <pub-id pub-id-type="pmid">27313401</pub-id>
</mixed-citation>
</ref>
<ref id="B121">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Liu</surname> <given-names>T.</given-names></name>
<name><surname>Zhang</surname> <given-names>L.</given-names></name>
<name><surname>Joo</surname> <given-names>D.</given-names></name>
<name><surname>Sun</surname> <given-names>S. C.</given-names></name>
</person-group> (<year>2017</year>). 
<article-title>NF-KB signaling in inflammation</article-title>. <source>Signal Transduction Targeted Ther.</source> <volume>2</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/sigtrans.2017.23</pub-id>, PMID: <pub-id pub-id-type="pmid">29158945</pub-id>
</mixed-citation>
</ref>
<ref id="B122">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Lu</surname> <given-names>Y.</given-names></name>
<name><surname>Wen</surname> <given-names>Z.</given-names></name>
<name><surname>Liu</surname> <given-names>X.</given-names></name>
<name><surname>Zhang</surname> <given-names>T.</given-names></name>
<name><surname>Liu</surname> <given-names>M.</given-names></name>
<name><surname>Zhang</surname> <given-names>L.</given-names></name>
<etal/>
</person-group>. (<year>2025</year>). 
<article-title>Research progress on bacterial outer membrane vesicles in antibiotic resistance and clinical anti-infective therapy</article-title>. <source>Front. Microbiol.</source> <volume>16</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2025.1670307</pub-id>, PMID: <pub-id pub-id-type="pmid">40980325</pub-id>
</mixed-citation>
</ref>
<ref id="B123">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Luo</surname> <given-names>M.</given-names></name>
<name><surname>Zhao</surname> <given-names>F.</given-names></name>
<name><surname>Cheng</surname> <given-names>H.</given-names></name>
<name><surname>Su</surname> <given-names>M.</given-names></name>
<name><surname>Wang</surname> <given-names>Y.</given-names></name>
</person-group> (<year>2024</year>). 
<article-title>Macrophage polarization: an important role in inflammatory diseases</article-title>. <source>Front. Immunol.</source> <volume>15</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2024.1352946</pub-id>, PMID: <pub-id pub-id-type="pmid">38660308</pub-id>
</mixed-citation>
</ref>
<ref id="B124">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Mao</surname> <given-names>P.</given-names></name>
<name><surname>Wang</surname> <given-names>Z.</given-names></name>
<name><surname>Yuan</surname> <given-names>C.</given-names></name>
<name><surname>Liu</surname> <given-names>K.</given-names></name>
<name><surname>Guo</surname> <given-names>L.</given-names></name>
<name><surname>Dong</surname> <given-names>J.</given-names></name>
<etal/>
</person-group>. (<year>2025</year>). 
<article-title>Klebsiella pneumoniae induced ferroptosis by inhibition of the Nrf2/XCT/GPX4 pathway in bovine mastitis: <italic>in vivo</italic> and <italic>in vitro</italic></article-title>. <source>Virulence</source> <volume>16</volume>, <elocation-id>2600142</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/21505594.2025.2600142</pub-id>, PMID: <pub-id pub-id-type="pmid">41343264</pub-id>
</mixed-citation>
</ref>
<ref id="B125">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>March</surname> <given-names>C.</given-names></name>
<name><surname>Moranta</surname> <given-names>D.</given-names></name>
<name><surname>Regueiro</surname> <given-names>V.</given-names></name>
<name><surname>Llobet</surname> <given-names>E.</given-names></name>
<name><surname>Tom&#xe1;s</surname> <given-names>A.</given-names></name>
<name><surname>Garmendia</surname> <given-names>J.</given-names></name>
<etal/>
</person-group>. (<year>2011</year>). 
<article-title>Klebsiella pneumoniae outer membrane protein A is required to prevent the activation of airway epithelial cells</article-title>. <source>J. Biol. Chem.</source> <volume>286</volume>, <fpage>9956</fpage>&#x2013;<lpage>9675</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M110.181008</pub-id>, PMID: <pub-id pub-id-type="pmid">21278256</pub-id>
</mixed-citation>
</ref>
<ref id="B126">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Martin</surname> <given-names>R. M.</given-names></name>
<name><surname>Bachman</surname> <given-names>M. A.</given-names></name>
</person-group> (<year>2018</year>). 
<article-title>Colonization, infection, and the accessory genome of Klebsiella pneumoniae</article-title>. <source>Front. Cell. Infection Microbiol.</source> <volume>8</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2018.00004</pub-id>, PMID: <pub-id pub-id-type="pmid">29404282</pub-id>
</mixed-citation>
</ref>
<ref id="B127">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Mathavarajah</surname> <given-names>S.</given-names></name>
<name><surname>Salsman</surname> <given-names>J.</given-names></name>
<name><surname>Dellaire</surname> <given-names>G.</given-names></name>
</person-group> (<year>2019</year>). 
<article-title>An emerging role for calcium signalling in innate and autoimmunity via the CGAS-STING axis</article-title>. <source>Cytokine Growth Factor Rev.</source> <volume>50</volume>, <fpage>43</fpage>&#x2013;<lpage>51</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cytogfr.2019.04.003</pub-id>, PMID: <pub-id pub-id-type="pmid">30955997</pub-id>
</mixed-citation>
</ref>
<ref id="B128">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Mechnikov</surname> <given-names>I. I.</given-names></name>
</person-group> (<year>1988</year>). 
<article-title>Immunity in infective diseases. By Il&#x2019;ia Il&#x2019;ich Mechniko</article-title>. <source>Rev. Infect. Dis.</source> <volume>10</volume>, <fpage>223</fpage>&#x2013;<lpage>227</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/clinids/10.1.223</pub-id>, PMID: <pub-id pub-id-type="pmid">3281221</pub-id>
</mixed-citation>
</ref>
<ref id="B129">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Merciecca</surname> <given-names>T.</given-names></name>
<name><surname>Bornes</surname> <given-names>S.</given-names></name>
<name><surname>Nakusi</surname> <given-names>L.</given-names></name>
<name><surname>Theil</surname> <given-names>S.</given-names></name>
<name><surname>Rendueles</surname> <given-names>O.</given-names></name>
<name><surname>Forestier</surname> <given-names>C.</given-names></name>
<etal/>
</person-group>. (<year>2022</year>). 
<article-title>Role of Klebsiella pneumoniae type VI secretion system (T6SS) in long-term gastrointestinal colonization</article-title>. <source>Sci. Rep.</source> <volume>12</volume>, <fpage>1</fpage>&#x2013;<lpage>145</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-022-21396-w</pub-id>, PMID: <pub-id pub-id-type="pmid">36216848</pub-id>
</mixed-citation>
</ref>
<ref id="B130">
<mixed-citation publication-type="book">
<person-group person-group-type="author">
<name><surname>Metchnikoff</surname> <given-names>E.</given-names></name>
</person-group> (<year>1893</year>). &#x201c;
<article-title>Lectures on the Comparative Pathology of Inflammation: Delivered at the Pasteur Institute in 1891</article-title>,&#x201d; in <source>Le&#xe7;ons Sur La Pathologie Compar&#xe9;e de l&#x2019;inflammation.English</source> (
<publisher-name>Kegan Paul, Trench, Tr&#xfc;bner</publisher-name>, <publisher-loc>London</publisher-loc>). Available online at: <uri xlink:href="https://catalog.hathitrust.org/Record/011596557">https://catalog.hathitrust.org/Record/011596557</uri>. (Accessed <date-in-citation content-type="access-date">June 2025</date-in-citation>).
</mixed-citation>
</ref>
<ref id="B131">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Mogensen</surname> <given-names>T. H.</given-names></name>
</person-group> (<year>2009</year>). 
<article-title>Pathogen recognition and inflammatory signaling in innate immune defenses</article-title>. <source>Clin. Microbiol. Rev.</source> <volume>22</volume>, <fpage>240</fpage>&#x2013;<lpage>273</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/CMR.00046-08</pub-id>, PMID: <pub-id pub-id-type="pmid">19366914</pub-id>
</mixed-citation>
</ref>
<ref id="B132">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Mohd Asri</surname> <given-names>N. A.</given-names></name>
<name><surname>Ahmad</surname> <given-names>S.</given-names></name>
<name><surname>Mohamud</surname> <given-names>R.</given-names></name>
<name><surname>Hanafi</surname> <given-names>N. M.</given-names></name>
<name><surname>Zaidi</surname> <given-names>N. F. M.</given-names></name>
<name><surname>Irekeola</surname> <given-names>A. A.</given-names></name>
<etal/>
</person-group>. (<year>2021</year>). 
<article-title>Global prevalence of nosocomial multidrug-resistant Klebsiella pneumoniae: A systematic review and meta-analysis</article-title>. <source>Antibiotics</source> <volume>10</volume>, <fpage>1508</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/antibiotics10121508</pub-id>, PMID: <pub-id pub-id-type="pmid">34943720</pub-id>
</mixed-citation>
</ref>
<ref id="B133">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Moloudizargari</surname> <given-names>M.</given-names></name>
<name><surname>Moradkhani</surname> <given-names>F.</given-names></name>
<name><surname>Asghari</surname> <given-names>N.</given-names></name>
<name><surname>Fallah</surname> <given-names>M.</given-names></name>
<name><surname>Asghari</surname> <given-names>M. H.</given-names></name>
<name><surname>Moghadamnia</surname> <given-names>A. A.</given-names></name>
<etal/>
</person-group>. (<year>2019</year>). 
<article-title>NLRP inflammasome as a key role player in the pathogenesis of environmental toxicants</article-title>. <source>Life Sci.</source> <volume>231</volume>, <elocation-id>116585</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.lfs.2019.116585</pub-id>, PMID: <pub-id pub-id-type="pmid">31226415</pub-id>
</mixed-citation>
</ref>
<ref id="B134">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Mosser</surname> <given-names>D. M.</given-names></name>
<name><surname>Hamidzadeh</surname> <given-names>K.</given-names></name>
<name><surname>Goncalves</surname> <given-names>R.</given-names></name>
</person-group> (<year>2021</year>). 
<article-title>Macrophages and the maintenance of homeostasis</article-title>. <source>Cell. Mol. Immunol.</source> <volume>18</volume>, <fpage>579</fpage>&#x2013;<lpage>875</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41423-020-00541-3</pub-id>, PMID: <pub-id pub-id-type="pmid">32934339</pub-id>
</mixed-citation>
</ref>
<ref id="B135">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Murray</surname> <given-names>P. J.</given-names></name>
<name><surname>Wynn</surname> <given-names>T. A.</given-names></name>
</person-group> (<year>2011</year>). 
<article-title>Protective and pathogenic functions of macrophage subsets</article-title>. <source>Nat. Rev. Immunol.</source> <volume>11</volume>, <fpage>723</fpage>&#x2013;<lpage>375</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nri3073</pub-id>, PMID: <pub-id pub-id-type="pmid">21997792</pub-id>
</mixed-citation>
</ref>
<ref id="B136">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Mussbacher</surname> <given-names>M.</given-names></name>
<name><surname>Derler</surname> <given-names>M.</given-names></name>
<name><surname>Bas&#xed;lio</surname> <given-names>J.</given-names></name>
<name><surname>Schmid</surname> <given-names>J. A.</given-names></name>
</person-group> (<year>2023</year>). 
<article-title>NF-KB in monocytes and macrophages &#x2013; an inflammatory master regulator in multitalented immune cells</article-title>. <source>Front. Immunol.</source> <volume>14</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2023.1134661</pub-id>, PMID: <pub-id pub-id-type="pmid">36911661</pub-id>
</mixed-citation>
</ref>
<ref id="B137">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Nunes</surname> <given-names>P.</given-names></name>
<name><surname>Demaurex</surname> <given-names>N.</given-names></name>
</person-group> (<year>2010</year>). 
<article-title>The role of calcium signaling in phagocytosis</article-title>. <source>J.&#xa0;Leukocyte Biol.</source> <volume>88</volume>, <fpage>57</fpage>&#x2013;<lpage>685</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1189/jlb.0110028</pub-id>, PMID: <pub-id pub-id-type="pmid">20400677</pub-id>
</mixed-citation>
</ref>
<ref id="B138">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Opoku-Temeng</surname> <given-names>C.</given-names></name>
<name><surname>Kobayashi</surname> <given-names>S. D.</given-names></name>
<name><surname>DeLeo</surname> <given-names>F. R.</given-names></name>
</person-group> (<year>2019</year>). 
<article-title>Klebsiella pneumoniae capsule polysaccharide as a target for therapeutics and vaccines</article-title>. <source>Comput. Struct. Biotechnol. J.</source> <volume>17</volume>, <fpage>1360</fpage>&#x2013;<lpage>1366</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.csbj.2019.09.011</pub-id>, PMID: <pub-id pub-id-type="pmid">31762959</pub-id>
</mixed-citation>
</ref>
<ref id="B139">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Pandey</surname> <given-names>S.</given-names></name>
<name><surname>Kant</surname> <given-names>S.</given-names></name>
<name><surname>Khawary</surname> <given-names>M.</given-names></name>
<name><surname>Tripathi</surname> <given-names>D.</given-names></name>
</person-group> (<year>2022</year>). 
<article-title>Macrophages in microbial pathogenesis: commonalities of defense evasion mechanisms</article-title>. <source>Infection Immun.</source> <volume>90</volume>, <fpage>e00291</fpage>&#x2013;<lpage>e00215</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/iai.00291-21</pub-id>, PMID: <pub-id pub-id-type="pmid">34780281</pub-id>
</mixed-citation>
</ref>
<ref id="B140">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Parzych</surname> <given-names>K. R.</given-names></name>
<name><surname>Klionsky</surname> <given-names>D. J.</given-names></name>
</person-group> (<year>2014</year>). 
<article-title>An overview of autophagy: morphology, mechanism, and regulation</article-title>. <source>Antioxidants Redox Signaling</source> <volume>20</volume>, <fpage>460</fpage>&#x2013;<lpage>735</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1089/ars.2013.5371</pub-id>, PMID: <pub-id pub-id-type="pmid">23725295</pub-id>
</mixed-citation>
</ref>
<ref id="B141">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Peng</surname> <given-names>X.</given-names></name>
<name><surname>Pu</surname> <given-names>F.</given-names></name>
<name><surname>Zhou</surname> <given-names>F.</given-names></name>
<name><surname>Dai</surname> <given-names>X.</given-names></name>
<name><surname>Xu</surname> <given-names>F.</given-names></name>
<name><surname>Wang</surname> <given-names>J.</given-names></name>
<etal/>
</person-group>. (<year>2025</year>). 
<article-title>Has-MiR-30c-1-3p inhibits macrophage autophagy and promotes mycobacterium tuberculosis survival by targeting ATG4B and ATG9B</article-title>. <source>Sci. Rep.</source> <volume>15</volume>, <fpage>102405</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-025-94452-w</pub-id>, PMID: <pub-id pub-id-type="pmid">40133377</pub-id>
</mixed-citation>
</ref>
<ref id="B142">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Pennini</surname> <given-names>M. E.</given-names></name>
<name><surname>Marco</surname> <given-names>A. D.</given-names></name>
<name><surname>Pelletier</surname> <given-names>M.</given-names></name>
<name><surname>Bonnell</surname> <given-names>J.</given-names></name>
<name><surname>Cvitkovic</surname> <given-names>R.</given-names></name>
<name><surname>Beltramello</surname> <given-names>M.</given-names></name>
<etal/>
</person-group>. (<year>2017</year>). 
<article-title>Immune stealth-driven O2 serotype prevalence and potential for therapeutic antibodies against multidrug resistant Klebsiella pneumoniae</article-title>. <source>Nat. Commun.</source> <volume>8</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41467-017-02223-7</pub-id>, PMID: <pub-id pub-id-type="pmid">29222409</pub-id>
</mixed-citation>
</ref>
<ref id="B143">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Pereira</surname> <given-names>M.</given-names></name>
<name><surname>Durso</surname> <given-names>D. F.</given-names></name>
<name><surname>Bryant</surname> <given-names>C. E.</given-names></name>
<name><surname>Kurt-Jones</surname> <given-names>E. A.</given-names></name>
<name><surname>Silverman</surname> <given-names>N.</given-names></name>
<name><surname>Golenbock</surname> <given-names>D. T.</given-names></name>
<etal/>
</person-group>. (<year>2022</year>). 
<article-title>The IRAK4 scaffold integrates TLR4-driven TRIF and MYD88 signaling pathways</article-title>. <source>Cell Rep.</source> <volume>40</volume>, <fpage>111225</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.celrep.2022.111225</pub-id>, PMID: <pub-id pub-id-type="pmid">35977521</pub-id>
</mixed-citation>
</ref>
<ref id="B144">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Pu</surname> <given-names>Q.</given-names></name>
<name><surname>Gan</surname> <given-names>C.</given-names></name>
<name><surname>Li</surname> <given-names>R.</given-names></name>
<name><surname>Li</surname> <given-names>Y.</given-names></name>
<name><surname>Tan</surname> <given-names>S.</given-names></name>
<name><surname>Li</surname> <given-names>X.</given-names></name>
<etal/>
</person-group>. (<year>2017</year>). 
<article-title>Atg7 deficiency intensifies inflammasome activation and pyroptosis in Pseudomonas sepsis</article-title>. <source>J. Immunol.</source> <volume>198</volume>, <fpage>3205</fpage>&#x2013;<lpage>3213</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.1601196</pub-id>, PMID: <pub-id pub-id-type="pmid">28258192</pub-id>
</mixed-citation>
</ref>
<ref id="B145">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Qin</surname> <given-names>Y.</given-names></name>
<name><surname>Zhou</surname> <given-names>G.</given-names></name>
<name><surname>Jiao</surname> <given-names>F.</given-names></name>
<name><surname>Cheng</surname> <given-names>C.</given-names></name>
<name><surname>Meng</surname> <given-names>C.</given-names></name>
<name><surname>Wang</surname> <given-names>L.</given-names></name>
<etal/>
</person-group>. (<year>2024</year>). 
<article-title>Brucella mediates autophagy, inflammation, and apoptosis to escape host killing</article-title>. <source>Front. Cell. Infection Microbiol.</source> <volume>14</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2024.1408407</pub-id>, PMID: <pub-id pub-id-type="pmid">39507949</pub-id>
</mixed-citation>
</ref>
<ref id="B146">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Qiu</surname> <given-names>H.</given-names></name>
<name><surname>KuoLee</surname> <given-names>R.</given-names></name>
<name><surname>Harris</surname> <given-names>G.</given-names></name>
<name><surname>Van Rooijen</surname> <given-names>N.</given-names></name>
<name><surname>Patel</surname> <given-names>G. B.</given-names></name>
<name><surname>Chen</surname> <given-names>W.</given-names></name>
</person-group> (<year>2012</year>). 
<article-title>Role of macrophages in early host resistance to respiratory acinetobacter baumannii infection</article-title>. <source>PloS One</source> <volume>7</volume>, <elocation-id>e400195</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/JOURNAL.PONE.0040019</pub-id>, PMID: <pub-id pub-id-type="pmid">22768201</pub-id>
</mixed-citation>
</ref>
<ref id="B147">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Rasmussen</surname> <given-names>H.</given-names></name>
<name><surname>Barrett</surname> <given-names>P.</given-names></name>
<name><surname>Smallwood</surname> <given-names>J.</given-names></name>
<name><surname>Bollag</surname> <given-names>W.</given-names></name>
<name><surname>Isales</surname> <given-names>C.</given-names></name>
</person-group> (<year>1990</year>). 
<article-title>Calcium ion as intracellular messenger and cellular toxin</article-title>. <source>Environ. Health Perspect.</source> <volume>84</volume>, <fpage>17</fpage>&#x2013;<lpage>25</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1289/ehp.908417</pub-id>, PMID: <pub-id pub-id-type="pmid">2190811</pub-id>
</mixed-citation>
</ref>
<ref id="B148">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Regueiro</surname> <given-names>V.</given-names></name>
<name><surname>Moranta</surname> <given-names>D.</given-names></name>
<name><surname>Campos</surname> <given-names>M. A.</given-names></name>
<name><surname>Margareto</surname> <given-names>J.</given-names></name>
<name><surname>Garmendia</surname> <given-names>J.</given-names></name>
<name><surname>Bengoechea</surname> <given-names>J. A.</given-names></name>
</person-group> (<year>2009</year>). 
<article-title>Klebsiella pneumoniae increases the levels of toll-like receptors 2 and 4 in human airway epithelial cells</article-title>. <source>Infection Immun.</source> <volume>77</volume>, <fpage>714</fpage>&#x2013;<lpage>245</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.00852-08</pub-id>, PMID: <pub-id pub-id-type="pmid">19015258</pub-id>
</mixed-citation>
</ref>
<ref id="B149">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Rendueles</surname> <given-names>O.</given-names></name>
<name><surname>Garcia-Garcer&#xe0;</surname> <given-names>M.</given-names></name>
<name><surname>N&#xe9;ron</surname> <given-names>B.</given-names></name>
<name><surname>Touchon</surname> <given-names>M.</given-names></name>
<name><surname>Rocha</surname> <given-names>E. P.C.</given-names></name>
</person-group> (<year>2017</year>). 
<article-title>Abundance and co-occurrence of extracellular capsules increase environmental breadth: implications for the emergence of pathogens</article-title>. <source>PLoS Pathog.</source> <volume>13</volume>, <elocation-id>e10065255</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.ppat.1006525</pub-id>, PMID: <pub-id pub-id-type="pmid">28742161</pub-id>
</mixed-citation>
</ref>
<ref id="B150">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Riwu</surname> <given-names>K. H. P.</given-names></name>
<name><surname>Effendi</surname> <given-names>M. H.</given-names></name>
<name><surname>Rantam</surname> <given-names>F. A.</given-names></name>
<name><surname>Khairullah</surname> <given-names>A. R.</given-names></name>
<name><surname>Widodo</surname> <given-names>A.</given-names></name>
</person-group> (<year>2022</year>). 
<article-title>A review: virulence factors of Klebsiella pneumonia as emerging infection on the food chain</article-title>. <source>Veterinary World</source> <volume>15</volume>, <fpage>2172</fpage>&#x2013;<lpage>2795</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.14202/vetworld.2022.2172-2179</pub-id>, PMID: <pub-id pub-id-type="pmid">36341059</pub-id>
</mixed-citation>
</ref>
<ref id="B151">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Roodman</surname> <given-names>G. D.</given-names></name>
</person-group> (<year>1999</year>). 
<article-title>Cell biology of the osteoclast</article-title>. <source>Exp. Hematol.</source> <volume>27</volume>, <fpage>1229</fpage>&#x2013;<lpage>1241</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s0301-472x(99)00061-2</pub-id>, PMID: <pub-id pub-id-type="pmid">10428500</pub-id>
</mixed-citation>
</ref>
<ref id="B152">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>R&#xf6;szer</surname> <given-names>Tam&#xe1;s.</given-names></name>
</person-group> (<year>2018</year>). 
<article-title>Understanding the biology of self-renewing macrophages</article-title>. <source>Cells</source> <volume>7</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/cells7080103</pub-id>, PMID: <pub-id pub-id-type="pmid">30096862</pub-id>
</mixed-citation>
</ref>
<ref id="B153">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Sadikot</surname> <given-names>R. T.</given-names></name>
<name><surname>Blackwell</surname> <given-names>T. S.</given-names></name>
<name><surname>Christman</surname> <given-names>J. W.</given-names></name>
<name><surname>Prince</surname> <given-names>A. S.</given-names></name>
</person-group> (<year>2005</year>). 
<article-title>Pathogen-host interactions in Pseudomonas aeruginosa pneumonia</article-title>. <source>Am. J. Respir. Crit. Care Med.</source> <volume>171</volume>, <fpage>1209</fpage>&#x2013;<lpage>1235</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1164/rccm.200408-1044SO</pub-id>, PMID: <pub-id pub-id-type="pmid">15695491</pub-id>
</mixed-citation>
</ref>
<ref id="B154">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Schwaller</surname> <given-names>B.</given-names></name>
</person-group> (<year>2010</year>). 
<article-title>Cytosolic Ca2+ Buffers</article-title>. <source>Cold Spring Harbor Perspect. Biol.</source> <volume>2</volume>, <elocation-id>a004051</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1101/cshperspect.a004051</pub-id>, PMID: <pub-id pub-id-type="pmid">20943758</pub-id>
</mixed-citation>
</ref>
<ref id="B155">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Shah</surname> <given-names>R. K.</given-names></name>
<name><surname>Ni</surname> <given-names>Z. H.</given-names></name>
<name><surname>Sun</surname> <given-names>X. Y.</given-names></name>
<name><surname>Wang</surname> <given-names>G. Q.</given-names></name>
<name><surname>Li</surname> <given-names>F.</given-names></name>
</person-group> (<year>2017</year>). 
<article-title>The determination and correlation of various virulence genes, ESBL, serum bactericidal effect and biofilm formation of clinical isolated classical Klebsiella pneumoniae and hypervirulent Klebsiella pneumoniae from respiratory tract infected patients</article-title>. <source>Polish J. Microbiol.</source> <volume>66</volume>, <fpage>501</fpage>&#x2013;<lpage>585</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.5604/01.3001.0010.7042</pub-id>, PMID: <pub-id pub-id-type="pmid">29319515</pub-id>
</mixed-citation>
</ref>
<ref id="B156">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Shankar</surname> <given-names>C.</given-names></name>
<name><surname>Nabarro</surname> <given-names>L. E.B.</given-names></name>
<name><surname>Anandan</surname> <given-names>S.</given-names></name>
<name><surname>Ravi</surname> <given-names>R.</given-names></name>
<name><surname>Babu</surname> <given-names>P.</given-names></name>
<name><surname>Munusamy</surname> <given-names>E.</given-names></name>
<etal/>
</person-group>. (<year>2018</year>). 
<article-title>Extremely high mortality rates in patients with carbapenem-resistant, hypermucoviscous Klebsiella pneumoniae blood stream infections</article-title>. <source>J. Assoc. Physicians India</source> <volume>66</volume>, <fpage>13</fpage>&#x2013;<lpage>16</lpage>. Available online at: <uri xlink:href="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85057608815&amp;partnerID=40&amp;md5=7b07b37e4dbc940e36804f408beb3d53">https://www.scopus.com/inward/record.uri?eid=2-s2.0-85057608815&amp;partnerID=40&amp;md5=7b07b37e4dbc940e36804f408beb3d53</uri>. (Accessed <date-in-citation content-type="access-date">October 2025</date-in-citation>), PMID: <pub-id pub-id-type="pmid">31313543</pub-id>
</mixed-citation>
</ref>
<ref id="B157">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Shao</surname> <given-names>B. Z.</given-names></name>
<name><surname>Xu</surname> <given-names>Z. Q.</given-names></name>
<name><surname>Han</surname> <given-names>B. Z.</given-names></name>
<name><surname>Su</surname> <given-names>D. F.</given-names></name>
<name><surname>Liu</surname> <given-names>C.</given-names></name>
</person-group> (<year>2015</year>). 
<article-title>NLRP3 inflammasome and its inhibitors: A review</article-title>. <source>Front. Pharmacol.</source> <volume>6</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fphar.2015.00262</pub-id>, PMID: <pub-id pub-id-type="pmid">26594174</pub-id>
</mixed-citation>
</ref>
<ref id="B158">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Shon</surname> <given-names>A. S.</given-names></name>
<name><surname>Bajwa</surname> <given-names>R. P. S.</given-names></name>
<name><surname>Russo</surname> <given-names>T. A.</given-names></name>
</person-group> (<year>2013</year>). 
<article-title>Hypervirulent (Hypermucoviscous) Klebsiella pneumoniae: A new and dangerous breed</article-title>. <source>Virulence</source> <volume>4</volume>, <fpage>1075</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4161/VIRU.22718</pub-id>, PMID: <pub-id pub-id-type="pmid">23302790</pub-id>
</mixed-citation>
</ref>
<ref id="B159">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Silwal</surname> <given-names>P.</given-names></name>
<name><surname>Kim</surname> <given-names>J. K.</given-names></name>
<name><surname>Kim</surname> <given-names>Y. J.</given-names></name>
<name><surname>Jo</surname> <given-names>E. K.</given-names></name>
</person-group> (<year>2020</year>). 
<article-title>Mitochondrial reactive oxygen species: double-edged weapon in host defense and pathological inflammation during infection</article-title>. <source>Front. Immunol.</source> <volume>11</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2020.01649</pub-id>, PMID: <pub-id pub-id-type="pmid">32922385</pub-id>
</mixed-citation>
</ref>
<ref id="B160">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Singh</surname> <given-names>R. P.</given-names></name>
<name><surname>Kapoor</surname> <given-names>A.</given-names></name>
<name><surname>Sinha</surname> <given-names>A.</given-names></name>
<name><surname>Ma</surname> <given-names>Y.</given-names></name>
<name><surname>Shankar</surname> <given-names>M.</given-names></name>
</person-group> (<year>2025</year>). 
<article-title>Virulence factors of Klebsiella pneumoniae: insights into canonical and emerging mechanisms driving pathogenicity and drug resistance</article-title>. <source>Microbe</source> <volume>7</volume>, <elocation-id>100289</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.microb.2025.100289</pub-id>
</mixed-citation>
</ref>
<ref id="B161">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Song</surname> <given-names>S.</given-names></name>
<name><surname>Yang</surname> <given-names>S.</given-names></name>
<name><surname>Zheng</surname> <given-names>R.</given-names></name>
<name><surname>Yin</surname> <given-names>D.</given-names></name>
<name><surname>Cao</surname> <given-names>Y.</given-names></name>
<name><surname>Wang</surname> <given-names>Y.</given-names></name>
<etal/>
</person-group>. (<year>2024</year>). 
<article-title>Adaptive evolution of carbapenem-resistant hypervirulent <italic>Klebsiella pneumoniae</italic> in the urinary tract of a single patient</article-title>. <source>Proc. Natl. Acad. Sci.</source> <volume>121</volume>, <elocation-id>e2400446121</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.2400446121</pub-id>, PMID: <pub-id pub-id-type="pmid">39150777</pub-id>
</mixed-citation>
</ref>
<ref id="B162">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Struve</surname> <given-names>C.</given-names></name>
<name><surname>Krogfelt</surname> <given-names>K. A.</given-names></name>
</person-group> (<year>2003</year>). 
<article-title>Role of capsule in Klebsiella pneumoniae virulence: lack of correlation between <italic>in vitro</italic> and <italic>in vivo</italic> studies</article-title>. <source>FEMS Microbiol. Lett.</source> <volume>218</volume>, <fpage>149</fpage>&#x2013;<lpage>545</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0378-1097(02)01117-5</pub-id>, PMID: <pub-id pub-id-type="pmid">12583911</pub-id>
</mixed-citation>
</ref>
<ref id="B163">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Suda</surname> <given-names>T.</given-names></name>
<name><surname>Takahashi</surname> <given-names>N.</given-names></name>
<name><surname>Martin</surname> <given-names>T. J.</given-names></name>
</person-group> (<year>1992</year>). 
<article-title>Modulation of osteoclast differentiation</article-title>. <source>Endocrine Rev.</source> <volume>13</volume>, <fpage>66</fpage>&#x2013;<lpage>80</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/edrv-13-1-66</pub-id>, PMID: <pub-id pub-id-type="pmid">1555533</pub-id>
</mixed-citation>
</ref>
<ref id="B164">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Tabibzadeh</surname> <given-names>S.</given-names></name>
</person-group> (<year>2023</year>). 
<article-title>Role of autophagy in aging: the good, the bad, and the ugly</article-title>. <source>Aging Cell</source> <volume>22</volume>, <elocation-id>e13753</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/acel.13753</pub-id>, PMID: <pub-id pub-id-type="pmid">36539927</pub-id>
</mixed-citation>
</ref>
<ref id="B165">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Tano</surname> <given-names>J.-Y.</given-names></name>
<name><surname>Vazquez</surname> <given-names>G.</given-names></name>
</person-group> (<year>2011</year>). 
<article-title>Requirement for non-regulated, constitutive calcium influx in macrophage survival signaling</article-title>. <source>Biochem. Biophys. Res. Commun.</source> <volume>407</volume>, <fpage>432</fpage>&#x2013;<lpage>375</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bbrc.2011.03.048</pub-id>, PMID: <pub-id pub-id-type="pmid">21414290</pub-id>
</mixed-citation>
</ref>
<ref id="B166">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Tedesco</surname> <given-names>S.</given-names></name>
<name><surname>Scattolini</surname> <given-names>V.</given-names></name>
<name><surname>Albiero</surname> <given-names>M.</given-names></name>
<name><surname>Bortolozzi</surname> <given-names>M.</given-names></name>
<name><surname>Avogaro</surname> <given-names>A.</given-names></name>
<name><surname>Cignarella</surname> <given-names>A.</given-names></name>
<etal/>
</person-group>. (<year>2019</year>). 
<article-title>Mitochondrial calcium uptake is instrumental to alternative macrophage polarization and phagocytic activity</article-title>. <source>Int. J. Mol. Sci.</source> <volume>20</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms20194966</pub-id>, PMID: <pub-id pub-id-type="pmid">31597355</pub-id>
</mixed-citation>
</ref>
<ref id="B167">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Tiwari</surname> <given-names>V.</given-names></name>
<name><surname>Sharma</surname> <given-names>A.</given-names></name>
<name><surname>Braga</surname> <given-names>R.</given-names></name>
<name><surname>Garcia</surname> <given-names>E.</given-names></name>
<name><surname>Appiah</surname> <given-names>R.</given-names></name>
<name><surname>Fleeman</surname> <given-names>R.</given-names></name>
<etal/>
</person-group>. (<year>2024</year>). 
<article-title>Klebsiella pneumoniae dedA family proteins have redundant roles in divalent cation homeostasis and resistance to phagocytosis</article-title>. <source>Microbiol. Spectr.</source> <volume>12</volume>, <fpage>1</fpage>&#x2013;<lpage>205</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/spectrum.03807-23</pub-id>, PMID: <pub-id pub-id-type="pmid">38214522</pub-id>
</mixed-citation>
</ref>
<ref id="B168">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Tonnus</surname> <given-names>W.</given-names></name>
<name><surname>Meyer</surname> <given-names>C.</given-names></name>
<name><surname>Paliege</surname> <given-names>A.</given-names></name>
<name><surname>Belavgeni</surname> <given-names>A.</given-names></name>
<name><surname>von M&#xe4;ssenhausen</surname> <given-names>A.</given-names></name>
<name><surname>Bornstein</surname> <given-names>S. R.</given-names></name>
<etal/>
</person-group>. (<year>2019</year>). 
<article-title>The pathological features of regulated necrosis</article-title>. <source>J. Pathol.</source> <volume>247</volume>, <fpage>697</fpage>&#x2013;<lpage>7075</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/path.5248</pub-id>, PMID: <pub-id pub-id-type="pmid">30714148</pub-id>
</mixed-citation>
</ref>
<ref id="B169">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Tran</surname> <given-names>N.</given-names></name>
<name><surname>Mills</surname> <given-names>E. L.</given-names></name>
</person-group> (<year>2024</year>). 
<article-title>Redox regulation of macrophages</article-title>. <source>Redox Biol.</source> <volume>72</volume>, <elocation-id>103123</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.redox.2024.103123</pub-id>, PMID: <pub-id pub-id-type="pmid">38615489</pub-id>
</mixed-citation>
</ref>
<ref id="B170">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Traver</surname> <given-names>M. K.</given-names></name>
<name><surname>Henry</surname> <given-names>S. C.</given-names></name>
<name><surname>Cantillana</surname> <given-names>V.</given-names></name>
<name><surname>Oliver</surname> <given-names>T.</given-names></name>
<name><surname>Hunn</surname> <given-names>J. P.</given-names></name>
<name><surname>Howard</surname> <given-names>J. C.</given-names></name>
<etal/>
</person-group>. (<year>2011</year>). 
<article-title>Immunity-related GTPase M (IRGM) proteins influence the localization of guanylate-binding protein 2 (GBP2) by modulating macroautophagy</article-title>. <source>J. Biol. Chem.</source> <volume>286</volume>, <fpage>30471</fpage>&#x2013;<lpage>30805</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M111.251967</pub-id>, PMID: <pub-id pub-id-type="pmid">21757726</pub-id>
</mixed-citation>
</ref>
<ref id="B171">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Trevejo-Nu&#xf1;ez</surname> <given-names>G.</given-names></name>
<name><surname>Lin</surname> <given-names>B.</given-names></name>
<name><surname>Fan</surname> <given-names>L.</given-names></name>
<name><surname>Aggor</surname> <given-names>F. E.Y.</given-names></name>
<name><surname>Biswas</surname> <given-names>P. S.</given-names></name>
<name><surname>Chen</surname> <given-names>K.</given-names></name>
<etal/>
</person-group>. (<year>2021</year>). 
<article-title>Regnase-1 deficiency restrains klebsiella pneumoniae infection by regulation of a type I interferon response</article-title>. <source>MBio</source> <volume>13</volume>, <elocation-id>e03792215</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/mbio.03792-21</pub-id>, PMID: <pub-id pub-id-type="pmid">35100872</pub-id>
</mixed-citation>
</ref>
<ref id="B172">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Uematsu</surname> <given-names>S.</given-names></name>
<name><surname>Akira</surname> <given-names>S.</given-names></name>
</person-group> (<year>2007</year>). 
<article-title>Toll-like receptors and type I interferons</article-title>. <source>J. Biol. Chem.</source> <volume>282</volume>, <fpage>15319</fpage>&#x2013;<lpage>15245</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.R700009200</pub-id>, PMID: <pub-id pub-id-type="pmid">17395581</pub-id>
</mixed-citation>
</ref>
<ref id="B173">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Underhill</surname> <given-names>D. M.</given-names></name>
<name><surname>Ozinsky</surname> <given-names>A.</given-names></name>
<name><surname>Smith</surname> <given-names>K. D.</given-names></name>
<name><surname>Aderem</surname> <given-names>A.</given-names></name>
</person-group> (<year>1999</year>). 
<article-title>Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A</source> <volume>96</volume>, <fpage>14459</fpage>&#x2013;<lpage>14463</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.96.25.14459</pub-id>, PMID: <pub-id pub-id-type="pmid">10588727</pub-id>
</mixed-citation>
</ref>
<ref id="B174">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Uthaisangsook</surname> <given-names>S.</given-names></name>
<name><surname>Day</surname> <given-names>N. K.</given-names></name>
<name><surname>Bahna</surname> <given-names>S. L.</given-names></name>
<name><surname>Good</surname> <given-names>R. A.</given-names></name>
<name><surname>Haraguchi</surname> <given-names>S.</given-names></name>
</person-group> (<year>2002</year>). 
<article-title>Innate immunity and its role against infections</article-title>. <source>Ann. Allergy Asthma Immunol.</source> <volume>88</volume>, <fpage>253</fpage>&#x2013;<lpage>265</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s1081-1206(10)62005-4</pub-id>, PMID: <pub-id pub-id-type="pmid">11926618</pub-id>
</mixed-citation>
</ref>
<ref id="B175">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Verma</surname> <given-names>C.</given-names></name>
<name><surname>Rana</surname> <given-names>A. K.</given-names></name>
<name><surname>Anang</surname> <given-names>V.</given-names></name>
<name><surname>Tiwari</surname> <given-names>B. K.</given-names></name>
<name><surname>Singh</surname> <given-names>A.</given-names></name>
<name><surname>Saraswati</surname> <given-names>S. S. K.</given-names></name>
<etal/>
</person-group>. (<year>2020</year>). 
<article-title>Calcium dynamics regulate protective responses and growth of Staphylococcus aureus in macrophages</article-title>. <source>Biomolecular Concepts</source> <volume>11</volume>, <fpage>230</fpage>&#x2013;<lpage>395</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1515/bmc-2020-0021</pub-id>, PMID: <pub-id pub-id-type="pmid">33726488</pub-id>
</mixed-citation>
</ref>
<ref id="B176">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Vig</surname> <given-names>M.</given-names></name>
<name><surname>Kinet</surname> <given-names>J.-P.</given-names></name>
</person-group> (<year>2009</year>). 
<article-title>Calcium signaling in immune cells</article-title>. <source>Nat. Immunol.</source> <volume>10</volume>, <fpage>21</fpage>&#x2013;<lpage>275</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ni.f.220</pub-id>, PMID: <pub-id pub-id-type="pmid">19088738</pub-id>
</mixed-citation>
</ref>
<ref id="B177">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Viola</surname> <given-names>M. F.</given-names></name>
<name><surname>Boeckxstaens</surname> <given-names>G.</given-names></name>
</person-group> (<year>2021</year>). 
<article-title>Niche-specific functional heterogeneity of intestinal resident macrophages</article-title>. <source>Gut</source> <volume>70</volume>, <fpage>1383</fpage>&#x2013;<lpage>1955</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/gutjnl-2020-323121</pub-id>, PMID: <pub-id pub-id-type="pmid">33384336</pub-id>
</mixed-citation>
</ref>
<ref id="B178">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wanford</surname> <given-names>J. J.</given-names></name>
<name><surname>Hachani</surname> <given-names>A.</given-names></name>
<name><surname>Odendall</surname> <given-names>C.</given-names></name>
</person-group> (<year>2022</year>). 
<article-title>Reprogramming of cell death pathways by bacterial effectors as a widespread virulence strategy</article-title>. <source>Infection Immun.</source> <volume>90</volume>, <fpage>e00614</fpage>&#x2013;<lpage>e00215</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/iai.00614-21</pub-id>, PMID: <pub-id pub-id-type="pmid">35467397</pub-id>
</mixed-citation>
</ref>
<ref id="B179">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wanford</surname> <given-names>J. J.</given-names></name>
<name><surname>Hames</surname> <given-names>R. G.</given-names></name>
<name><surname>Carreno</surname> <given-names>D.</given-names></name>
<name><surname>Jasiunaite</surname> <given-names>Z.</given-names></name>
<name><surname>Chung</surname> <given-names>W. Y.</given-names></name>
<name><surname>Arena</surname> <given-names>F.</given-names></name>
<etal/>
</person-group>. (<year>2021</year>). 
<article-title>Interaction of Klebsiella pneumoniae with tissue macrophages in a mouse infection model and <italic>ex-vivo</italic> pig organ perfusions: an exploratory investigation</article-title>. <source>Lancet. Microbe</source> <volume>2</volume>, <fpage>e695</fpage>&#x2013;<lpage>e703</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S2666-5247(21)00195-6</pub-id>, PMID: <pub-id pub-id-type="pmid">34901898</pub-id>
</mixed-citation>
</ref>
<ref id="B180">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname> <given-names>X.</given-names></name>
<name><surname>Bi</surname> <given-names>C.</given-names></name>
<name><surname>Xin</surname> <given-names>X.</given-names></name>
<name><surname>Zhang</surname> <given-names>M.</given-names></name>
<name><surname>Fu</surname> <given-names>H.</given-names></name>
<name><surname>Lan</surname> <given-names>L.</given-names></name>
<etal/>
</person-group>. (<year>2023</year>). 
<article-title>Pyroptosis, apoptosis, and autophagy are involved in infection induced by two clinical Klebsiella pneumoniae isolates with different virulence</article-title>. <source>Front. Cell. Infection Microbiol.</source> <volume>13</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2023.1165609</pub-id>, PMID: <pub-id pub-id-type="pmid">37223846</pub-id>
</mixed-citation>
</ref>
<ref id="B181">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname> <given-names>P.</given-names></name>
<name><surname>Geng</surname> <given-names>J.</given-names></name>
<name><surname>Gao</surname> <given-names>J.</given-names></name>
<name><surname>Zhao</surname> <given-names>H.</given-names></name>
<name><surname>Li</surname> <given-names>J.</given-names></name>
<name><surname>Shi</surname> <given-names>Y.</given-names></name>
<etal/>
</person-group>. (<year>2019</year>). 
<article-title>Macrophage Achieves Self-Protection against Oxidative Stress-Induced Ageing through the Mst-Nrf2 Axis</article-title>. <source>Nat. Commun.</source> <volume>10</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41467-019-08680-6</pub-id>, PMID: <pub-id pub-id-type="pmid">30765703</pub-id>
</mixed-citation>
</ref>
<ref id="B182">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname> <given-names>C. Y.</given-names></name>
<name><surname>Guttridge</surname> <given-names>D. C.</given-names></name>
<name><surname>Mayo</surname> <given-names>M. W.</given-names></name>
<name><surname>Baldwin</surname> <given-names>A. S.</given-names> <suffix>Jr</suffix></name>
</person-group> (<year>1999</year>). 
<article-title>NF-KappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis</article-title>. <source>Mol. Cell. Biol.</source> <volume>19</volume>, <fpage>5923</fpage>&#x2013;<lpage>5929</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/MCB.19.9.5923</pub-id>, PMID: <pub-id pub-id-type="pmid">10454539</pub-id>
</mixed-citation>
</ref>
<ref id="B183">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname> <given-names>Y.</given-names></name>
<name><surname>Huang</surname> <given-names>J.</given-names></name>
<name><surname>Sun</surname> <given-names>Y.</given-names></name>
<name><surname>Stubbs</surname> <given-names>D.</given-names></name>
<name><surname>He</surname> <given-names>J.</given-names></name>
<name><surname>Li</surname> <given-names>W.</given-names></name>
<etal/>
</person-group>. (<year>2021</year>). 
<article-title>SARS-CoV-2 suppresses MRNA expression of selenoproteins associated with ferroptosis, endoplasmic reticulum stress and DNA synthesis</article-title>. <source>Food Chem. Toxicol.</source> <volume>153</volume>, <elocation-id>112286</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.fct.2021.112286</pub-id>, PMID: <pub-id pub-id-type="pmid">34023458</pub-id>
</mixed-citation>
</ref>
<ref id="B184">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname> <given-names>S.</given-names></name>
<name><surname>Liu</surname> <given-names>G.</given-names></name>
<name><surname>Li</surname> <given-names>Y.</given-names></name>
<name><surname>Pan</surname> <given-names>Y.</given-names></name>
</person-group> (<year>2022</year>). 
<article-title>Metabolic reprogramming induces macrophage polarization in the tumor microenvironment</article-title>. <source>Front. Immunol.</source> <volume>13</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2022.840029</pub-id>, PMID: <pub-id pub-id-type="pmid">35874739</pub-id>
</mixed-citation>
</ref>
<ref id="B185">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname> <given-names>S.</given-names></name>
<name><surname>Long</surname> <given-names>H.</given-names></name>
<name><surname>Hou</surname> <given-names>L.</given-names></name>
<name><surname>Feng</surname> <given-names>B.</given-names></name>
<name><surname>Ma</surname> <given-names>Z.</given-names></name>
<name><surname>Wu</surname> <given-names>Y.</given-names></name>
<etal/>
</person-group>. (<year>2023</year>). 
<article-title>The mitophagy pathway and its implications in human diseases</article-title>. <source>Signal Transduction Targeted Ther.</source> <volume>8</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41392-023-01503-7</pub-id>, PMID: <pub-id pub-id-type="pmid">37582956</pub-id>
</mixed-citation>
</ref>
<ref id="B186">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname> <given-names>J.</given-names></name>
<name><surname>Zhang</surname> <given-names>L.</given-names></name>
<name><surname>Liu</surname> <given-names>Y.</given-names></name>
<name><surname>Liu</surname> <given-names>Y.</given-names></name>
<name><surname>Xiong</surname> <given-names>A.</given-names></name>
<name><surname>Ran</surname> <given-names>Q.</given-names></name>
<etal/>
</person-group>. (<year>2025</year>). 
<article-title>Epithelial Atg5 deficiency intensifies caspase-11 activation, fueling extracellular mtDNA release to activate CGAS-STING-NLRP3 axis in macrophages during Pseudomonas infection</article-title>. <source>MedComm</source> <volume>6</volume>, <elocation-id>e70239</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/mco2.70239</pub-id>, PMID: <pub-id pub-id-type="pmid">40529614</pub-id>
</mixed-citation>
</ref>
<ref id="B187">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Watson</surname> <given-names>R. O.</given-names></name>
<name><surname>Manzanillo</surname> <given-names>P. S.</given-names></name>
<name><surname>Cox</surname> <given-names>J. S.</given-names></name>
</person-group> (<year>2012</year>). 
<article-title>Extracellular M. Tuberculosis DNA targets bacteria for autophagy by activating the host DNA-sensing pathway</article-title>. <source>Cell</source> <volume>150</volume>, <fpage>803</fpage>&#x2013;<lpage>155</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cell.2012.06.040</pub-id>, PMID: <pub-id pub-id-type="pmid">22901810</pub-id>
</mixed-citation>
</ref>
<ref id="B188">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wei</surname> <given-names>S.</given-names></name>
<name><surname>Xu</surname> <given-names>T.</given-names></name>
<name><surname>Chen</surname> <given-names>Y.</given-names></name>
<name><surname>Zhou</surname> <given-names>K.</given-names></name>
</person-group> (<year>2023</year>). 
<article-title>Autophagy, cell death, and cytokines in K. Pneumoniae infection: therapeutic perspectives</article-title>. <source>Emerging Microbes Infections</source> <volume>12</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/22221751.2022.2140607</pub-id>, PMID: <pub-id pub-id-type="pmid">36287114</pub-id>
</mixed-citation>
</ref>
<ref id="B189">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Weiss</surname> <given-names>D. S.</given-names></name>
<name><surname>Raupach</surname> <given-names>B.</given-names></name>
<name><surname>Takeda</surname> <given-names>K.</given-names></name>
<name><surname>Akira</surname> <given-names>S.</given-names></name>
<name><surname>Zychlinsky</surname> <given-names>A.</given-names></name>
</person-group> (<year>2004</year>). 
<article-title>Toll-like receptors are temporally involved in host defense</article-title>. <source>J. Immunol.</source> <volume>172</volume>, <fpage>4463</fpage>&#x2013;<lpage>4695</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.172.7.4463</pub-id>, PMID: <pub-id pub-id-type="pmid">15034062</pub-id>
</mixed-citation>
</ref>
<ref id="B190">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wen</surname> <given-names>A. Y.</given-names></name>
<name><surname>Sakamoto</surname> <given-names>K. M.</given-names></name>
<name><surname>Miller</surname> <given-names>L. S.</given-names></name>
</person-group> (<year>2010</year>). 
<article-title>The role of the transcription factor CREB in immune function</article-title>. <source>J. Immunol. (Baltimore Md. : 1950)</source> <volume>185</volume>, <fpage>6413</fpage>&#x2013;<lpage>6195</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.1001829</pub-id>, PMID: <pub-id pub-id-type="pmid">21084670</pub-id>
</mixed-citation>
</ref>
<ref id="B191">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wessling-Resnick</surname> <given-names>M.</given-names></name>
</person-group> (<year>2015</year>). 
<article-title>Nramp1 and other transporters involved in metal withholding during infection</article-title>. <source>J. Biol. Chem.</source> <volume>290</volume>, <page-range>18984&#x2013;18990</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.R115.643973</pub-id>, PMID: <pub-id pub-id-type="pmid">26055722</pub-id>
</mixed-citation>
</ref>
<ref id="B192">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>West</surname> <given-names>A. E.</given-names></name>
<name><surname>Chen</surname> <given-names>W. G.</given-names></name>
<name><surname>Dalva</surname> <given-names>M. B.</given-names></name>
<name><surname>Dolmetsch</surname> <given-names>R. E.</given-names></name>
<name><surname>Kornhauser</surname> <given-names>J. M.</given-names></name>
<name><surname>Shaywitz</surname> <given-names>A. J.</given-names></name>
<etal/>
</person-group>. (<year>2001</year>). 
<article-title>Calcium regulation of neuronal gene expression</article-title>. <source>Proc. Natl. Acad. Sci.</source> <volume>98</volume>, <fpage>11024</fpage>&#x2013;<lpage>11315</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.191352298</pub-id>, PMID: <pub-id pub-id-type="pmid">11572963</pub-id>
</mixed-citation>
</ref>
<ref id="B193">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wu</surname> <given-names>J.</given-names></name>
<name><surname>Li</surname> <given-names>Z.</given-names></name>
<name><surname>Deng</surname> <given-names>Y.</given-names></name>
<name><surname>Lu</surname> <given-names>X.</given-names></name>
<name><surname>Luo</surname> <given-names>C.</given-names></name>
<name><surname>Mu</surname> <given-names>X.</given-names></name>
<etal/>
</person-group>. (<year>2023</year>). 
<article-title>Function of TRP channels in monocytes/macrophages</article-title>. <source>Front. Immunol.</source> <volume>14</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2023.1187890</pub-id>, PMID: <pub-id pub-id-type="pmid">37404813</pub-id>
</mixed-citation>
</ref>
<ref id="B194">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wu</surname> <given-names>M.-Y.</given-names></name>
<name><surname>Lu</surname> <given-names>J.-H.</given-names></name>
</person-group> (<year>2019</year>). 
<article-title>Autophagy and macrophage functions: inflammatory response and phagocytosis</article-title>. <source>Cells</source> <volume>9</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/cells9010070</pub-id>, PMID: <pub-id pub-id-type="pmid">31892110</pub-id>
</mixed-citation>
</ref>
<ref id="B195">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wurfel</surname> <given-names>M. M.</given-names></name>
<name><surname>Gordon</surname> <given-names>A. C.</given-names></name>
<name><surname>Holden</surname> <given-names>T. D.</given-names></name>
<name><surname>Radella</surname> <given-names>F.</given-names></name>
<name><surname>Strout</surname> <given-names>J.</given-names></name>
<name><surname>Kajikawa</surname> <given-names>O.</given-names></name>
<etal/>
</person-group>. (<year>2008</year>). 
<article-title>Toll-like receptor 1 polymorphisms affect innate immune responses and outcomes in sepsis</article-title>. <source>Am. J. Respir. Crit. Care Med.</source> <volume>178</volume>, <fpage>710</fpage>&#x2013;<lpage>720</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1164/rccm.200803-462OC</pub-id>, PMID: <pub-id pub-id-type="pmid">18635889</pub-id>
</mixed-citation>
</ref>
<ref id="B196">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wynn</surname> <given-names>T. A.</given-names></name>
<name><surname>Chawla</surname> <given-names>A.</given-names></name>
<name><surname>Pollard</surname> <given-names>J. W.</given-names></name>
</person-group> (<year>2013</year>). 
<article-title>Macrophage biology in development, homeostasis and disease</article-title>. <source>Nature</source> <volume>496</volume>, <fpage>445</fpage>&#x2013;<lpage>455</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nature12034</pub-id>, PMID: <pub-id pub-id-type="pmid">23619691</pub-id>
</mixed-citation>
</ref>
<ref id="B197">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Xaus</surname> <given-names>J.</given-names></name>
<name><surname>Comalada</surname> <given-names>M.</given-names></name>
<name><surname>Valledor</surname> <given-names>A. F.</given-names></name>
<name><surname>Card&#xf3;</surname> <given-names>M.</given-names></name>
<name><surname>Herrero</surname> <given-names>C.</given-names></name>
<name><surname>Soler</surname> <given-names>C.</given-names></name>
<etal/>
</person-group>. (<year>2001</year>). 
<article-title>Molecular mechanisms involved in macrophage survival, proliferation, activation or apoptosis</article-title>. <source>Immunobiology</source> <volume>204</volume>, <fpage>543</fpage>&#x2013;<lpage>505</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1078/0171-2985-00091</pub-id>, PMID: <pub-id pub-id-type="pmid">11846217</pub-id>
</mixed-citation>
</ref>
<ref id="B198">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Xia</surname> <given-names>H.</given-names></name>
<name><surname>Zhang</surname> <given-names>Z.</given-names></name>
<name><surname>You</surname> <given-names>F.</given-names></name>
</person-group> (<year>2021</year>). 
<article-title>Inhibiting Acsl1-related ferroptosis restrains murine coronavirus infection</article-title>. <source>Viruses</source> <volume>13</volume>, <fpage>1</fpage>&#x2013;<lpage>175</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/v13122383</pub-id>, PMID: <pub-id pub-id-type="pmid">34960652</pub-id>
</mixed-citation>
</ref>
<ref id="B199">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Xiang</surname> <given-names>C.</given-names></name>
<name><surname>Li</surname> <given-names>H.</given-names></name>
<name><surname>Tang</surname> <given-names>W.</given-names></name>
</person-group> (<year>2023</year>). 
<article-title>Targeting CSF-1R represents an effective strategy in modulating inflammatory diseases</article-title>. <source>Pharmacol. Res.</source> <volume>187</volume>, <elocation-id>106566</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.phrs.2022.106566</pub-id>, PMID: <pub-id pub-id-type="pmid">36423789</pub-id>
</mixed-citation>
</ref>
<ref id="B200">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Xie</surname> <given-names>Y.</given-names></name>
<name><surname>Hou</surname> <given-names>W.</given-names></name>
<name><surname>Song</surname> <given-names>X.</given-names></name>
<name><surname>Yu</surname> <given-names>Y.</given-names></name>
<name><surname>Huang</surname> <given-names>J.</given-names></name>
<name><surname>Sun</surname> <given-names>X.</given-names></name>
<etal/>
</person-group>. (<year>2016</year>). 
<article-title>Ferroptosis: process and function</article-title>. <source>Cell Death Differentiation</source> <volume>23</volume>, <fpage>369</fpage>&#x2013;<lpage>379</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/cdd.2015.158</pub-id>, PMID: <pub-id pub-id-type="pmid">26794443</pub-id>
</mixed-citation>
</ref>
<ref id="B201">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Xu</surname> <given-names>L.</given-names></name>
<name><surname>Li</surname> <given-names>J.</given-names></name>
<name><surname>Wu</surname> <given-names>W.</given-names></name>
<name><surname>Wu</surname> <given-names>X.</given-names></name>
<name><surname>Ren</surname> <given-names>J.</given-names></name>
</person-group> (<year>2024</year>). 
<article-title>Klebsiella pneumoniae capsular polysaccharide: mechanism in regulation of synthesis, virulence, and pathogenicity</article-title>. <source>Virulence</source> <volume>15</volume>, <fpage>24395095</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/21505594.2024.2439509</pub-id>, PMID: <pub-id pub-id-type="pmid">39668724</pub-id>
</mixed-citation>
</ref>
<ref id="B202">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Yan</surname> <given-names>L.</given-names></name>
<name><surname>Wang</surname> <given-names>J.</given-names></name>
<name><surname>Cai</surname> <given-names>X.</given-names></name>
<name><surname>Liou</surname> <given-names>Y.-C.</given-names></name>
<name><surname>Shen</surname> <given-names>H.-M.</given-names></name>
<name><surname>Hao</surname> <given-names>J.</given-names></name>
<etal/>
</person-group>. (<year>2024</year>). 
<article-title>Macrophage plasticity: signaling pathways, tissue repair, and regeneration</article-title>. <source>MedComm</source> <volume>5</volume>, <elocation-id>e6585</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/mco2.658</pub-id>, PMID: <pub-id pub-id-type="pmid">39092292</pub-id>
</mixed-citation>
</ref>
<ref id="B203">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Yang</surname> <given-names>P.-Y.</given-names></name>
<name><surname>Chen</surname> <given-names>W.-X.</given-names></name>
<name><surname>Chang</surname> <given-names>F.-Y.</given-names></name>
<name><surname>Chen</surname> <given-names>H.-W.</given-names></name>
<name><surname>Lin</surname> <given-names>C.-H.</given-names></name>
<name><surname>Hsu</surname> <given-names>Y.-C.</given-names></name>
<etal/>
</person-group>. (<year>2012</year>). 
<article-title>HepG2 cells infected with Klebsiella pneumoniae show DNA laddering at apoptotic and necrotic stages</article-title>. <source>Apoptosis</source> <volume>17</volume>, <fpage>154</fpage>&#x2013;<lpage>635</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s10495-011-0666-1</pub-id>, PMID: <pub-id pub-id-type="pmid">22038342</pub-id>
</mixed-citation>
</ref>
<ref id="B204">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Yang</surname> <given-names>F.-L.</given-names></name>
<name><surname>Yang</surname> <given-names>Y.-L.</given-names></name>
<name><surname>Liao</surname> <given-names>P.-C.</given-names></name>
<name><surname>Chou</surname> <given-names>J.-C.</given-names></name>
<name><surname>Tsai</surname> <given-names>K.-C.</given-names></name>
<name><surname>Yang</surname> <given-names>A.-S.</given-names></name>
<etal/>
</person-group>. (<year>2011</year>). 
<article-title>Structure and immunological characterization of the capsular polysaccharide of a pyrogenic liver abscess caused by Klebsiella pneumoniae: activation of macrophages through toll-like receptor 4</article-title>. <source>J. Biol. Chem.</source> <volume>286</volume>, <fpage>21041</fpage>&#x2013;<lpage>21051</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M111.222091</pub-id>, PMID: <pub-id pub-id-type="pmid">21478151</pub-id>
</mixed-citation>
</ref>
<ref id="B205">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Yang</surname> <given-names>M.</given-names></name>
<name><surname>Zhou</surname> <given-names>X.</given-names></name>
<name><surname>Bao</surname> <given-names>Y.</given-names></name>
<name><surname>Zhang</surname> <given-names>Y.</given-names></name>
<name><surname>Liu</surname> <given-names>B.</given-names></name>
<name><surname>Gan</surname> <given-names>L.</given-names></name>
<etal/>
</person-group>. (<year>2023</year>). 
<article-title>Comprehensive genomic analysis reveals extensive diversity of type I and type IV secretion systems in Klebsiella pneumoniae</article-title>. <source>Curr. Microbiol.</source> <volume>80</volume>, <fpage>2705</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00284-023-03362-5</pub-id>, PMID: <pub-id pub-id-type="pmid">37402963</pub-id>
</mixed-citation>
</ref>
<ref id="B206">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Yao</surname> <given-names>J.</given-names></name>
<name><surname>Sterling</surname> <given-names>K.</given-names></name>
<name><surname>Wang</surname> <given-names>Z.</given-names></name>
<name><surname>Zhang</surname> <given-names>Y.</given-names></name>
<name><surname>Song</surname> <given-names>W.</given-names></name>
</person-group> (<year>2024</year>). 
<article-title>The role of inflammasomes in human diseases and their potential as therapeutic targets</article-title>. <source>Signal Transduction Targeted Ther.</source> <volume>9</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41392-023-01687-y</pub-id>, PMID: <pub-id pub-id-type="pmid">38177104</pub-id>
</mixed-citation>
</ref>
<ref id="B207">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Yoneyama</surname> <given-names>M.</given-names></name>
<name><surname>Fujita</surname> <given-names>T.</given-names></name>
</person-group> (<year>2009</year>). 
<article-title>RNA recognition and signal transduction by RIG-I-like receptors</article-title>. <source>Immunol. Rev.</source> <volume>227</volume>, <fpage>54</fpage>&#x2013;<lpage>655</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1600-065X.2008.00727.x</pub-id>, PMID: <pub-id pub-id-type="pmid">19120475</pub-id>
</mixed-citation>
</ref>
<ref id="B208">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Youle</surname> <given-names>R. J.</given-names></name>
<name><surname>Narendra</surname> <given-names>D. P.</given-names></name>
<name><surname>Manuscript</surname> <given-names>A.</given-names></name>
<name><surname>Hattori</surname> <given-names>N.</given-names></name>
<name><surname>Saiki</surname> <given-names>S.</given-names></name>
<name><surname>Imai</surname> <given-names>Y.</given-names></name>
</person-group> (<year>2014</year>). 
<article-title>Ding WX&amp;Yin XM 2012.Pdf</article-title>. <source>Int. J. Biochem. Cell Biol.</source> <volume>393</volume>, <fpage>9</fpage>&#x2013;<lpage>145</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1515/hsz-2012-0119.Mitophagy</pub-id>
</mixed-citation>
</ref>
<ref id="B209">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Yu</surname> <given-names>Q.</given-names></name>
<name><surname>Yang</surname> <given-names>J.</given-names></name>
<name><surname>Chen</surname> <given-names>H.</given-names></name>
<name><surname>Liu</surname> <given-names>R.</given-names></name>
<name><surname>Hu</surname> <given-names>R.</given-names></name>
<name><surname>Cai</surname> <given-names>J.</given-names></name>
<etal/>
</person-group>. (<year>2025</year>). 
<article-title>Macrophages hijack carbapenem-resistance hypervirulent Klebsiella pneumoniae by blocking SLC7A11/GSH-manipulated iron oxidative stress</article-title>. <source>Free Radical Biol. Med.</source> <volume>230</volume>, <fpage>234</fpage>&#x2013;<lpage>247</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2025.02.019</pub-id>, PMID: <pub-id pub-id-type="pmid">39965717</pub-id>
</mixed-citation>
</ref>
<ref id="B210">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Yu</surname> <given-names>P.</given-names></name>
<name><surname>Zhang</surname> <given-names>X.</given-names></name>
<name><surname>Liu</surname> <given-names>N.</given-names></name>
<name><surname>Tang</surname> <given-names>L.</given-names></name>
<name><surname>Peng</surname> <given-names>C.</given-names></name>
<name><surname>Chen</surname> <given-names>X.</given-names></name>
</person-group> (<year>2021</year>). 
<article-title>Pyroptosis: mechanisms and diseases</article-title>. <source>Signal Transduction Targeted Ther.</source> <volume>6</volume>, <fpage>1285</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41392-021-00507-5</pub-id>, PMID: <pub-id pub-id-type="pmid">33776057</pub-id>
</mixed-citation>
</ref>
<ref id="B211">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Zhou</surname> <given-names>X.</given-names></name>
<name><surname>Yang</surname> <given-names>W.</given-names></name>
<name><surname>Li</surname> <given-names>J.</given-names></name>
</person-group> (<year>2006</year>). 
<article-title>Ca2+- and protein kinase C-dependent signaling pathway for nuclear factor-KB activation, inducible nitric-oxide synthase expression, and tumor necrosis factor-&#x3b1; Production in lipopolysaccharide-stimulated rat peritoneal macrophages*</article-title>. <source>J. Biol. Chem.</source> <volume>281</volume>, <fpage>31337</fpage>&#x2013;<lpage>31475</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0021-9258(19)84046-2</pub-id>, PMID: <pub-id pub-id-type="pmid">16923814</pub-id>
</mixed-citation>
</ref>
</ref-list>
<fn-group>
<fn id="n1" fn-type="custom" custom-type="edited-by">
<p>Edited by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1920053">Chaitenya Verma</ext-link>, Sharda University, India</p></fn>
<fn id="n2" fn-type="custom" custom-type="reviewed-by">
<p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/3301619">Peng He</ext-link>, Sanford Burnham Prebys Medical Discovery Institute, United States</p>
<p><ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1580562">Chunji Ma</ext-link>, Ningxia Vocational And Technical University, China</p></fn>
</fn-group>
</back>
</article>